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Abstract
The present study investigated the in vitro antioxidant and ACE-inhibitory activities 
of egg albumen hydrolysate (EAH) prepared with pepsin and pancreatin enzymes. 
The EAH and peptides were purified by ultrafiltration (UF), gel filtration (GF), and 
High Performance Liquid Chromatography (HPLC) and tested for antioxidant and 
ACE-inhibitory activities. Antioxidant activity was assessed by lipid peroxidation 
inhibition in a linoleic acid system using the ferric thiocyanate (FTC) and 
thiobarbituric acid reactive species (TEARS) methods. The EAH, and 2, 5 and 10 
kDa UF fractions, as well as the GF26 peptide fractions (1 mg/ml) inhibited linoleic 
acid autoxidation, by 40, 76, 63, 53 and 79 % respectively, which was inversely 
related to peptide fraction size. However, 0.01 % butylated hydroxytoluene (BHT) 
and 0.01 % trolox had higher activity (95 and 82 %, respectively) compared with the 
peptide fractions (p<0.05). Similarly, inhibition of TEARS was in the order 29, 39, 
27, 17, 70 and 78 % for EAH, 2 kDa, 5 kDa, 10 kDa, trolox and EHT respectively. 
The putative antioxidant mechanism of EAH involved scavenging activity based on 
the 1, 1-diphenyl-2-picrylhydrazyl (DPPH*), hydroxyl (OH*) and superoxide anion 
(O2 ' ) radical scavenging assays, and ferric (Fe^ )^ reducing and ferrous (Fe^ )^ ion 
chelating activities in a dose-dependent manner. All peptide fractions exhibited ACE- 
inhibitory activity, based on the ACE-catalyzed liberation of hippuric acid from the 
hippuryl-L-histidyl-L-leucine residue, which improved on further GF and HPLC 
purification. The 2, 5 and 10 kDa peptides exhibited % ACE inhibitory activities of 
78, 71 and 62 %, respectively, compared to the positive control captopril (96 %). The 
2, 5 and 10 kDa peptides had IC50 values of 6.01, 6.86 and 7.93 mg/ml respectively. 
Further, GF and HPLC purification of the 2 kDa peptides improved the IC50 values to 
5.76 and 5.13 mg/ml, respectively. Cell viability of human colon carcinoma mono-
I
layer (caco-2) cell line, assayed by the tétrazolium dye (MTT) colorimetric assay 
confirmed that the 2 kDa peptides were not toxic. The 2 kDa peptides (0.1 mg/ml) 
reduced most of the endogenous antioxidant enzyme activities in a dose-dependent 
manner, indicating scavenging of ROS. It was evident that a significant proportion of 
the 2 kDa peptides were resistant to cellular aminopeptidases present in caco-2 cell 
epithelium and were therefore transported in their intact forms across the caco-2 cell 
epithelium. In addition. The 2 kDa peptides exhibited significant ROS scavenging 
activity evidenced by enhanced viability of the Ea.hy926 (HUVECs) cell lines, using 
the lucigenin-enhanced chemiluminescent and fluorescence methods. The results 
confirm that bioactive peptides derived from the EAH have significant antioxidant 
and ACE-inhibitory activities and potentially useful neutraceutical applications.
II
In the name of God, the Most Merciful, 
the Most Compassionate
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CHAPTER 1
1. GENERAL INTRODUCTION AND LITERATURE REVIEW
1.1 Proteins
Proteins are one of the important sets of biological macromolecules with unique 
and versatile properties that contribute to the structure and function of cells in all 
biological processes that maintain life. They are involved in vital cellular activities 
such as metabolic reactions, vesicular transport of micromolecules, replication of 
genetic materials (DNA), immunologic recognition, and responding to cellular stimuli 
(Bock and Gough, 2001; Davies, 2012). In essence, proteins are heteropolymers of a- 
amino acids (polypeptides); where the amino acids as the building blocks are 
covalently linked via peptide bonds as linear chains (Ebeling and Nadler, 1995; 
Davies, 2012). Amino acids are micromolecules consisting of a central (alpha) carbon 
atom linked to an amino or an amine group (R-NH2), a hydrogen atom (-H), a 
carboxyl (-COOH), and a variable ‘R’ group as a side-chain (Fig 1.1 A). The side- 
chains form the distinguishing criteria for the 2 0  amino acids characterised in proteins 
(Berg et al, 2002).
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Figure 1.1 Amino acid condensation reaction showing the formation of a peptide linkage 
with the elimination of a water molecule (Metzler, 2001).
The different atomic groups of amino acids permit biochemical interactions 
between two or more amino acid residues to form dipeptides and the higher-ordered 
polyptides, respectively. Peptides are essentiality metastable covalent bonds formed in 
metabolic pathways when the acidic carboxyl and the basic amide groups of the 
adjacent amino acid residues undergo condensation reaction with elimination of water 
molecules (Fig 1.1 A). The terminal end of the peptides or polypeptides with free a- 
amino group is called the amino-terminus (N-terminus), whereas the carboxyl- 
terminus (C-terminus) is the terminal end with a free carboxyl group (Fig I.IB). The 
long-chained polypeptides are formed by repeated linkages of peptides, where the 
linear amino acid sequence forms the primary protein structure (Berg et al, 2002; 
Davies, 2012).
1.1.1 Protein structure
The structural characteristics of different proteins are influenced by the amino acid 
constituents and amino acid sequence. The side-chains of amino acids exhibit varying 
chemistries due to polar/non-polar states and the prevailing net charge (Davies, 2012). 
While a majority of amino acids have non-polar side chains, some carry net positive 
or negative charges. However, some amino acid side chains are polar but uncharged. 
Therefore, amino acids are classified as polar, non-polar, acidic, basic or neutral 
depending on the polarity and charge on the side-chain substituent (Berg et al, 2002; 
Davies, 2012).
Table 1.1 Amino acid classification according to side chain chemistry (Berg et al, 2002).
Group Characteristics Amino acid
Non- polar Hydrophobic Alanine (Ala), Valine (Val), Leucine 
(Leu), Proline (Pro), Isoleucine (He), 
Phenylalanine (Phe), Tryptophan (Try) 
Methionine (Met)
Polar Hydrophilic Glycine (Gly), Serine (Ser), Cystine 
(Cys), Threonine (Thr), Tyrosine 
(Tyr), Glutamine (Gin), Asparagine 
(Asn)
Acidic Negative (-) charge Aspartic acid (Asp), Glutamic acid 
(Glu)
Basic Positive (+) charge Lysine (Lys), Arginine (Arg), Histidine 
(His)
Amino acid side chains can bond together depending on the prevailing charge. For 
instance, two amino acid side chains; one carrying a positive charge and the other a 
negative charge can form an ionic bond, whereas hydrogen bonding can occur 
between polar side chains (Davies, 2012). However, interactions of amino acid side 
chains rarely involve covalent bonds but rather via the weak van der Waals forces. 
These amino acid chemistries underlie the unique structural and conformational 
characteristics of different types of proteins. The location of amino acids in an amino 
acid sequence, determines where folds occur in given protein and the degree of 
folding. Different amino acid side chains on peptides or proteins confer different 
chemical, physical and structural effects on a given protein (Berg et al, 2002; Davies, 
2012).
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Figure 1.2 Primary, secondary, tertiary and quaternary protein structures (Vasudevan 
et aL, 2013).
Amino acid polarity and net charge are highly versatile since they are highly 
sensitive to extrinsic factors such as pH, temperature, and salinity. This explains why 
protein structure is influenced by the prevailing pH, temperature, and salinity. While 
the linear amino acid sequence forms the primary protein structure, secondary, tertiary 
and quaternary protein structures (Fig 1.2) are formed depending on chemical 
interactions between side chains of amino acids (Berg et al, 2002; Davies, 2012).
1.1.1.1 Primary structure
The long linear amino acid sequence forming a polypeptide chain is the primary 
level of protein structure (Davies, 2012). The peptide bonds in the linear primary 
protein structure are covalent. Depending on the composition and sequence of the L- 
a-amino acid residues, the primary structures of protein are incredibly diverse (Cserzo 
and Simon, 1989). Figure 1.3 shows a linear amino acid sequence forming 
polypeptide chain as the primary protein structure.
Ribonuclease
Figure 1.3 The primary protein structure: a linear peptide chain linked via covalent 
bonds (Garrett and Grisham, 2011).
1.1.1.2 Secondary structure
The intra-moleeular bonding between side chains of amino acids in the primary 
protein structures influences the folding behaviour of proteins to high-ordered shapes 
(Davies, 2012; Huang and Chen, 2013). Consequently, the amino acid sequences in 
the primary polypeptide chains influence the structure and function of the resultant 
secondary proteins. This strongly suggests that it is possible to predict secondary 
protein structure from the amino acid sequence in primary polypeptide chains and the 
protein function (Bock and Gough, 2001; Koga et al, 2012; Huang and Chen, 2013). 
Specific locations of the amino acid residues, side chain sizes, and hydrogen bonding 
reactivity between free amino and carboxyl groups in the adjacent regions of the 
linear primary protein structure, contribute to the specific protein folding 
characteristics (Huang and Chen, 2013). Secondary protein structure (Figl.4) is 
formed when parts containing N-C-C backbone in the primary polypeptide chain 
undergo folding and coiling to form ^-pleated sheets (^-sheets) and a-helix, 
respectively (Koga et al, 2012).
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Figure 1.4 Secondary protein structure: folding and coiling of the linear polypeptide 
chain to form ^-pleated sheets and a-helix secondary protein shapes (Allison, 2007).
1.1.1.2.1 The a-helix
The a-helical structures of protein are polypeptide strands coiled in a right-handed 
fashion such that the side-chains of the involved amino acids extend outwards. The a- 
helieal protein structure is preferentially right-handed sinee this conformation occurs 
under low interaction energy as compared to the left-handed conformation (Kosuge et 
al, 1973; Davies, 2012). The oxygen atom in the carbonyl group (C=0) of each 
peptide bond in the primary polypeptide chain interacts with one of the hydrogen 
atoms of the -NH2 group of the peptide bond within strands, via hydrogen bonding. 
Although the hydrogen bonds are generally weak, they tend to stabilize the helical 
secondary protein structures (Peters and Peters, 1999; Kim and Cross, 2002; Patgiri et 
al, 2 0 1 0 ).
1.1.1.2.2 P-sheets
Unlike a-helical protein structures, the hydrogen bonding, stabilizing the yff-pleated 
protein sheet forms preferably between peptide strands (inter-strand) such that pairs of 
peptide strands are laid side-by-side. The oxygen atom in the carbonyl group of one 
peptide strand undergoes hydrogen bonding with the hydrogen atoms of the amide 
group in the adjacent polypeptide strand (Peters and Peters, 1999). However, 
depending on the directions of the pairing strands with respect to C- and N-terminus, 
the interactions can be parallel or anti-parallel. In this respect, it has been suggested 
that hydrogen bonds in yff-sheets with anti-parallel paring are well-aligned and 
therefore, slightly more stable than parallel yff-sheets (Fig 1.5) as demonstrated by 
Qiang a/. (2012).
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Figure 1.5 Schematic representations of parallel p-sheet, antiparallel p-sheets and the 
right-handed a-helix. Unlike the parallel p-sheet, the peptide chains in the antiparallel p- 
sheet run in opposite directions with respect to C- and N-terminus of the pairing peptide 
chains (Lowik et al., 2010).
1.1.1.3 Tertiary structure
Tertiary protein structures are formed when secondary protein structures of the 
same protein undergo further irregular folding and complexation to form more 
compact and stable structures. Tertiary protein structures are essentially three- 
dimensional (3D) in shape, which is permanently maintained by the intramolecular 
bonds. Therefore, tertiary protein structures are the final specific geometric shape that 
a given protein assumes (Fig 1.6) (Lowik et al., 2010; Qiang et al, 2012).
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Figure 1.6 Tertiary protein structure of myoglobin (Ficher, 2006).
The final 3D shapes of the tertiary protein structures are determined by multiple 
bonding interactions between amino acid side chains. Hydrogen bonds, disulfide 
bonds, and non-polar hydrophobic interactions are the main bonding interaetions 
involved in the formation and stabilization of tertiary protein structures. However, the 
covalent disulfide bonds are largely involved in the stabilization of the tertiary protein 
structures (Carugo et ah, 2003; Lowik et aL, 2010). Disulfide bonds (S-S) are formed 
when sulfhydryl (SH) groups on the side ehains of two cysteine residues undergo 
oxidation to form a disulfide bridge called cystine (Fig 1.7).
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Figure 1.7 Formation of a disulfide bridge (cystine) through oxidation of thiol groups of 
two cysteine residues (Harvey and Ferrier, 2011).
1.1.1.4 Quaternary structure
The quaternary protein struetures are formed when several separately folded 
peptide or protein chains are clustered to form a final protein complex with spécifié 
shape. The final protein structures are determined by different bonding interactions 
particularly, hydrogen bonding, disulfide bonds, and salt bridges. The polypeptide 
subunits in quaternary proteins complexes can be identical or non-identical and may 
involve transition metals as a central atom (Davies, 2012). For instanee, haemoglobin 
is a globular protein made up of four subunits (tetramer) each containing a 
polypeptide chain called globin (two a and two P) and a central heme group (Fig 1.8).
Heme group
Figure 1.8 Haemoglobin quaternary structure: the polypeptide chains are non-identical 
(2 alpha and 2 beta subunits) each with a central haem group (Toole and Toole, 2004).
1.1.2 Separation of proteins and peptides
Different quaternary protein structures have different combinations of polypeptide 
chains. Proteins, polypeptides, peptides and individual amino acids, can be separated 
based on their physicochemical properties partieularly, moleeular size (weight), 
shape, amino acid sequence, hydrophobicity, charge, solubility, and affinity for a 
ligand (Davies, 2012).
1.1.2.1 Molecular Size
Molecular sizes of different proteins, polypeptides, peptides and individual amino 
acids differ and can be therefore, separated based on their sizes in Daltons (Da). 
Separation of proteins based on size is the simplest analytical separation method in 
proteomies. This can be carried out using size exclusion (gel filtration) 
chromatography, dialysis, sedimentation (eentrifugation) and polyacrylamide gel 
electrophoresis (Lodish et al, 2000; Davies, 2012).
1.1.2.2 Charge
Proteins are amphoteric carrying both positive and negative charges. The net 
charge of proteins, polypeptides and peptides depend on the amino acid composition 
or sequence and the prevailing pH. For instance, the pH at whieh the net eharge of a 
protein/peptide is zero (or the Isoelectric Point (pi)) is determined by the proportion 
of the ionisable amino acid residues within its structure (Davies, 2012). Positive 
eharges are contributed by Arg, Lys, and His residues, depending on the pH of the
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surrounding buffer. In addition, free amines at N-termini also contribute to the 
positive eharge under pH conditions of below 8 . On the other hand, negative charges 
are contributed by aspartatic acid and glutamic acid residues coupled with the 
carboxyl groups at the C-termini. Therefore, proteins and their respective subunits can 
be separated based on eharge using ion-exchange chromatography, electrophoresis 
and iso-eleetric focusing techniques (Lodish et al, 2000; Davies, 2012).
1.1.2.3 Solubility and stability
Different proteins and peptides exhibit different solubility properties in different 
solvents which are important for protein purification. The structure and the amino 
acid composition determine the solubility of proteins and peptides. For instanee, in 
most high-order protein structures (tertiary and quaternary), the hydrophilic amino 
acids tend to reside on the protein surface while the hydrophobic amino acids are 
located in the interior of the protein core. This strongly indicates that the proportions 
of hydrophilic and hydrophobic amino acids in a protein or a peptide determine the 
solubility in common polar solvents such as water and alcohol (Pace et aL, 2004).
Proteins and peptides can be separated based on their solubility, which also 
depends on the ionic strengths, pH, and temperature of the polar solvents (Pace et aL, 
2004). For instance, when proteins or peptides are dissolved in polar solvents with 
high ionic strength, addition of salt reduces protein stability, displaces proteins for 
solvation and therefore, precipitates out proteins. Conversely, proteins and peptides 
can be separated based on pH, urea and detergent solubility.
1.1.2.4 Hydrophobicity
Hydrophobicity is a measure of non-polarity and therefore insolubility of a 
molecule in water. Each of the 20 amino aeids has a speeific hydrophobicity, which 
determines their spatial arrangement in protein molecules. The hydrophobic amino 
acid residues (He, Val, Leu, Trp, Pro, Ala and Phe) are spatially located in the protein 
cores, whereas the hydrophilic (polar) amino acids (Arg, Asn Asp, Cys, Glu, Gin, 
Gly, His, Thr and Tyr) tend to reside on the surface of protein molecules (Davies,
2012). Therefore, it appears that hydrophobicity of amino acids in proteins also
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contribute significantly to the overall folding behaviour of proteins (Moelbert et al, 
2004). Therefore, proteins and peptides can be separated based on their 
hydrophobicity differences using two different techniques: hydrophobic interaction 
chromatography (HIC) and reversed-phase chromatography (RPC). In both HIC and 
RPC, the analyte proteins are retained differently in the chromatographic columns 
based on their hydrophobicity (Lodish et al, 2000; Davies, 2012).
1.1.2.5 Affinity
Proteins and peptides bring about their speeific biological function through specific 
chemical interactions with other molecules acting as ligands with different affinities. 
The interacting proteins/peptides have unique binding sites corresponding to the 
binding surfaces of their specific ligands. The binding affinities of different 
proteins/peptides to biospecific ligand are contributed by the electrostatic 
(hydrophobic) interactions coupled with hydrogen bonding and the van der Waals 
forces. Therefore, separation of proteins/peptides based on their respective biological 
affinities can be achieved using affinity chromatography, free ligand-beads- 
centrifugation, ligand-magnetic-beads, and immuno-assays on solid supports (Davies, 
2012).
For instance, in affinity chromatography, an analyte protein sample is loaded onto 
a chromatographic column containing a polymer-bound ligand for a specific protein 
of interest. The analyte protein samples are allowed to interact with the ehosen 
ligands where the protein of interest binds reversibly to the ligand while the unwanted 
proteins (not interacting with the ligand) are washed through the eolumn. The protein 
of interest is then eluted from the column by breaking the protein-ligand interaction 
using a ligand solution (Lodish et al, 2000; Davies, 2012).
1.2 Bioactive peptides
Biologically active (bioactive) peptides are speeific short chain polypeptide 
fragments that confer positive physiologieal effect on the functioning of animals. As 
signalling molecules, bioactive peptides also confer modulatory effects of disease 
pathogenesis and therefore, influence health positively beyond their basic role in
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human nutrition (Korhonen and Pihlanto, 2006; Perez-Espitia et al, 2012). They are 
usually short-chained peptides (oligopeptides) with amino acid residues of between 3- 
16 units. Their bioactivity is principally influenced by the amino acid composition, 
sequence and peptide size.
The health benefits of bioactive peptides are due to their different in vivo 
protective effects as antimicrobials (Agyei and Danquah, 2012), antioxidants, 
anticancer, hypoeholesterolemie, anticalmodulin (Alouglu and Oner, 2011; Udenigwe 
and Aluko, 2012), antihypertensive, cytomodulatory, and immunomodulatory 
(Danquah and Agyei, 2012; Perez-Espitia et al, 2012).
1.2.1 Production of bioactive peptides
It is now well recognized that most dietary proteins are rich sources of bioactive 
peptides, which occur as inactive prepropeptides within the sequences of parent 
proteins. They can be activated and released through hydrolytie activities of digestive 
enzymes, proteolytie enzymes and microorganisms (Korhonen and Pihlanto, 2006). 
Essentially, bioactive peptides can be produeed in vitro from preeursor dietary 
proteins in three ways: hydrolytic digestive enzymes, proteolytic fermentation 
bacteria (proteolytic starter cultures) and proteolytic enzymes purified from plants or 
mieroorganisms (Korhonen and Pihlanto, 2006). Bioactive peptide chains typically 
contain 3-20 amino acid residues (Shahidi and Zong, 2008). However, diverse short- 
chained bioactive peptides can be produced through combined hydrolytic and 
proteolytic activities of digestive enzymes and mieroorganisms (Korhonen and 
Pihlanto, 2006).
1.2.1.1 Enzymatic production of bioactive peptides
In vitro enzymatic production of bioactive peptides ean be aehieved through 
enzymatic hydrolysis, enzyme-catalyzed proteolytic fermentation and thermal food 
processing (Korhonen and Pihlanto, 2006; Udenigwe and Aluko, 2012; Kim et al,
2013). In vivo release of bioactive peptides occurs in the digestive tract of humans 
after dietary protein intake (Udenigwe and Aluko, 2012).
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1.2.1.1.1 Enzymatic hydrolysis
Parent protein molecules ean yield several bioaetive peptides when subjected to 
enzymatic hydrolysis. In vivo hydrolysis of dietary proteins in the gastrointestinal 
tract is aided by gastrointestinal proteolytic enzymes particularly; pancreatic enzymes 
(trypsin, chymotrypsin, and aminopeptidases) and pepsin. Pepsin and trypsin have 
been identified as the most efficient gastrointestinal enzymes in the production of 
short-chained bioaetive peptides (Korhonen and Pihlanto, 2006; Udenigwe and 
Aluko, 2012).
For instanee, angiotensin-converting enzyme inhibitory (ACEI) peptides are key 
antihypertensive bioaetive peptides eommonly produced by the hydrolytic activity of 
trypsin (Korhonen and Pihlanto, 2006). ACE-inhibitory peptides have been 
extensively isolated and purified from tryptic protein hydrolysates of milk casein, egg 
yolk, fish, whey protein, porcine blood and skeletal muscle, seal protein, canola 
protein (Shahidi and Zong, 2008; Wei and Chiang, 2009; Ryan et al, 2011). 
Individual or combinations of digestive enzyme such as pepsin, chymotrypsin, 
pancreatin, alcalase, and thermolysin have also good hydrolytic activities that can 
yield hydrolysates with diverse short-chained bioaetive peptides fi”om various dietary 
proteins (Korhonen and Pihlanto, 2006).
1.2.1.1.2 Proteolytic microbial fermentation
Most of the starter and non-starter cultures used in the dairy industry are proteolytic 
in nature and ean therefore, enrich processed dairy produets with bioaetive peptides. 
For instance, starter and non-starter cultures of the Lactobacillus helveticus, L. 
plantarum, L. acidophilus, L. rhamnosus, L. lactis, L. delbrueckii ssp. bulgaricus, and 
Streptococcus thermophilus used in the production of fermented dairy products 
consist of proteinases including intracellular peptidases, endopeptidases, dipeptidases, 
aminopeptidases and tripeptidases, which are involved in the initiation steps of 
proteolysis. These proteolytic enzymes catalyse the degradation of milk easein to 
oligopeptides, which can undergo further proteolysis by the highly proteolytic strains 
of lactic acid bacteria (LAB) to yield hydrolysates with diverse bioaetive peptides in 
fermented dairy products (Korhonen and Pihlanto, 2006).
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Various antihypertensive, antioxidative immunomodulatory, antimutagenic 
peptides have been purified from milk casein hydrolysates fermented with microbial 
proteolysis (Korhonen and Pihlanto, 2006; Pihlanto, 2013).
1.2.1.1.3 Food processing
Thermal food processing can result in enhanced thermolysis of dietary proteins 
into bioaetive peptides perhaps by enhancing interactions between thermolysin 
enzymes and proteins due to thermal-activated protein unfolding (Udenigwe and 
Aluko, 2012). Hydrostatic pressure and sonieation pre-treatments of proteins during 
food proeessing can also enhance the release of bioaetive peptides (Lei et aL, 2011; 
Piccolomini et al, 2012; Udenigwe and Aluko, 2012). Sonieation promotes 
proteolytie aetivity of thermolysin enzymes by inereasing the reactivity of sulphydryl 
groups in the processed proteins and, therefore, increasing the release of bioaetive 
peptides (Lei et aL, 2011).
1.2.2 Extraction, fractionation and enrichment of bioaetive peptides
There are several tools for extraction and fractionation of peptides derived from 
dietary proteins, based on the physical, chemical and structural properties of proteins 
particularly molecular weight, solubility, hydrophobicity, and isoelectric point (pi) 
(Martinez-Maqueda et aL, 2013). The three key fractionation techniques for food 
proteins and peptides include ultrafiltration, gel-filtration and Reversed Phase High- 
Performance Liquid Chromatography (RP-HPLC) (Lodish et al, 2000).
1.2.2.1 Ultrafiltration
Ultrafiltration is ideal for fraetionating peptides and separating proteins and other 
micromolecules based on their molecular weight because they neither require sample 
dilution nor organic solvents (Martinez-Maqueda et al, 2013). The dedicated 
ultrafiltration membranes for fractionation and concentration of peptides are typically 
made of polysulfone or cellulose derivatives. The cellulose-based ultrafiltration 
membranes are advantageous over polysulfone membranes because they exhibit 
excellent hydrophilicity, which minimizes fouling. However, cellulose-based
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membranes have low chemical resistance and mechanical strength as compared to 
polysulfone membranes (Doyen et al, 2011). Ultrafiltration membranes are available 
eommercially in wide range of molecular weight cut-offs (500-1 kDa). Fractionation 
of peptides from protein hydrolysates has been aehieved using ultrafiltration 
membranes of different molecular weight cut-offs (10, 5, and 2 kDa) (Chiang et al, 
2006; Samaranayaka et al, 2010).
1.2.2.2 Gel filtration
Gel filtration ehromatography also called size exelusion chromatography (SEC) 
allows continuous separation of oligonucleotides, peptides, and proteins based on 
their moleeular weights as they pass through gel filtration column using both mobile 
and stationary phases. Low moleeular weight molecules diffuse deeper into the 
porous beads in the gel filtration medium and therefore move down the eolumn more 
slowly (Lodish et al, 2000). In contrast, high molecular weight molecules diffuse 
poorly into the porous beads and therefore move down the column through the void 
volume more rapidly. Therefore, molecules are eluted over time from the highest to 
the lowest molecular weight analytes (Lodish et al, 2000; Ly and Wasinger, 2011).
Resins used in gel filtration chromatography come in different pore sizes, which 
determine the fractionation range. For instance, the Sephadex G25 column contains 
cross-linked dextran resins that can fractionate peptides with molecular weight range 
of 0.5-5 kDa, while Sephadex G25 eolumn is only adequate for small peptides, which 
are below 0.7 kDa in size (Poliwoda and Wieczorek, 2009; Mora et al, 2011). 
Importantly, analyte peptides can be eluted through the gel filtration eolumn with 
water, ammonia (or ammonium salts), and organic acids depending on resin 
composition (Lodish et al, 2000; Mora et al, 2011).
1.2.2.3 Reversed Phase High-Performance Liquid Chromatography
The reversed Phase High-Performance Liquid Chromatography (RP-HPLC) 
technique can separate peptide molecules based on their polarity interactions with a 
hydrophobic matrix, which correspond to their amino acid composition (Josic and 
Kovac, 2010). The hydrophobic matrix comprises spherical porous silica beads (3-5p)
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with linear oetadecylsilane groups (Cl8 ) attached to the surface via covalent bonds. 
The C l8  groups are highly non-polar and bind to polar molecules like charged peptide 
moleeules in the presence of a highly polar solvent (such as water). Charged peptide 
moleeules bind to the hydrophobie matrix in an aqueous buffer and can then be eluted 
from the matrix with a gradient of organic solvent in water. Aeetonitrile containing 
0.1 % TFA is frequently used as a gradient elution buffer. The polar peptides are 
eluted first whereas the non-polar peptides are eluted later (Josic and Kovac, 2010; 
Kamysz et al, 2004).
1.2.3 Physiological function of bioaetive peptides derived from food
Once absorbed through the intestine into the blood cireulatory system in their intact 
forms, individual bioaetive peptides can independently exert various physiological 
effects and therefore, act as metabolic modulators (Ryan et al, 2011; Shahidi and 
Zhong, 2008). The specific physiological effects that bioaetive peptides are 
influenced by the amino acid composition and sequence (Shahidi and Zhong, 2008). 
Furthermore, physiological effects of each bioaetive peptide are hormone-like 
suggesting that their activities are dependent on their respective blood concentration. 
The putative physiological effects of bioaetive peptides have been extensively 
documented to confer antihypertensive, antioxidant, antihypercholesterolemic and 
antiearcinogenie effeets (Alouglu and Oner, 2011; Shahidi and Zhong, 2008; 
Udenigwe and Aluko, 2012).
1.2.3.1 Antioxidative peptides
Endogenous generation of reactive oxygen species (ROS) and oxygen free radicals 
during normal metabolic processes underlie the pathogenesis of degenerative 
disorders including carcinogenesis, due to oxidative stress build-up (Kim et al, 2013; 
Ma et al, 2010). However, the deleterious effects of ROS and oxygen free radicals 
can be minimised through quenching activity of endogenous and exogenous 
antioxidants (Kim et al, 2013). Protein hydrolysates from various plant and animal
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proteins have been shown to confer notable antioxidative effects suggesting the 
presence of specific peptides with antioxidant activity (Siow and Gan, 2013).
Antioxidant peptides are bioaetive peptides with antioxidation activity and are 
present in both animal and plant proteins (Elias et al, 2008; Puchalska et al, 2014). It 
has been extensively documented that proteins as antioxidants can generally inhibit 
lipid peroxidation by scavenging free radicals, act as chelators of pro-oxidative 
transition metal ions, reducing hydroperoxides (Wu et al, 2003; Puchalska et al,
2014). Therefore, the antioxidant activities of proteinaceous antioxidants are due to 
the bioaetive peptides rather than the intact protein molecules. Antioxidant peptides, 
therefore contribute significantly to the endogenous dietary antioxidant capacity (Wu 
et al, 2003; Elias et al, 2008).
The overall antioxidative power of proteins can be enhaneed by disruption of their 
tertiary structures to increase accessibility of the antioxidant amino acid residues. 
Therefore, hydrolytic degradation of proteins appears to be the most efficient strategy 
for producing proteinaceous antioxidants (Elias et al, 2008). Bioaetive peptides with 
antioxidant activities are usually short-chained (3-10 amino acid residues) with 
specific amino acid sequences (Gomez-Ruiz et al, 2008; Ma et al, 2010). For 
instance, a novel antioxidant peptide derived fi'om Riiditapes philippinarum (a marine 
mollusc) was found to have an amino acid sequence of Ser-Val-Glu-Ile-Gln-Ala-Leu- 
Cys-Asp-Met (Kim et al, 2013). The high antioxidative activity of goat milk casein 
hydrolysates has been attributed to five antioxidant oligopeptides with different amino 
acid sequence Tyr-Val-Pro-Glu-Pro-Phe, Val-Tyr-Pro-Phe, Phe-Pro-Tyr-Cys-Ala-Pro, 
Tyr-Pro-Pro-Tyr-Glu-Thr-Tyr, and Phe-Gly-Gly-Met-Ala-His (Li et al, 2013). A 
recent study attributed the antioxidant activity of oligopeptides to the presence of 
specific amino acid residues: Tyr, Trp, Met, Lys, Pro, Cys, His, Val and Leu the 
majority being essential amino acids (Coda et al, 2012).
1.2.3.2 Antihypertensive peptides
Hypertension, defined as blood pressure (BP) exceeding 140/90 mm Hg, affects 
over 30 % of adult populations worldwide. It is associated with increased risk of
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cardiovascular diseases such as coronary heart disease, stroke, arteriosclerosis and 
kidney failure, which translates to more than 7.6 million deaths each year (Chow et 
al, 2013). While synthetic antihypertensive drugs with excellence potency are 
available, it has been recognised over the last decade that apart from their basie 
nutritional benefits, many dietary proteins contain different bioaetive peptides 
encrypted within the primary protein sequence (Hernandez-Ledesma et al, 2011). 
Some of the putative bioaetive peptides exhibit antithrombotic and antihypertensive 
aetivity that would confer protective benefit against hypertension. Consequently, 
antihypertensive peptides from dietary protein sources are the most widely studied 
bioaetive peptides and have received speeial attention in the past 15 years (Shahidi 
and Zhong, 2008; Hernandez-Ledesma et aï. 2011; Martinez-Maqueda et al, 2012).
Numerous studies have eharacterised, isolated and purified the putative 
antihypertensive peptides from plant and animal proteins. Antihypertensive peptides 
have been isolated from plant sources sueh as buekwheat {Fagopyrum esculentum) 
(Koyama et al, 2013), soybean protein (Mallikarjun et al, 2006; Vallabha and Tiku,
2013) and animal proteins such as fish (Kim et al, 2012), chicken meat (Nakade et 
al, 2008) and chicken egg (Miguel and Aleixandre, 2006). The putative 
antihypertensive activity of most these food-derived peptides have been demonstrated 
in vivo using animal models and humans (Martinez-Maqueda et al, 2012).
1.2.3.3 Antihypercholesterolemic peptides
Antihypercholesterolemic peptides confer cholesterol-lowering effects by 
suppressing accumulation of plasma cholesterol and stimulating fecal excretion of 
steroid (Wang et al, 1995). It is extensively documented that the undigested fraction 
of soy protein confers cholesterol-lowering effects and lowers the risk of 
atherosclerosis (Wang et al, 1995; Jenkins et al, 2000; Jenkins et al, 2000). This 
strongly suggests that soy protein hydrolysates contain antihypercholesterolemic 
peptides. Sulphur-containing amino acid residues, particularly, methionine and 
cystine have been suggested to contribute to antihypercholesterolemic peptides (Oda, 
2006). The two amino acid residues have been demonstrated to lower plasma 
cholesterol in hypercholesterolemic rats and mice (Itokawa et aL, 1973; Tomotake et 
aL, 2001). While the sulphur-containing amino acid residues confer cholesterol-
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lowering effects, the antihypercholesterolemic peptides from dietary proteins are 
poorly characterised.
1.2.3.4 Antiearcinogenie peptides
Mutations in the genomic DNA underlie carcinogenesis. It occurs following 
irreparable DNA-damage induced by excessive cellular oxidative stress, chemical 
pollutants and ionizing radiation. While animal cells are constantly at risk of cancer, 
there are a variety bioaetive peptides from dietary sources with antimutagenic 
properties and therefore, conferring antiearcinogenie effects. Various in vitro studies 
have demonstrated that peptides from milk casein hydrolysates have antimutagenic 
properties and suppress tumour development (Tellez et al, 2010). The antimutagenic 
properties of milk casein hydrolysates have been attributed to a high proportion of 
cystine-cysteine and y-glutamylcysteine dipeptides, which are efficient precursors of 
for the synthesis of glutathione, a highly potent cellular antioxidant that quenches 
oxidative potential reactive oxygen species, detoxifies carcinogens and inhibit the 
mutagenic activity of carcinogens (Parodi, 2007). For instance, whey protein 
components particularly a-lactalbumin and p-lactoglobulin have been demonstrated to 
increase intracellular glutathione levels by converting cysteine to glutathione and 
therefore, confer antiearcinogenie effects (Tsai et al, 2000; Marshall, 2004). One of 
the milk casein peptide with amino acid sequence, Tyr-Val-Pro-Phe-Pro (fl58-162) 
has been shown to inhibit the proliferation of the T47D human breast cancer cell-line 
in a dose-dependent manner (Kampa et al, 1996).
1.3 Egg albumen
The egg albumen (egg white) and egg yolk aecount for approximately 60 and 30 % 
of the egg, respectively. Egg white exhibits unique physicochemical properties owing 
to the diverse amino aeids and mineral elements it contains (Campbell et al, 2003).
1.3.1 Physicochemical and functional properties of egg albumen protein systems
The egg albumen contains a complex mixture of proteins particularly ovalbumin, 
ovotransferrin, ovomucoid, ovomucin, lysozyme, G2 globulin, G3 globulin, 
ovoinhibitor, ovoglycoprotein, ovoflavoprotein, ovomacroglobulin, and cystatin
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among others (Mine, 1995; Campbell et aL, 2003; Miguel and Aleixandre, 2006; 
Abeyrathne et aL, 2013). These proteins are typically globular proteins, with varying 
physieochemical and functional properties that are critical for the preparation of 
various food products (Mine et al, 1990). Ovalbumin accounts for over 50 % of egg 
albumen proteins and contributes signifieantly to the physicochemical and functional 
properties of egg albumen (Campbell et aL, 2003).
These globular proteins undergo dénaturation when subjected to physical changes 
(sueh as heating and high pressure) or chemicals (acids, salts and enzymes). 
Dénaturation of the globular proteins essentially involves unfolding of the high- 
ordered protein structure to a different conformational state (Babu and Bhakuni, 1997; 
Aral and Hirai, 1999; Campbell et aL, 2003). During protein dénaturation, the 
unfolding of secondary structure of egg white proteins exposes the “buried” 
hydrophobic sulfhydryl groups, suggesting a decrease and an increase in a-helix and 
P-sheet components, respectively (Handa and Kuroda, 1999; Campbell et aL, 2003; Li 
et aL 2004). This results in redueed functionality properties of egg albumen proteins 
particularly solubility, coagulation, gelation, émulsification and water-binding 
properties (Campbell et aL, 2003).
Thermal coagulation is one of the most important functional properties of egg 
albumen (Mine et aL, 1990). For instance, thermally denatured egg albumen proteins 
exhibit irreversible loss of solubility and therefore readily undergo protein 
precipitation or coagulation (Arai and Hirai, 1999; Campbell et aL, 2003). Thermally 
denatured egg albumen proteins have partially unfolded struetures, whieh allow 
interaction of side chains under favourable chemieal conditions to form mixed protein 
complexes. For instance, aggregation of polypeptides from different globular egg 
white proteins was observed at eoagulation temperature ranges of 61.5 °C -  62.5 °C 
and 71.0 °C -  73.0 °C (Campbell et aL, 2003). Thermally denatured egg albumen 
proteins have relatively high proportion of hydrophobic amino acids in the unfolded 
polypeptide chains (Mine et aL, 1990; Campbell et aL, 2003).
Similarly, ionic strength and pH can influence the functionally of egg albumen 
proteins. For instance, egg albumen protein complexes form soluble protein
20
aggregates in aqueous solutions of low ionic strength and alkaline pH (Mine et aL, 
1990).
1.3.2 Nutritional composition of egg albumen
A whole egg is essentially a eomplex mixture of nutrients particularly proteins, 
cholesterol and fat. Avian eggs are important sources of proteins and dietary nitrogen 
in human nutrition. Egg albumen contains significant nutritional composition similar 
to the egg yolk (Campbell et aL 2003; Miguel and Aleixandre, 2006). The total solid 
component of the egg albumen is only 10.6-12.1 % dissolved and suspended in 87.9-
89.4 % of water. The solid egg albumen portion includes 9.7-10.6 % protein, 0.03 % 
lipids, 0.4-0.9 % carbohydrates, and 0.5-0.6 % ash. The 0.4-0.9 % of total 
carbohydrates exists in free form or eonjugated in proteins (Mine, 1995; Campbell et 
aL, 2003; Abeyrathne et aL, 2013). This strongly indicates that the protein component 
forms the bulk of the total solids in egg albumen. The egg white also contains 
minerals, vitamins, antioxidants, lipids and fats. However, egg albumen contains less 
than 0.01 % of total lipids (Mine, 1995). Table 1.2 shows composition of proteins, 
lipids and carbohydrates in the egg albumen, yolk and whole egg.
Table 1.2 Composition of egg albumen, egg yolk, and whole egg (Miguel and Aleixandre, 
2006).
Egg component Protein Lipid Carbohydrate
Albumen(g/100 g) 9.7-10.6 0.03 0.4-0.9
Yolk (g/lOOg) 15.7-16.6 31.8-35.5 0 .2 - 1 . 0
Whole egg (g/100 g) 12.8-13.4 10.5-11.8 0.3-1.0
1.3.2.1 Proteins
Egg white is a rich source of proteins. More than 24 different proteins have been 
isolated and purified form egg white (Mine, 1995). However, ovalbumin, 
ovotransferrin, ovomueoid, ovomucin and lysozyme are major proteins while G2 
globulin, G3 globulin, ovoinhibitor, ovoglycoprotein, ovoflavoprotein, 
ovomacroglobulin, and cystatin are minor protein components of egg albumen (Mine, 
1995; Miguel and Aleixandre, 2006; Abeyrathne et aL, 2013). The protein
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composition of egg albumen and their selected physicochemical properties are shown 
in table 1.3.
Table 1.3 Proteins in egg albumen with selected physicochemical properties (Miguel and 
Aleixandre, 2006).
In
albumen
(%)
Isoelectric 
Point (pi)
Molecular 
mass (kDa)
Dénaturation 
Temp. (°C)
Protein
Characteristics
Ovalbumin 54 4.5 44.5 84.0 Phosphoglycoprotein
Ovotransferrin 1 2 6 . 1 77.7 61.0 Binds transition metal- 
cations
Ovomucoid 11 4.1 28 79.0 A trypsin inhibitor
Ovomucin 3.5 4.5-5.0 5500-8800 ■— Sialoprotein, viscous
Lysozyme 3.4 10.7 14.3 75^ Destroys cell walls of 
Gram(-) bacteria
Gz globulin 4.0 5.5 30-45 925 —
G3 globulin 4.0 4.8 — — — '
Ovoinhibitor 1.5 5.1 49 — Inhibits serine- 
proteases
Ovoglycoprotein 1 . 0 3.9 24.4 — Sialoprotein
Ovoflavoprotein 0 . 8 4.0 32 — Binds riboflavin
Ovomacroglobulin 0.5 4.5 770 •— - Strongly antigenic
Gy statin 0.05 5.1 12.7 — Inhibits thiol-proteases
Avidin 0.05 1 0 6 8 J 85 Binds biotin
Ovalbumin is the most abundant protein aceounting for about 54 % of the total 
albumin proteins. Furthermore, it exhibits the highest dénaturation temperature 
threshold (84 °C) suggesting that it undergoes less dénaturation during eooking. 
When heated to above its dénaturation temperature, it forms a thermally stable S- 
ovalbumin (Mine, 1995; Miguel and Aleixandre, 2006). The peptide ehain of 
ovalbumin from hen egg eomprises 385 amino acid residues with overall molecular 
weight of =44.5 kDa. It is the only albumen protein that contains free thiol groups (- 
SH) in its structure (Fig 1.9). Importantly, ovalbumin is conjugated with some 
albumen earbohydrates and phosphates to form spherical phosphoglycoprotein 
structures. Serine residues at position 6 8  and 344 of the peptide ehain have OH- 
groups esterified by the phosphorie acid while an oligosaecharide is conjugated to the 
side chain of Asp-292 (Mine, 1995).
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Figure 1.9 3D crystal structure of ovalbumin with a-helix (green) and p-sheet (in red) 
(Stein et ciL, 1991).
The proportion of ovotransferrin in egg albumen (12 %) is second to ovalbumin. 
Ovotransferrin, also called conalbumin, is an iron-binding protein with a MW of 77.7 
kDa. The peptide chain of chicken ovotransferrin comprises of 6 8 6  amino acid 
residues with a total of 15 disulfide bridges. It also contains mannose and N- 
acetylglucosamine residues as a single glycan ehain within the C-terminal domain 
suggesting that it is conjugated with some albumen carbohydrates (Miguel and 
Aleixandre, 2006; Mine, 1995). Unlike ovalbumin, which has a spherical structure, 
ovotransferrin structure is bilobal; consisting of two homologous lobes at the N- 
terminus (N-lobe) and C-terminus (C-lobe). The protein structure is further stabilised 
by two-iron cations- (or other transition metal-cations) as central atoms (Fig 1.10). 
When stabilised with iron cations, ovotransferrin exhibits bacteriostatic activity 
particularly against Salmonella enteritidis (Kurokawa et al, 1995; Mine, 1995; 
Miguel and Aleixandre, 2006).
Figure 1.10 3D crystal structure of chicken egg ovotransferrin (Rawas et at., 1996).
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Ovomucoid or trypsin inhibitor accounts for 11 % of albumen protein. It comprises 
about 186 amino acid residues and is highly glycosylated with glycogen found in egg 
albumen and therefore, a glycoprotein (Miguel and Aleixandre, 2006). However, 
depending on the amount of glycogen bonded via the Asp residue, ovomucoid occurs 
in various forms (Salahuddin and Baig, 1985; Mine, 1995). Chicken egg ovomucoid 
has nine disulfide bridges without free -SH groups. It has a relatively stable spatial 
structure and a high dénaturation temperature threshold (77 °C) due to high content 
composition (>80 %) of helical and (3-pleated sheet structures. Ovomucoid is not 
denatured even when boiled at temperatures above 1 0 0  °C under acidic conditions. 
Importantly, it has three domains that are homologous to the pancreatic trypsin 
inhibitor (Mine, 1995). However, ovomucoid is highly immunogenic and therefore, 
has been attributed to cases of egg allergy (Caubet and Wang, 2011).
Ovomucin accounting for only 3.5 % of the albumen protein is the largest in 
molecular weight (5000-8000 kDa). Its peptide chain is heavily conjugated with a 
variety of carbohydrates: hexoses, glactosamine, glucosamine, and sialic acid. It is 
referred to as sialoprotein since it has a greater proportion of sialic acid (Miguel and 
Aleixandre, 2006). Furthermore, the substantial portion of -OH groups in the side 
chains of the amino acid residues are esterified with sulphuric acid (Mine, 1995). 
They tend to aggregate to form filamentous and fibroid structures owing to their polar 
nature. The high viscosity and gel-like properties of the egg white is due to the high 
molecular weight and aggregation property of ovomucin (Mine, 1995; Omana et al, 
2010).
Lysozyme also called mucopeptide N-acetylmuramoylhydrolase (EC 3.2.1.17) is 
another important egg white protein with notable enzyme activity. It has the lowest 
molecular weight of 14.3 kDa and comprises of 129 amino acid residues with four 
disulfide bridges (Mine, 1995; Vocadlo et al, 2001). The compact globular structure 
of lysozyme (Fig 1.11) is fabricated fi'om a-helices, p-pleated sheets, p-turns, random 
coils, and the four-disulfide bonds (Vocadlo et al, 2001). The enzyme can cleave 
specific bonds polysaccharides of cell wall components of many Gram-negative 
bacteria by hydrolyzing the 1,4-beta-linkages between N-acetylmuramic acid and the 
N-acetyimuramoylhydrolase of peptidoglycanin the bacterial cell wall (Mine, 1995).
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This could partly explain the antibacterial activity of lysozyme that is protective 
against infeetion to the growing embryo (Mine, 1995; Vocadlo et al., 2001; Miguel 
and Aleixandre, 2006).
Figure 1.11 3D structure of hen egg white lysozyme (Knubovets et al, 1999).
1.3.2.2 Amino acids
Egg albumen contains nearly all the essential and non-essential amino acids 
required in the human body for growth and tissue repair (King'ori, 2012). Being the 
most abundant albumin protein, ovalbumin generally contains the highest 
composition of essential and non-essential amino acids by weight (Table 1.4). 
However, while ovomucoid and lysozyme composition in egg albumen is comparable 
(3.5 and 3.4%, respectively), lysozyme contains the higher amino acid composition 
than ovomucoid. This is because the molecular weight of lysozyme (14.3 kDa) is 
almost half that of ovomucoid (28 kDa), therefore peptide chains are tightly packed 
with many amino acids.
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Table 1.4 Amino acid composition in g per 100 grams of some of major albumen 
proteins (Messier, 1991).
Ovalbumin Ovotransferrin Ovomucoid Lysozyme
Ala 6.72 4.4 2.3 5.4
Val 7.05 8.2 6.0 4.8
Leu 9.2 8.8 5.1 6.9
He 7.0 5.0 1.43 5.2
Pro 3.6 4.9 2.72 1.4
Phe 7.66 5.7 2.91 3.12
Try 1.20 3.0 0.3 10.6
Meth 5.2 2.03 0.95 2.06
Tyr 3.68 4.6 3.18 3.6
Gly 3.05 5.7 3.8 5.7
Ser 8.15 6.3 4.2 6.7
Thr 4.03 5.9 5.5 5.5
Cys 1.35 - - 0.00
Cystine 0.51 3.8 6.7 6.8
Asp + Glu 1.02 1.04 1.0 1.71
Arg 5.72 7.6 3.7 12.7
His 2.35 2.57 2.15 1.04
Lysine (+) 6.30 10.0 6.0 5.7
Aspartate 9.30 13.3 13.0 18.2
Glutamate 16.50 11.9 6.5 4.32
1.3.2.3 Mineral elements and vitamins
Chicken egg albumen also contains important mineral elements and vitamin 
complexes required for enhancing human health. It contains essential mineral 
elements, particularly manganese, iron, copper, zinc, phosphorus, iodine, and 
selenium (Goran et al, 2010). It is an excellent source of iodine, required for 
endocrine production of thyroid hormone. Its high selenium content contributes to the 
antioxidative property of egg proteins. Phosphorus present in egg albumen is required 
for healthy bones, while zinc is important for wound healing. Egg albumen contains 
most vitamins except vitamin C. The vitamins include mainly vitamin A, D, B2, B6 
and traces of vitamin B12 complexes.
1.3.3 Bioactive peptides derived from egg albumen
1.3.3.1 Antioxidant peptides
Egg albumen protein hydrolysates have been shown to have antioxidant activity, 
suggesting the presence of an antioxidant peptide fraction. The antioxidant activity of
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egg albumen peptides depends on the type and the sequence of amino acids 
(Wiriyaphan et al., 2012). The antioxidant activities of some bioactive peptides have 
been attributed to the following amino acid residues: His, Tyr, Met, Lys, Trp, Cys, 
Phe and Pro. These amino acids have side chain groups which serve as hydrogen 
donors that quench the oxidative radical and non-radical ROS (Udenigwe and Aluko, 
2011; Wiriyaphan et al., 2012). For instance, a nonapeptide (Tyr-Ala-Glu-Glu-Arg- 
Tyr-Pro-Ile-Leu), containing two Tyr amino acid residues and a pentapeptide (Tyr- 
Leu-Gly-Ala-Lys) containing Tyr and Lys amino acid residues were isolated from egg 
albumen protein hydrolysates. The two oligopeptides were subsequently shown to 
exhibit in vitro antioxidant activity (Davalos et al., 2004; Chen et al., 2012).
1.3.3.2 Antihypertensive peptides
Egg albumen hydrolysates have diverse bioactive pepides, most of which have 
antihypertensive bioactivity. A peptide with eight amino acid residues (octapeptide) 
with an amino acid sequence of Phe-Arg-Ala-Asp-His-Pro-Phe-Leu was originally 
fractionated from egg albumen hydrolysates. The peptide fragment 358-365 called 
ovokinin was found to correspond to a similar peptide in ovalbumin, the major egg 
albumen protein. The octapeptide was observed to exert antihypertensive and direct 
endothelium-dependent vasodilative effects (Fujita et al, 1995). When administered 
to spontaneously hypertensive rats, the octapeptide exerted an antihypertensive effect 
in a dose-dependent manner (Fujita et al, 1995).
Another antihypertensive peptide fragment enzymatically derived from egg 
albumen contained six amino acid residues. The hexapeptide amino acid sequence 
Arg-Ala-Asp-His-Phe-Leu appears to be a sub-fragment of ovokinin, since when 
purified it was observed to correspond to the amino acid residues 359-364 of 
ovalbumin (Matoba et al, 1999). Just like ovokinin, the hexapeptide exerted 
endothelium-dependent vasodilation of the mesenteric arteries when administered by 
gavage to spontaneously hypertensive rats.
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Inhibition of the angiotensin I-converting enzyme (ACE) explains the 
antihypertensive benefits of these bioactive peptides derived from egg albumen 
hydrolysates. It was recently demonstrated that pepsin hydrolysates of major egg 
albumen proteins (ovalbumin and ovotransferrin) exhibit significant ACE-inhibitory 
activity (Abeyrathne et al., 2013; Zambrowicz et al., 2013).
Table 1.5 Antihypertensive peptides enzymatically derived from whole egg albumen, 
ovalbumin and egg yolk (Miguel and Aleixandre, 2006).
Peptide fragment Peptide origin Enzyme Bioactivity demonstrated
Arg-Ala-Asp-His-Pro-Phe-Leu Albumen Pepsin ACEI/Anti hypertensive
T yr-Arg-Glu-Gl u-Arg-T yr-Pro- 
lle-Leu
Albumen Pepsin ACEI/Antihypertensive
Ile-Val-Phe Albumen Pepsin ACEI/Antihypertensive
RADHP Albumen Pepsin/ 
Corolase PP
ACEI/Antihypertensive
Phe-Arg-Ala-Asp-His-Pro-Phe-
Leu
Ovalbumin Pepsin Vasorelaxing/Antihypertensive
Arg-Ala-Asp-His-Phe-Leu Ovalbumin Chymotrypsin Vasorelaxing/Antihypertensive
FGRCVSP Ovalbumin Pepsin ACEI
ERKIKVYL Ovalbumin Pepsin ACEI
FFGRCVSP Ovalbumin Pepsin ACEI
LW Ovalbumin Pepsin ACEFAntihypertensive
FCF Ovalbumin Pepsin ACEI
NIFYCP Ovalbumin Pepsin ACEI
1.4 Oxidative stress phenomena in biological systems
The diatomic oxygen moleeules contain two unpaired electrons and can therefore, 
undergo reduction by gaining extra electron(s) to form a number of radical and 
nonradical reactive oxygen species (ROS), which include: superoxide radieal (O2 ' ), 
hydrogen peroxide (H2O2); hydroxyl radical (OH ), nitric oxide radical (NO ), peroxyl 
radical (ROO ), alkoxyl radicals (RO ) and the singlet oxygen ('O2) as summarised in 
table 1.6 below (Kohen and Nyska, 2002).
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Table 1.6 Radical and nonradical reactive oxygen species.
ROS type Name Symbol
Radical ROS
Oxygen (bi-radical) O2
Superoxide ion (O2")
Hydroxyl ion OH
Peroxyl radical ROO
Alkoxyl radical RO
Nitric oxide radical NO
Nonradical ROS
Hydrogen peroxide H2O2
Singlet oxygen 'O2
In biological systems, such ROS are usually produeed as metabolie by-produets of 
the mitoehondrial eleetron transport ehain (mETC) when eleetrons "leak" from the 
mETC (Kohen and Nyska, 2002; Bergamini et al, 2004). The ROS are highly 
reaetive and therefore eause structural damage of cells and important biomolecules 
particularly free and membrane lipids, proteins, and nucleic acids (Kohen and Nyska, 
2002). Consequently, aceumulation of ROS results in massive eell senescence and 
senescence-associated deaths. ROS coupled with other exogenous free radicals are 
involved in cellular mutation, earcinogenesis, and pathogenesis of degenerative 
disorders and the aging proeess (Kohen and Nyska, 2002; Bergamini et al, 2004).
1.4.1 Lipid and free radical (ROS) in biological systems
Lipids are water-insoluble biomolecules but highly soluble in the non-polar 
organic solvents. Lipids occurring abundantly in living systems are essentially fatty 
acids and triglycerides including lipids in their different functional forms such as 
phospholipids, glycolipids, sterols and sphingomyelin (Mylonas and Kouretas, 1999). 
When lipids are conjugated with phosphates they form phospholipids, which are the 
key structural components of eell membranes owing to their unique physieoehemical 
characteristics. The hydrophobie lipid (fatty acid chains) and the hydrophilie 
phosphate groups of the phospholipids confer unique physicochemieal characteristies 
of cell membranes (Mylonas and Kouretas, 1999).
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Given that lipids are the key structural components of cell membranes, membrane 
lipids are eonstantly exposed to the deleterious ROS released during normal cellular 
metabolic activities related to the mETC. High coneentrations of ROS ean alter 
structural characteristics of cell membrane through dénaturation of membrane 
proteins coupled with oxidation of membrane lipids (Noguchi et al, 2002).
1.4.2 Lipid oxidation mechanisms
The mechanisms involved in lipid oxidation are multifaceted depending on the 
involved radical and non-radical ROS, which include enzyme-catalysed oxidation, 
auto-oxidation and photo-oxidation.
Enzyme-catalysed lipid oxidation (or lipid peroxidation) is a natural process 
occurring to a small extent in the biological systems, in vivo, with deleterious effeets 
on cellular structure and survival (Mylonas and Kouretas, 1999). The lipoxygenase 
(LOX) enzyme, catalyses peroxidation of the unsaturated fatty acid in the presence of 
molecular oxygen to form specific hydroperoxides. The LOX-mediated lipid 
peroxidation essentially involves oxidative degradation of lipids, where free radicals 
abstract electrons from the polyunsaturated fatty acids and therefore initiate a self- 
propagating chain reaction (Mylonas and Kouretas, 1999).
Lipid auto-oxidation occurs when lipid molecules are coupled in a chain reaction 
initiated by free radieal ROS such as O2 ', OH, ROO , RO and NO'. This lipid 
oxidation mechanism involves chain initiating, propagating, and terminating steps. In 
the chain initiating step, unsaturated fatty acids lose their hydrogen atom to form a 
highly reactive lipid radieal which subsequently attacks molecular oxygen to generate 
another highly reactive peroxyl radieal (ROO). The reactive peroxyl radical 
subsequently abstraets a hydrogen atom fi'om another polyunsaturated fatty acid to 
form stable hydroxyl peroxide (ROOH) and a new lipid radical that starts over the 
peroxidation ehain reaction.
On the other hand, in vivo photo-oxidation of lipids can occur in skin surfaces 
exposed to Ultraviolet (UV) B irradiation. UV-B induced lipid peroxidation underlies
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photo-oxidative stress, which promotes photoageing and photocarcinogenesis of the 
skin (Schneider et al, 2006). Photo-oxidation involves the highly electrophilic non- 
radieal singlet oxygen (^ 0 2 ) produced from photolysis. The singlet oxygen attacks 
double bonds within the polyunsaturated fatty acid therefore generating oxidized 
lipids.
1.4.3 Primary lipid oxidation products
While lipids are important macromolecules in food, the quality of food lipids can 
be degraded by auto-oxidation during processing coupled with photo-oxidation during 
transit or storage. The primary lipid oxidation products are mainly lipid 
hydroperoxides, which are typically odourless and tasteless but chemically unstable 
(Pegg, 2001; Halvorsen and Blomhoff, 2011). However, aeeumulation of lipid 
hydroperoxides underlies the development of off-flavours in lipid-based food 
products. The degree of lipid peroxidation can be estimated by measuring the 
primary lipid oxidation products, particularly hydroperoxides, to give peroxide value 
(Pegg, 2001; Halvorsen and Blomhoff, 2011). The eoncentration of hydroperoxides as 
the peroxide value (PV) is traditionally determined by the iodometric titration, which 
is based on iodine liberated from potassium iodide displaced by the hydroperoxides in 
the presence of excess iodide presents in the analytes (Pegg, 2001). The PV value can 
be determined spectrophotometrieally based on the ability of the hydroperoxides to 
oxidize ferrous ions (Fe^ '^ ) to ferric ions (Fe^ )^, which can subsequently form a 
eomplex with xylenol orange (Pegg, 2001).
1.4.4 Secondary lipid oxidation products
The unstable, primary lipid oxidation products, particularly, lipid hydroperoxides, 
may undergo decomposition to produce seeondary oxidation produets such as 4- 
hydroxy-2-alkenals, anisidine and malondialdehyde (MDA), which are the highly 
reaetive and cytotoxic to cells even at low concentrations (Halvorsen and Blomhoff, 
2011). The anisidine value and MDA eoncentration are the common measures of the 
low molecular weight secondary lipid peroxidation products (Pegg, 2001; Halvorsen 
and Blomhoff, 2011). For instance, the thiobarbituric acid test (TBA) is widely used 
for measuring MDA eoncentration. The TBA technique is based on the ability of the
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monoenolic form of MDA to chemically interact with the active methylene groups of 
TBA to form a red-coloured complex. The concentration of MDA-TBA eomplex can 
be determined speetrophometrically at 532 nm (Pegg, 2001). Moreover, seeondary 
oxidation products can be measured using eommercially available assay kits (Pegg, 
2001; Halvorsen and Blomhoff, 2011).
1.5 Antioxidants
Antioxidants are compounds from natural or synthetic sources that inhibit the 
oxidation of other molecules and therefore, protect cells from oxidative damage. 
Antioxidants act as electron donors, which neutralize unstable molecules (free 
radicals) generated from oxidative deeomposition of biomolecules such as lipids and 
proteins in the human body (Klein et al, 2005).
1.5.1 Antioxidant mechanisms
Different types of antioxidants have different antioxidation mechanisms. The most 
common antioxidants are free radical terminators, oxygen scavengers and metal ion 
chelators. Primary antioxidants are basically free radical scavenging antioxidants, 
which involve chain-terminating reactions to interrupt or prevent oxidation activity of 
radical oxidants. Secondary antioxidants are hydroperoxide deeomposers, which slow 
down the kinetics of chain initiation steps by decomposing hydroperoxides into non­
radical, non-reactive, and thermally stable products (Klein et al, 2005).
1.5.1.1 Free radical terminator
Free radical scavenging antioxidants have reactive -OH or -NH groups including 
sterically hindered phenols and secondary aromatic amines. They inhibit the oxidation 
activity of radical oxidants by donating a proton to the reactive free radical species 
therefore stabilizing its oxidation potential. Phenolic stabilizers as primary 
antioxidants donate hydrogen atom to the peroxy radicals to form hydroperoxides 
while blocking the abstraction of hydrogen from the stabilized polymer backbone 
(Klein et al, 2005).
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Sterically hindered phenols eonfer antioxidant proteetion by trapping oxy and 
peroxy radieals. The bulky substituents on phenoxy radicals are stabilized through 
sterieal hindrance and therefore, eannot attack the polymer backbone but instead 
recombine with more peroxy radicals as shown in figure 1.12 below (Klein et al, 
2005).
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Figure 1.12 Primary antioxidant mechanism of the sterically hindered phenols: P 
represents the polymer backbone (Klein et al., 2005).
1.5.1.2 Oxygen scavengers
The presenee of moleeular oxygen (O2) in food packages underlies oxidation of 
lipids, and proteins. Therefore, oxygen scavengers such as ferrous iron powder, 
ascorbic acid, photosensitive polymers, palmitate, erythorbie aeid, and sulphites are 
inereasingly being used during food paekaging to reduee oxygen in food paekages 
and to stabilize fatty food. These oxygen seavengers are reducing agents (Cooksey, 
2002; Kerry et al, 2006). For instance, ferrous iron powder scavenges for moleeular 
oxygen while it is oxidized to ferric oxide. Iron powder reaets with oxygen aeeording 
to the ehemical reaetions below (Cooksey, 2002).
Fe Fe^  ^+ 2e“
O2 + 2 H2O + 4 e —> 4 OH”
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On the other hand, ascorbic aeid and sulphites scavenge molecular oxygen by 
irreversible bonding to moleeular oxygen and therefore, making it unavailable for 
oxidative decomposition of food (Kerry et al, 2006).
1.5.1.3 Metal chelators
A variety of heavy metals such as Fe, Cu, Mn, Cr, Ni, V, and Zn have high 
oxidative states that can induce oxidative stress when assimilated into cells (Flora et 
al, 2008). Owing to multiple oxidative states, heavy metals often result in lipid 
peroxidation through self-sustained chain reaction. Metal chelators confer antioxidant 
activity against pro-oxidant heavy metals by providing multiple sites for bonding; 
where the metal acts as the central atom. Examples of metal chelators applied in the 
food, beverages and pharmaceutical industries are ethylenediaminetetraacetic aeid 
(EDTA), citric acid and phosphoric acid (Flora and Pachauri, 2010). Metal chelators 
ideal for application in the food, beverage and pharmaceutical industries should have 
greater affinity for the pro-oxidation of metals with low toxicity. They should have 
the ability to cross membrane barriers and be highly competitive with natural 
chelators to form non-toxic complexes. Importantly, the antioxidants should be highly 
water-soluble to enhance elimination of chelated metals (Flora and Pachauri, 2010). 
Figure 1.13 shows the chelating activity of EDTA.
O -
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Figure 1.13 Ethylenediaminetetraacetic acid (EDTA) chelating with metal ion (M) 
(Taylor and Williams, 1995).
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1.6 Antioxidant defence systems
Both animals and plants are constantly exposed to endogenous ROS generated 
during normal metabolic processes, which damage structural proteins and therefore 
impair their structural and physiological function. Impaired cellular structure and 
function underlies rapid ageing, pathogenesis of degenerative disease, genomic 
instability, and carcinogenesis (De Moraes Mourao et al, 2009). However, living 
systems contain eomplex intracellular and extracellular antioxidant defence systems 
comprising of multiple enzyme systems that abolish oxidative activity of radical ROS 
by quenching them. Therefore, the normal physiological state for good human health 
is maintained by the state of balance between the production of endogenous ROS and 
the robustness the endogenous antioxidant defence systems in the body. The human 
antioxidant defence system consists of both endogenous and exogenous antioxidants, 
which play pivotal roles in protecting cells and tissues from oxidative damage by the 
exogenous ROS (Symons and Gutteridge, 1998; De Moraes Mourao et al, 2009).
1.6.1 Endogenous antioxidative system
The endogenous antioxidative systems comprise three main endogenous enzyme 
systems, which include superoxide dismutase (SOD), catalase and glutathione 
peroxidase (GPx). These enzymes arrest chain reactions initiated by radieal ROS by 
quenching their electron affinity (De Moraes Mourao et al, 2009).
1.6.1.1 Superoxide dismutase (SOD)
Superoxide dismutase (EC 1.15.1.1; SOD) belongs to a larger family of 
metalloenzymes present in most aerobic cells. SOD generally catalyzes simultaneous 
oxidation and reduction (dismutation) of two superoxide radieals (O2 ' ), giving H2O2 
and molecular oxygen as shown in the chemical equation below (De Moraes Mourao 
et al, 2009).
O2  + 0% '+ 2 l f  ► H2 O2  + O2
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1.6.1.2 Catalase
Catalase also called H2O2 oxidoreductase (EC 1.11.1.6; CAT) is an intracellular 
enzyme belonging to a group of oxidoreduetases present in most aerobic cells. 
Catalase dismutates two H2O2 to form water and molecular oxygen as shown in the 
ehemical equation below.
2 H 2 O 2 _______ ^  2 H 2 O  +  O 2
1.6.1.3 Glutathione Peroxidase (GPx)
Glutathione peroxidase (GPx) (EC 1.11.1.9; GPx) is a selenium-containing 
enzyme belonging to an enzyme family with peroxidase activity (peroxidases). It 
inhibits oxidative chain reactions mediated by radical ROS by inhibiting the chain 
propagation step. It also catalyses reduction of lipid peroxides and free peroxides in 
animal muscles especially fish and chicken (Symons and Gutteridge, 1998).
1.6.2 Exogenous antioxidant system
In most cases, the total oxidative state in the human body eannot be quenched 
adequately by the endogenous antioxidant systems. This is because the state of 
balance between oxidative and antioxidative systems often deteriorates with age, 
unhealthy lifestyle and constant exposure to chemical pollutants. Therefore, 
exogenous antioxidants ftom dietary sources are important for bridging the 
antioxidative deficit. Dietary antioxidants can be natural or synthetic.
1.6.2.1 Natural antioxidant
Natural antioxidants are obtained from dietary sources that are referred to as 
phytochemicals and include the water-soluble aseorbates (vitamin C) and lipid- 
soluble tocopherols (vitamin E), carotenoids, ((3-carotene), lyeopene, lutein, 
isofiavones and other polyphenols, which are present in fresh fruits and vegetables 
(Podsedek, 2007). These phytochemicals have exceptional scavenging capacity for 
free radieals by quenching their oxidative state. Therefore, consumption of fresh fruits 
and vegetables is extensively recommended for preventing metabolie diseases such as 
type-2 diabetes and cardiovascular diseases.
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1.6.2.2 Synthetic antioxidants
Synthetic phenolic antioxidants particularly, butylated hydroxytoluene (BHT) and 
butylated hydroxyanisole (BHA) contain phenolic groups. These phenolic 
antioxidants have been demonstrated to decrease A-acetylating activity and DNA- 
adduct formation by carcinogens (Chung, 1999; Lu et aJ., 2002). Consequently, BHT 
and BHA are increasingly being used for dietary antioxidant supplementation (Patil et 
al., 2010). However, there are controversies surrounding the safety of BHT and BHA 
as antioxidant food supplements (Kahl and Kappus, 1993; Williams et al, 1999). It 
has been suggested that BHA can induce tumours of the forestomach in a dose- 
dependant manner while BHT ean induce liver tumours following prolonged 
exposure, suggesting that the two synthetic phenolic antioxidants are tumour 
promoters (Kahl and Kappus, 1993; Williams et al, 1999).
1.6.3 Antioxidant peptides from food sources
Bioaetive peptides with antioxidative activity have been reported in dietary 
proteins of animal and plant origin. They have been isolated from proteolytic digests 
of various plant proteins especially soy protein and from animal proteins such as 
chicken meat, fish, eggs, milk. For instance, P-alanyl-L-histidine (carnosine), p- 
alanyl-L-1 -methylhistidine (anserine), and P-alanyl-L-3-methylhistidine (ophidine) 
are bioactive dipeptides found in mammalian muscle and brain tissue, but their 
concentrations vary from one animal muscle to another (Babizhayev et al, 1994). 
These dipeptides are capable of inhibiting liposomal peroxidation of linoleie aeid and 
phosphatidylcholine. Carnosine is an excellent scavenger for OH radieal (Babizhayev 
et al, 1994; Egorov et al, 1997). Apart from these bioaetive dipeptides, there are 
other antioxidative oligopeptides present in dietary proteins.
1.7 Angiotensin I converting enzyme (ACE) and hypertension
The ACE, also called dipeptidyl earboxypeptidase enzyme (EC. 3.4.15.1 ACE) or 
kininase II is a monomeric zinc metalloenzyme occurring as a polypeptide comprising 
of 1306-amino-acid residues (Aeharya et al, 2003). It is a eomplex two-domain 
enzyme comprising both C- and N-domains containing different active sites, which
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bind to distinct substrates (Aeharya et ah, 2003). ACE catalyses in vivo conversion of 
angiotensin I (Ang I), an inactive decapeptide circulating in the plasma, to a highly 
potent vasopressor, angiotensin II (Ang II), through catalytic cleavage of the C- 
terminal dipeptide from Ang I and bradykinin, particularly His-Leu (Brown and 
Vaughan, 1998; Aeharya et al, 2003; Wijesekara and Kim, 2010). Ang I is 
synthesised via renin-catalyzed hydrolytic cleavage of the peptide bond between Leu 
and Val amino acid residues within the peptide chain of angiotensinogen, a 55 kDa 
plasma protein derived &om liver. ACE can also catalyse the in vitro formation of 
dipeptides through hydrolytic cleavage of a wide variety of oligopeptides (Aeharya et 
aï., 2003). While the etiological factors for hypertension are multifaceted, ACE 
underlies blood pressure regulation. As shown by Udenigwe and Aluko (2012), blood 
pressure is physiologically modulated by the renin-angiotensin system (RAS) coupled 
with the kinin-nitric oxide system (Fig 1.14).
Nitric oxIde-medlated 
vasodilationBioaetive
peptidesRenin
Angiotensin 1- 
convertlng enzyme 
(ACE)
Chymase
Bradykinin
Anglotensln-ll
Anglotensln-I
Angiotensinogen
inactive peptide 
fragments
At  rece pto r-m edi ated 
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Figure 1.14 A schematic representation of the interaction between ACE, the renin- 
angiotensin system (RAS) and the kinin-nitric oxide system (KNOS) in blood pressure 
(BP) modulation (Udenigwe and Aluko (2012).
ACE is encoded by the ACE gene and was originally isolated from horse blood 
(Wijesekara and Kim, 2010). The ACE gene regulates the downstream components of 
the RAS and therefore, increases enzymatic conversion of the inactive Ang I to a 
highly potent vasopressor Ang II which acts directly on vascular smooth muscle cells 
(Brown and Vaughan, 1998). ACE also suppresses the nitric oxide-mediated 
vasodilative activity of the bradykinin in kinin-nitric oxide system (Brown and
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Vaughan, 1998; Aeharya et al, 2003; Wijesekara and Kim, 2010). Therefore, high 
plasma levels of Ang II promote the release of sodium-retaining steroids and 
aldosterone hormone from the adrenal cortex, which independently induces 
vasopressor effect and therefore, hypertension (Wijesekara and Kim 2010). Patients 
with cardiovascular diseases, particularly hypertension, have elevated plasma levels 
of Ang II hormone, which sustains vasoconstriction of blood vessels and therefore, 
uncontrolled hypertension (Brown and Vaughan, 1998; Wijesekara and Kim 2010).
On the other hand, bradykinin stimulates production of nitric oxide, retention of 
arachidonic acid metabolites, and hyperpolarizing factors in the vascular endothelium, 
which independently sustains vasodilation of blood vessels (Brown and Vaughan, 
1998). ACE also increases blood pressure by abolishing the vasodilative activity of 
the bradykinin by catalyzing the hydrolytic cleavage of C-terminal dipeptide of the 
bradykinin (Aeharya et al, 2003).
1.7.1 ACE inhibitors
Inhibition of either ACE or the blockade of the Ang II receptor underlies the 
therapeutic target of antihypertensive drugs and some bioaetive peptides. 
Consequently, ACE inhibitors (ACEIs) and Ang II receptor blockers (Ang II receptor 
antagonist) are the two main antihypertensive drug classes (Abuissa et al., 2010; 
Sorensen et al., 2013; Verdecchia et al., 2010). Synthetic ACEIs approved by the US 
Food and Drug Administration (FDA) are grouped based on their molecular structure 
(Table 1.7).
Table 1.7 Synthetic Angiotensin I converting enzyme inhibitors grouped based on their 
moleeular structure (Kumar et ah, 2010).
Drug class Synthetic ACE inhibitors
Sulfhydryl-containing agents captopril and zofenopril
Dicarboxylate-containing agents enalapril, perindopril, ramipril, 
quinapril lisinopril and benazepril
Phosphonate-containing agents fosinopril
These synthetic ACEIs are used as first-line therapeutic management option for 
hypertension, myocardial infarction, congestive heart failure, and left ventricular
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systolic dysfunction. They are also recommended for therapeutic management of 
diabetic and non-diabetic nephropathy (Aeharya et al, 2003; Sweitzer, 2003; Kumar 
et al, 2010). However, synthetic ACEIs are known to induce undesirable side effects 
such as hypotension, acute renal failure, uncontrolled dry cough, angioneurotic 
oedema, hyperkalaemia, and skin rashes (Sweitzer, 2003).
Surprisingly, dietary proteins contain a wide range of bioaetive peptides with ACE 
inhibitory activity. Such bioaetive peptides are available in inactive forms within the 
amino acid sequence of the parent protein and can be released by proteolytic enzymes 
during gastrointestinal digestion of dietary proteins. The released ACE inhibitory 
peptides can collectively confer antihypertensive effects when absorbed in the blood 
circulation in their intact forms. However, ACE inhibitory peptides can be released 
from parent proteins through in vitro digestion with proteolytic enzymes under 
appropriate hydrolytic conditions. When the released ACE inhibitory peptides are 
fractionated, purified and formulated as antihypertensive nutraceuticals, they are 
likely to eliminate the undesirable side effects caused by the synthetic ACEIs 
(Wijesekara and Kim 2010).
1.7.1.1 ACE-inhibitory peptides from dietary plant protein sources
ACE-inhibitory peptides have been isolated from a variety of dietary plant protein 
sources especially soybean (Shin et al, 2001; Chen et al, 2002; Wu and Ding, 2002), 
pea and mung bean (Li et al, 2006). Peptides from these plant protein hydrolysates 
have been shown to exhibit excellent ACE-inhibitory activity.
1.7.1.2 ACE-inhibitory peptides from animal sources
ACE-inhibitory peptides are present in the primary sequence of animal proteins as 
bioaetive oligopeptides. ACE-inhibitory peptides from muscle proteins have been 
reported in fish, pork, chicken, milk, and avian eggs. Such bioaetive peptides can be 
released through proteolytic digestion by combined enzyme hydrolysis using pepsin, 
trypsin, R-chymotrypsin, thermolysin and papain. Thermolysin protein hydrolysates 
with two major bioaetive oligopeptides (with sequences ITTNP and MNPPK) were 
previously demonstrated to exhibit high ACE-inhibitory activity. For instance, when
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thermolysin protein hydrolysate of porcine skeletal muscle was administered to 
spontaneously hypertensive rat by gavage, the rats exhibited reduced hypertension 
(Arihara cr a/., 2001).
1.7.2 ACE inhibition mechanisms
ACEIs generally confer antihypertensive effect through blockade of the RAS, 
which mediates synthesis of Ang II. RAS blockade results in inhibition of ACE- 
catalysed conversion of the inactive Ang I to the highly vasopressor, Ang II hormone 
(Verdecchia et al, 2010). ACE inhibitory peptides inhibit the activity of the ACE via 
competitive inhibition. The active sites of the ACE inhibitory peptides competitively 
bind to the ligands of the substrate (Udenigwe and Aluko, 2012). However, according 
to Ni et al (2012), “most of the ACE inhibitory peptides are not competitive 
inhibitors of ACE” suggesting that there are other ACE inhibitory mechanisms, yet to 
be delineated (Ni et al, 2012).
1.8 Cytotoxic effect of free radical in epithelial and endothelial cells
Both epithelial and endothelial cells are vulnerable to the cytotoxic effects of 
various endogenous and exogenous free radicals. There is increasing evidence that 
cellular radical and non-radical ROS are involved in the remodelling of vascular cells 
by promoting permeability of micro vascular endothelial cells (Pacurari et al, 2012; 
Wang et al, 2013). While cellular radical ROS are involved in the physiological 
regulation of epithelial and endothelial cells, overproduction of radical ROS is highly 
cytotoxic to these cells. Radical ROS attack lipids including phospholipids present in 
the cell membrane and therefore, resulting in primary lipid peroxidation products that 
undergo further oxidation to produce the low molecular weight secondary lipid 
peroxidation products such as ethane, pentane, and malondialdehyde, which alter 
fluidity and impair the barrier function of cell membranes and therefore, reduced cell 
function and viability (Pawlak et al, 1998; Mylonas and Kouretas, 1999).
1.9 Protein hydrolysis and digestion in the body
Protein hydrolysis is the hydrolytic cleavage of peptide bonds under acidic 
conditions and optimal temperatures to form free amino acid residues. Protein
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molecules are hydrolysed into oligopeptides and free amino acids before assimilation 
into the human body. Proteases, also called peptidases or proteinases, are the group of 
enzymes that catalyse hydrolytic degradation of proteins by cleaving peptide bonds 
(Rao et al, 1998; Tavano, 2013). Surprisingly, proteases are enzymatic and therefore, 
proteins in nature. Proteases are classified into six groups depending on the 
proteolytic mechanism involved and the preferential amino residue site for cleavage, 
which include serine, threonine, cysteine, aspartate, glutamic acid and 
metalloproteases (Rao et al, 1998). Some of the well-characterised plant proteases of 
plant origin include papain, bromelain, keratinases, and ficin. On the other hand, 
proteases of animal origin include pancreatin trypsin, chymotrypsin, pepsin, and 
rennins (Rao et al., 1998).
The activities of these proteases are largely influenced by pH and temperature and 
therefore, have optimal pH and temperature. For instance, protein digestion in the 
human body involves pepsin, trypsin and chymotrypsin proteases which are optimized 
by the acidic pH of hydrochloric acid in the stomach (Tavano, 2013). Protein 
hydrolysates in the stomach contain short-chained and low molecular weight peptides 
and free amino acids, which are readily absorbed through the epithelial cells of the 
intestines bonds (Rao et al, 1998; Tavano, 2013).
1.10 Intestinal absorption of the peptide
Intestinal absorption of oligopeptides and free amino acids is influenced by several 
factors (Shimizu et al, 1997). The lumenal epithelial cell membranes of the 
adsorptive and absorptive cell possess at least four sodium-dependent transporter 
proteins for acidic, basic, and neutral amino acids. The sodium-dependent transporters 
first bind to sodium and then bind to amino acid residues. After biding to the amino 
acids, the loaded transporter protein undergoes conformational changes where both 
amino acids and sodium are offloaded into the cytoplasm of the next cell and the 
mechanism is repeated until the amino acid is finally delivered into the blood stream 
(Webb, 1990).
4 2
On the other hand, oligopeptides with about four amino residues are absorbed 
through the small intestine. Transepithelial transport of such oligopeptides involves 
three main transport pathways, which include the transporter (PepTl)-mediated flux 
of the di- and tri-peptides, paracellular pathway via intracellular junctions 
(tetrapeptides and peptides of more than 4 amino residues) and the intracellular 
pathway (adsorptive transcytosis) (Shimizu et al., 1997). The PepTl-mediated 
transport involves absorption of the di- and tri-peptides into the epithelial cells of the 
small intestine by the Na^ or H ions as the co-transport (Webb, 1990; Frenhani and 
Burini, 1999). The vast bulk of the absorbed peptides in the enterocyte are degraded 
by brush-border (cytoplasmic) aminopetidases into amino acids and then exported 
from the cell into the blood stream. Only a very small proportion of the di- and tri­
peptides evades the hydrolytic action of the cytoplasmic aminopeptidases and 
therefore absorbed in their intact forms into the bloodstream (Webb, 1990).
1.11 Summary and aims
The endogenous antioxidants in the human body cells are overwhelmed by 
increased oxidative stress induced by ROS generated from exposure to chemical 
pollutants and ionizing radiations. Accumulation of ROS underlies the pathogenesis 
of degenerative and metabolic disorders such as atherosclerosis, neurodegeneration, 
diabetes mellitus, myocardial infarction, heart failure, cancer and aging 
(Dworakowski et al, 2006; Ray et al, 2012). Proteins are excellent sources of 
bioaetive peptides with twin health-enhancing effects: antihypertensive and 
antioxidant properties. While natural antioxidants such ascorbic acid, a-tocopherols 
and carotenoids are extensively known for their protective effect against ROS- 
induced degenerative and metabolic disorders, bioaetive peptides from dietary 
proteins hydrolysates confer equally excellent antioxidant properties. Surprisingly, 
some bioaetive peptides have antihypertensive, anti-carcinogenic and metal chelating 
activities. Egg albumen contains a complex of globular proteins that can yield 
important ACE-inhibitory and antioxidant peptides when digested with proteolytic 
enzymes both in vivo and in vitro conditions.
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Therefore, the main aim of the present study was to conduct an in vitro study of 
the ACE-inhibitory and antioxidant activities of peptides obtained from egg albumen 
hydrolysates. The specific objectives are:
1. To isolate and characterize the putative antioxidant peptides from egg albumen 
protein hydrolysate prepared using pepsin and pancreatin enzymes.
2. To study the in vitro antioxidant mechanisms of egg albumen hydrolysate.
3. To study the in vitro antioxidant activity of 2 kDa egg albumen peptides on 
epithelial cells (caco-2 cells) and endothelial cells (Ea.hy926 cells) exposed to 
a synthetic proxidant.
4. To investigate the in vitro ROS scavenging activity of the 2 kDa egg albumen 
peptides in endothelial cells (Ea.hy926 cells).
5. To investigate the adsorption/absorption properties of 2 kDa egg albumen 
peptides on the caco-2 cell monolayer model and subsequent transcellular 
transport of the peptides.
6. To isolate and characterize peptides from egg albumen hydrolysates with 
angiotension converting enzyme inhibitory (ACEI) activity and to study the 
mechanism of ACE inhibition.
7. To analyse the amino acid composition of both antioxidant and angiotension 
converting enzyme inhibitory (ACEI) isolated peptides.
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CHAPTER 2
2. ISOLATION AND CHARACTERIZATION OF ANTIOXIDANT 
PEPTIDES FROM EGG ALBUMEN PROTEIN HYDROLYSATE
2.1 INTRODUCTION
Metabolically active cells constantly produce radical and non-radical reactive 
oxygen species (ROS). Low levels of cellular ROS are important in cell signalling 
cascades that control cell physiological response to environmental stress factors and 
cell fate in relation to apoptotic and necrotic cell deaths (Kuster et al, 2006; Finkel, 
2012; Ray et al, 2012). However, it is extensively recognized that high 
concentrations of cellular ROS underlie oxidative stress build-up, which may cause 
irreversible damage to cellular biomolecules such as proteins, lipids and the genomic 
DNA (Klaunig et al., 2010). Accumulation of cellular ROS also causes lipid oxidation 
(peroxidation) in metabolically active cells (Patil et al, 2010). Given that lipids (as 
phospholipids) are key structural components of cell membranes, lipid peroxidation is 
deleterious to structural integrity and functionality of cell membranes (Mylonas and 
Kouretas, 1999). The mechanism of lipid peroxidation is multifaceted since it 
involves enzyme-catalyzed oxidation, auto-oxidation and photo-oxidation. 
Peroxidation of the unsaturated fatty acid in the presence of molecular oxygen often 
forms hydroperoxides, which undergo further degradation to form 4-hydroxy-2- 
alkenals, anisidine and malondialdehyde (MDA), which are highly reactive and 
cytotoxic (Mylonas and Kouretas, 1999; Halvorsen and Blomhoff, 2011). Therefore, 
excessive cellular ROS is extensively implicated in various degenerative and 
metabolic disorders including carcinogenesis and accelerated aging (Dworakowski et 
al, 2006; Ray et al, 2012).
Increased consumption of non-enzymatic dietary antioxidants such vitamin C 
vitamin E, beta-carotene, and flavonoids are recommended to prevent degenerative, 
metabolic, cardiovascular disorders and carcinogenesis induced by oxidative stress 
build-up (Kratchanova et al, 2010; Patil et al, 2010). The commercially available 
synthetic antioxidants such as butylated hydroxylanisole (BHA), butylated 
hydroxytoluene (BHT), tert-butylhydroquinone (TBHQ) and propyl gallate (PG), may 
be toxic and potentially carcinogenic (Hahzadi et al, 2011). There is increasing
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evidence that enzyme (pepsin, pancreatin, papain, chymotrypsin, and trypsin) and 
acid (HCl) hydrolysatcs of food proteins from both plant and animal sources exhibit 
significant antioxidant activities. Surprisingly, some studies have demonstrated that 
egg protein (yolk or albumen or whole egg protein) hydrolysates exhibit in vitro 
antioxidant activities that are similar or higher than those of well-established synthetic 
antioxidants such as such as BHT, BHA, and PG (Davalos et al., 2004; Amarowiez, 
2008; Pawar et al, 2013).
The extensively observed antioxidant activity of protein hydrolysates is widely 
attributed to bioaetive peptides and free amino acids with antioxidant activities 
(Amarowiez, 2008). The putative antioxidant peptides and free amino acid residues 
are thought to scavenge for free radicals, chelate metal pro-oxidants, and terminate 
lipid peroxidation chain reactions (Sakanaka et al. 2004; Amarowiez, 2008). For 
instance, bioaetive peptides containing aromatic amino acid residues such as histidine 
(His), tryptophan (Trp) and tyrosine (Tyr), the hydrophobic amino acid residues such 
as valine (Val), leucine (Leu), methionine (Met), proline (Pro) and phenylalanine 
(Phe) and sulfur-eontaining amino acid cystine (Cys), exhibit antioxidant activities 
through ROS scavenging activities (Davalos et al, 2004; Amarowiez, 2008). Some of 
these amino acid residues contain non-bonded side chain hydroxyl groups, which 
serve as hydrogen atom donors that stabilize the reactivity of radicals (Udenigwe and 
Aluko, 2011; Wiriyaphan et al, 2012).
It is possible to isolate and purify different bioaetive peptide factions fi'om protein 
hydrolysates using simple and advanced separation/purification techniques such as 
ultrafiltration, gel-Filtration (OF) chromatography, and high performance liquid 
chromatography (HPLC) (Martinez-Maqueda et al, 2013). It is also possible to 
determine the degree of antioxidant activity of protein hydrolysates and purified 
peptide fractions based on their in vitro inhibition of lipid peroxidation (Pawar et al., 
2013). This can be achieved by measuring the concentration of primary or secondary 
lipid oxidation products in the presence of the protein hydrolysates or purified peptide 
fractions, in the linoleie acid system (Pegg, 2001; Sakanaka et al. 2004; Halvorsen 
and Blomhoff, 2011). The concentration of hydroperoxides as the primary lipid 
peroxidation products can be determined spectrophotometrieally using the ferric
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thiocyanate (FTC) assay, which is based on their ability to oxidize ferrous ions (Fe^ "^ ) 
to ferric ions (Fe^ )^. The Fe^ "^  can subsequently form a complex with xylenol orange 
and therefore, providing a speetrophotometrie means of measuring antioxidant 
activity (Pegg, 2001). Similarly, the MDA concentration as a secondary lipid 
peroxidation product can be measured based on the thiobarbiturie acid (TEA) method. 
The TEA method is based on the ability of the monoenolie form of the MDA to react 
with the active methylene groups of TEA to form a red-eoloured complex, which 
provides a speetrophotometrie means of measuring antioxidant activity (Pegg, 2001; 
Sakanaka er al. 2004; Pawar et al, 2013). Therefore, the aim of the present study was 
to isolate and characterize the putative antioxidant peptides from egg albumen protein 
hydrolysate prepared using pepsin and pancreatin enzymes. This study also compared 
the antioxidant activities of the crude egg albumen protein hydrolysate and purified 
peptides fractions.
2.2 MATERIALS AND METHODS
2.2.1 Materials
Egg albumen (egg white), purified pepsin and pancreatin enzymes, Sephadex G- 
25, linoleie acid (99 %), trolox, butylated hydroxytoluene (EHT), reagents such 
ferrous chloride (FeCE), ferric chloride (FeCls), sodium phosphate buffer, 
trichloroacetic acid (TCA), tetraethoxypropane (TEP), sodium dodeeyl sulphate, 2- 
thiobarbiturie acid (TEA), ammonium thiocyanate, amino acid standards, 
triethylamine (TEA) and phenylisothiocyanate (PITC) were obtained from Sigma- 
Aldrich Company Ltd. (Poole, Dorset, UK). High-quality 2, 5 and 10 kDa molecular 
weight cutoff (MWCO) ultrafiltration membranes were obtained from Vivaspin, 
Epsom, UK. Reagents such as sodium phosphate, sodium hydrogen carbonate, 
sodium hydroxide, hydrochloric acid and ethanol were of analytical grade. All these 
chemicals were obtained from Fisher Scientific UK Ltd. (Loughborough, UK).
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2.2.2 Methods
2.2.2.1 Enzymatic hydrolysis of egg albumen
Preparation of egg albumen protein hydrolysate was based on methods described 
previously by Hemandez-Ledesma et al (2005) with slight modifications (Chiang et 
al, 2006). Egg albumen protein premixed with deionised water in the ratio 1:2.5 
(w/w) was vortexed for about 3 min. The pH of the resultant egg albumen protein 
homogenate was adjusted to 2.0 (optimal for pepsin hydrolytic activity) using a 1.0 M 
HCl. The pH-adjusted egg albumen protein homogenate was then mixed with pepsin 
enzyme at a ratio of 35:1 (w/w) and then incubated at 37 °C for 1 hour with 
continuous shaking. The pH of the partially hydrolysed egg albumen protein 
homogenate was adjusted to 5.3 using 0.9 M NaHCOs and then adjusted further using 
1.0 M NaOH to 7.5 (optimal for pancreatin enzyme activity). The partially hydrolysed 
egg albumen protein homogenate was then mixed with pancreatin enzyme at a ratio of 
25:1 (w/w) and then re-incubated further for two hours at 37 °C with constant shaking 
to homogeneity. After 2 hours of pancreatin hydrolysis, the resultant egg albumen 
protein hydrolysate was warmed in a water bath at 100 °C for 10 min to stop the 
enzyme hydrolysis and then centrifuged at 1200 x g for 15 min. The resultant 
supernatant was freeze-dried (lyophilized) and stored pending fiirther analyses.
22.1,1 Ultrafiltration
Ultrafiltration of the lyophilized supernatant of the egg albumen hydrolysate was 
based on a similar protocol described previously (Newsholme et al, 2009; Chiang et 
al, 2006). The supernatant was thoroughly mixed with ultrapure milli-Q water at a 
ratio of 1:10 (v/v) and then ultrafiltered through 10, 5, and 2 kDa MWCO 
ultrafiltration membranes. The peptide filtrates were then centrifuged separately at 
3500 X g for 30 min where the resultant 2, 5, and 10 kDa peptide fractions were 
quantified, lyophilized again, and stored pending further analyses.
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2.2.2.3 Gel Filtration chrom atography
A 200 mg portion of the lyophilized 2 kDa bioaetive peptide fraction with the 
putatively higher antioxidant activity was dissolved in 5 ml aliquots of sodium 
phosphate buffer (50 mM, pH 7.0) and loaded onto a Sephadex G-25 gel filtration 
column (2.0 x 90 cm). The gel filtration column was equilibrated and the samples 
eluted using the same 50 mM sodium phosphate buffer (pH 7.0) at a rate of 1 ml/min 
for 10 hours. Aliquots (5 ml) of the resultant purified peptide fractions were collected 
and their respective absorbance values determined at a wavelength o f250 nm.
2.2.2.4 Measurement of lipid peroxidation inhibition
The antioxidant activities of the purified egg albumen peptides were determined 
based on in vitro lipid peroxidation inhibition assay by the ferric thiocyanate (FTC) 
method (Mistuda et al, 1996) and thiobarbiturie acid reactive species, TEARS 
(Aazza et al, 2011) with slight modification.
2.2.2.4.1 Preparation of reaction mixture
The freeze-dried hydrolysates or peptides sample (100 mg) were mixed with 4.87 ml 
aliquots of deionized water, 0.13 ml aliquots of linoleie acid, 10 ml aliquots of ethanol 
and 10 ml aliquots of 50 mM phosphate buffer (pH 7.0) in a glass tube, sealed with 
silicone rubber caps and placed in a dark oven at 40 °C. A similar protocol was 
followed to prepare reaction mixtures containing 0.01 % EHT and 0.01 % trolox (in 
place of the peptides) as positive controls, while the negative control was made up of 
the solution without the peptides. All reaction mixtures were prepared in triplicate.
2.2.2.4.2 Measurement of peroxide formation using the ferric thiocyanate (FTC) 
method
The antioxidant activities of the egg albumen hydrolysates or peptide fractions 
were determined according to the FTC method described previously by Mitsuda et al, 
(1996). The ferrous chloride component of FTC reacts with the peroxide to form a red 
pigment of ferric chloride. The concentration of peroxide decreases with increased
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antioxidant activity giving decreased absorbance at 500 nm. Aliquots of the reaction 
mixture (50 pi) were placed into test tubes containing 4.7 ml of 75 % ethanol (v/v), 
100 pi 20 mM ferrous chloride solution, and 100 pi 30% ammonium thiocyanate 
(w/v). The absorbance was measured at 500 nm after 3 min after the addition of 
ferrous chloride solution, after which lipid peroxidation inhibition was calculated. 
Lipid peroxidation inhibition activities of the 0.01 % BHT and 0.01 % trolox as 
positive controls were conducted in a similar procedure. Negative control included 
distilled water instead of the sample. All absorbance readings were recorded in 
triplicate, where the percentage inhibition of lipid peroxide generation was 
determined mathematically using equation below.
Lipid inhibition (%) = (Absorbance of control-Absorbance of sample) x  100
Absorbance of control
The standard curve for the FTC assay was prepared as follows: serial 
concentrations (0.1, 0.2 0.4, 0.6, 0.8 and 1.0 mg/ml) of the FeClg in 10 ml screw cap 
tubes were prepared as standards. Aliquots (100 pi) of each of the prepared standards 
were transferred into separate test tubes (in triplicate) containing 5 ml absolute 
ethanol and 200 pi hexane and then vortexed thoroughly. Aliquots (100 pi) of 
ammonium thiocyanate (30 %) were added to each of the tubes and vortexed further 
for 3 min. The absorbance values of the mixture were determined at wavelength of 
500 nm using a spectrophotometer (UNICAM Speetronic, Speetronic Tudor House, 
Leeds, UK). Absolute ethanol was the blank solution which was used to calibrate the 
spectrophotometer. The determined peroxide values were expressed as milli- 
equivalents active oxygen (i.e., peroxide) per kilogram oil/lipid (meq/kg).
2.2.2.4.S Lipid peroxidation inhibition assay using thiobarbiturie acid reactive 
species (TEARS)
Thiobarbiturie acid reactive species (TEARS) assay was carried out according to 
methods described by Aazza et al. (2011). Aliquots of the reaction mixture (50 pi) 
were added to separate test tubes containing 0.8 ml of deionized water, 0.2 ml of 1.1 
% (w/v) sodium dodeeyl sulphate (SDS), 1.5 ml of 20 % acetic acid (pH 3.5) and 1.5
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ml of 0.8 % (w/v) thiobarbiturie acid (TEA) solution. The resultant mixture was 
vortexed, heated at 100 °C for 60 min and cooled at room temperature. Afterwards, 
the mixture was cooled and centrifuged at 4300 x g for approximately 10 min. The 
organic top layers were transferred to a 96-well microtitre plate where the absorbance 
values were determined at a wavelength of 532 nm using an ELISA plate reader. The 
antioxidant capacity was expressed as malonaldehyde (MDA) concentrations and was 
determined in three replicates. The standard curve for the MDA was prepared from 
tetraethoxypropane (TEP) solution to give dilutions containing the equivalent of 1.25, 
2.5, 5.0 and 10 pg/ml malonaldehyde (MDA).
2.2.2.4.4 Lipid oxidation inhibitory concentration
Different concentrations (0.2, 0.4, 0.8 and 1 mg/ml) of the purified peptide 
fractions were dissolved separately in test tubes containing 4.87 ml of deionized 
water, 10 ml aliquots of 96 % ethanol, 0.13 ml aliquots of linoleie acid emulsion and 
10 ml aliquots of sodium phosphate buffer (50 mM, pH, 7.0) and vortexed 
thoroughly. The mixture was placed in a glass tube and sealed using silicon rubber 
caps. The glass tube with the mixture was then placed in a dark oven at 40 °C. The 
peroxide value was measured after 72 hours using the FTC method. Trolox and EHT 
at 0.0 1 % w/w were used as a positive control (Kasase, 2009).
2.2.2.S Amino acid determination of isolated egg albumen peptide
2.2.2.5.1 Preparation of samples and standards
The concentration of free amino acid in the egg albumen peptide was determined 
by HPLC (Eidlingmeyer et al, 1987) with slight modifications as described 
previously by Eadii and Howell (2001). Exactly 20 mg of the egg albumen peptide 
was further hydrolyzed with 15 ml of 6 N HCl in screw cap tubes to yield free amino 
acid residues. To optimize the acid hydrolysis of the peptides, the screw cap tubes 
were closed in nitrogen and boiled in an oven at 110 °C for 24 hours.
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1.12.5.1 Derivatization of amino acids with penylisothiocyanate (PITC)
The amino aeid standards and the acid hydrolyzed egg albumen samples were 
derivatized using phenylisothiocyanate (PITC). The 20 pi aliquots of amino acid 
standards and the aeid-hydrolyzed egg albumen peptide in glass tubes were dried 
under vacuum for about 20 min. The tubes were then treated with 100 pi aliquots of 
triethylamine (TEA), 200 pi aliquots of methanol and 1 M sodium acetate, where the 
resultant mixtures were vacuum-dried further for 10 min. Next, the derivatization 
reagent was constituted by mixing 50 pi PITC (stored under nitrogen at -20 °C), 350 
pi of HPLC grade methanol and 50 pi TEA in 50 pi milli-Q ultrapure water. The 
glass tubes containing the sample and amino acid standards were treated with 20 pi 
aliquots of the derivatization reagent, vortexed and then left to stand at room 
temperature for 20 min. The derivatized egg albumen peptide samples were vacuum- 
dried and homogenised in 100 pi of sample buffer (Eluent A, prepared by dissolving 
19 g of sodium acetate trihydrate in 1 L milli-Q water, after that 0.5 ml TEA was 
added, adjusted to pH 6.4 and filtered. To 940 ml of this solution was added 60 ml 
aeetonitrile). The hydrolysed egg albumen peptide solutions and amino acids 
standards were analyzed, in triplicate, by reverse phase HPLC.
2.2.2.6.3 HPLC equipment and conditions
The RP-HPLC analysis of the amino acids was undertaken using a C l8 reverse 
phase column (3.9 x 150 mm, 5 pm particle size) (Nova -Pak, Waters separations, 
Elstree, UK). The linear gradient solvent system was prepared from two solutions; 
sodium acetate buffer (0.2 M) treated with 0.05 % (v/v) TEA (pH adjusted 6.2) as 
solution (A) and 60 % aeetonitrile in deionized water (solution B). The linear gradient 
solvent system profile is summarised in table 4.1. The flow rate was I ml/min and 
detection wavelength 254 nm.
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Table 2.1 Gradient profile for the chromatographic separation of amino acids.
Time (min) Flow rate (ml/min) Solution A Solution B
(%) (%)
0 1.0 100 0
10 1.0 54 46
10.5 1.0 0 100
11.5 1.0 0 100
12 1.5 0 100
12.5 1.5 100 0
20.5 1.5 100 0
20.5 1.0 100 0
2.2.3 Statistical analysis
All assays were carried out in triplicate where values were expressed as a mean ± 
SD. Statistical analyses were performed using the SPSS statistical package. To 
determine if the difference between mean pairs of samples was statistically 
significant, a one-way analysis of variance (ANOVA) was performed. The confidence 
intervals using a post-hoc test coupled with a t-test were used to assess the difference 
between mean pairs, where a P-value of < 0.05 was considered a significant.
2.3 RESULTS AND DISCUSSION
2.3.1 Enzymatic hydrolysis and purification of antioxidant egg albumen peptides
Bioaetive peptides can be released from the parent egg albumen protein through 
enzyme hydrolysis, enzyme-catalyzed proteolytic fermentation and thermal 
processing (Korhonen and Pihlanto, 2006; Udenigwe and Aluko, 2012; Kim and 
Hwang et al, 2013). Most bioaetive peptides reported in the literature were produced 
from various types of food proteins by enzyme hydrolysis using proteases found in 
the gastrointestinal tract, particularly, pepsin, trypsin, chymotrypsin and pancreatin 
(Hernandez-Ledesma et al, 2005; Udenigwe and Aluko, 2012). However, these 
hydrolytic enzymes exhibit not only different optimal hydrolytic conditions but also 
different preferential sites of cleavage of polypeptide chains (Hernandez-Ledesma et 
a/., 2005).
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In the present study, pepsin and pancreatin enzymes were used for stepwise 
hydrolytic digestion of the egg albumen protein isolate. Pepsin enzyme exhibits 
optimal hydrolytic activity at a temperature range of 37-42°C at a pH of 2.0. Under 
these hydrolytic conditions, pepsin preferentially cleaves hydrophobic aromatic amino 
residues particularly Phe, Tyr and Trp and Leu (Kageyama et al, 2009). Therefore, in 
the present study pepsin was suitable, since it yields a high proportion of hydrophobic 
oligopeptides and free amino aeid residues with the putative antioxidant activity as 
desired. Importantly, both pepsin and pancreatin are involved in the human 
gastrointestinal tract and therefore, their in vitro hydrolytic activity may correspond to 
their in vivo hydrolytic activity.
The bioaetive peptides present in the egg albumen protein hydrolysate were 
fractioned and purified using 10, 5, 2 kDa MWCO ultrafiltration membranes followed 
by GF-chromatography (Martinez-Maqueda et al, 2013). The resultant hydrolysate 
and peptides were tested for their antioxidant activities and their amino aeid 
composition.
2.3.2 Antioxidant activity of egg albumen hydrolysatc (EAH) in a linoleie acid 
model system
The antioxidant activity of the crude EAH was determined based on their in vitro 
inhibition of lipid peroxidation. This was achieved by ferric thiocyanate (FTC) assay, 
which measures the concentration of lipid peroxidation products (peroxide value) as 
the primary lipid peroxidation product in a linoleie aeid system (Pegg, 2001; 
Halvorsen and Blomhoff, 2011). The time-dependent peroxide generation (peroxide 
value) from the linoleie aeid system in the presence of the EAH, BHT and trolox 
(positive controls) and negative control (no treatment) is shown in figure 2.1. The 
auto-oxidation of linoleie acid in the absence of an antioxidant (negative control), 
consistently exhibited the highest peroxide values, compared to samples containing 
EAH and positive controls, from day 1 to day 8 of the FTC assay. The peroxide value 
of the negative control peaked at day five and then decreased due to the formation of 
secondary linoleie aeid peroxidation products, particularly the MDA. However, in the 
presence of the egg albumen hydrolysate, the auto-oxidation of the linoleie acid was
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inhibited significantly, indicating the presence of antioxidant peptides and free amino 
residues. However, the antioxidant activities of BHT and trolox were significantly 
higher than that of the EAH (p<0.05).
Control TroloxEAH BHT
2.5
^  0.5
Time (Days)
Figure 2.1 The time-dependent lipid peroxidation inhibition activity of egg albumen
protein hydrolysate (EAH) (1 mg/ml) by the ferric thiocyanate (FTC) assay based on the 
linoleie acid system. Butylated hydroxytoluene (BHT) (0.01 %) and trolox (0.01 %) were 
assayed as positive controls and distilled water as the negative control. Values (n=3) 
presented as mean±S.D.
The linoleie aeid peroxidation inhibition activity of the EAH as compared to BHT 
and trolox is shown in figure 2.2. The EAH, BHT and trolox inhibited linoleie acid by 
40, 95 and 82 %, respectively. This data demonstrates that the EAH contains the 
putative antioxidant peptides and free amino residues (Sakanaka et ah, 2004). This 
strongly indicates that the pepsin enzymes yielded a high proportion of bioaetive 
peptides with hydrophobic amino acid residues (Kageyama et al, 2009), which are 
known to exhibit antioxidant activities through radical scavenging and metal chelation 
(Davalos et al, 2004; Amarowiez, 2008; Pawar et al, 2013).
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Figure 2.2 Lipid peroxidation inhibition activity of egg albumen hydrolysate (EAH) (1 
mg/ml). The antioxidant activities were tested against linoleie acid oxidation by the 
ferric thiocyanate (FTC) method. The degree of linoleie acid oxidation was assessed by 
measuring absorbance at 500 nm at day 5. Butylated hydroxytoluene (BHT) (0.01 %) 
and trolox (0.01 %) were used as positive controls. Values (n=3) presented as mean±S.D.
Oligopeptides containing one or more of His, Tyr, Met, Lys, Trp, Cys, Phe and Pro 
amino acid residues exhibit antioxidant activity (Davalos et al, 2004; Udenigwe and 
Aluko, 2011; Wiriyaphan et al, 2012). The nonapeptide, Tyr-Ala-Glu-Glu-Arg-Tyr- 
Pro-Ile-Leu, previously isolated from egg albumen protein hydrolysate, contains two 
Tyr and Pro hydrophobic amino aeid residues with putative antioxidant activity 
(Davalos et al, 2004). This allowed scavenging of chain propagation hydroperoxides 
therefore inhibiting auto-oxidation of the linoleie acid (Davalos et al, 2004; Wang et 
al, 2009; Li and Li, 2013).
2.3.3 Purification of egg albumen antioxidant peptides
2.3.3.1 Egg albumen hydrolysate fractionation
Stepwise fractionation of the EAH through 10, 5 and 2 kDa MWCO ultrafiltration 
(UF) membrane gave different percentage yields of 57, 28, and 15 %, for the 2, 5 and 
10 kDa peptide fractions respectively (Table 2). This data strongly indicates that the 
combined hydrolytic activity of the pancreatin and pepsin enzymes resulted in a high 
proportion of small oligopeptides. The high yield of the 2 kDa peptide fraction can be 
attributed to exhaustive cleavage of the Phe-Val, Gln-His, Glu-Ala, Ala-Leu, Leu- 
Tyr, Tyr-Leu, Gly-Phe, Phe-Phe and Phe-Tyr possibly present in the parent egg 
albumen protein polypeptide (Kageyama et al 2009).
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Table 2.2 Recovery yield acquired from egg albumen hydrolysate (EAH) fractionations.
Fractions Yield recovery (%)
2 kDa 57
5 kDa 28
10 kDa 15
The differential antioxidant activity of the 2, 5 and 10 kDa peptide fractions were 
determined using both FTC and TBA methods, which are based on their inhibitory 
activity towards linoleie acid peroxidation (Kikuzaki and Nakatani, 1993; Aighazeer 
et al, 2008; Pawar et al, 2013). The FTC method measures the amount of primary 
linoleie aeid peroxidation products while the thiobarbiturie acid reactive species 
(TBARS) assay measures the concentration of secondary linoleie aeid peroxidation 
products (Kikuzaki and Nakatani, 1993; Pegg, 2001; Aighazeer et al, 2008). The 
time-dependent (1-8 days) antioxidant activities of the egg albumen peptide fractions 
were compared with the negative control (no antioxidant) and BHT and trolox as 
positive controls (Fig 2.3). It is evident that all the antioxidants exhibited significantly 
low peroxide values when compared to the negative control (p<0.05). This indicates 
that all the tested antioxidants significantly inhibited linoleie acid peroxidation. The 2 
kDa egg albumen peptides inhibited linoleie acid peroxidation to a comparable degree 
to that of trolox. This is consistent with data from the literature, which indicates that 
low molecular weight peptides have high attributed bioactivity (Li and Li, 2013). The 
high antioxidant activity of the 2 kDa egg albumen peptide may be due to its 
hydrophobic amino acids, which could enhance access to the hydrophobic peroxide 
radical targets, therefore quenching their peroxidation potential (Ranathunga et al,
2006).
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Figure 2.3 The time-dependent lipid peroxidation inhibition activity of egg albumen 
hydrolysates (EAH) fractionated by ultrafiltration membranes (1 mg/ml) by the ferric 
thiocyanate (FTC) assay based on the linoleie acid system. EAH was incubated in a 
linoleie acid oxidation system for 8 days. The degree of linoleie acid oxidation was 
assessed by measuring absorbance at 500 nm at every 24h interval. Butylated 
hydroxytoluene (BHT) (0.01 %) and trolox (0.01 %) were used as positive controls and 
distilled water as the negative control. Values (n=3) presented as mean±S.D.
The percentage inhibition of the linoleie acid peroxidation by the 2, 5, and 10 kDa 
fractions was compared to those of negative control (no antioxidant treatment) and 
positive controls (BHT and trolox) as shown in figures 2.4 and 2.5. The 2, 5, 10 kDa 
peptide fractions, BHT and trolox exhibited percentage linoleie acid inhibition of 76, 
63, 53, 95 and 82 %, respectively. The 2 kDa peptide fraction exhibited antioxidant 
activity comparable to that of trolox (Davalos et al., 2004; Li and Li, 2013) at the 
concentrations used. This data clearly indicates that the antioxidant activity of the 
peptides was inversely related to the molecular weight (Li and Li, 2013).
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Figure 2.4 Lipid peroxidation inhibition activity of egg albumen hydrolysate (EAH) 
fractions (1 mg/ml). The antioxidant activities were tested against linoleie acid oxidation 
by the ferric thiocyanate (FTC) method. The degree of linoleie acid oxidation was 
assessed by measuring absorbance at 500 nm at day 5. Butylated hydroxytoluene (BHT) 
(0.01 %) and trolox (0.01 %) were used as positive controls. Values (n=3) presented as 
mean±S.D.
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Figure 2.5 Antioxidant activity of egg albumen peptide 2 kDa fraction (1 mg/ml) by the 
ferric thiocyanate (FTC) assay based on the linoleie acid module system. Butylated 
hydroxytoluene (BHT) (0.01 %) and trolox (0.01 %) were assayed as positive controls. 
Values (n=3) presented as mean±S.D.
The different antioxidant activities of the 2, 5, and 10 kDa peptide fractions 
compared to the negative control (no antioxidant) and positive controls (BHT and 
trolox), were also determined using the thiobarbiturie acid reactive species (TBARS) 
aldehydes and MDA produced from the primary hydroperoxides (Pawar et al., 2013). 
The concentration of MDA generated in the linoleie acid system in the presence of the 
peptide fractions and controls is shown in figure 2.6. It is evident that the peptide 
factions inhibited the linoleie aeid peroxidation, as indicated by reduced MDA 
production. The 2 kDa peptide fraction exhibited the highest lipid peroxidation 
inhibition activity compared to other higher molecular weight fractions (5 and 10 
KDa). However, both BHT and trolox exhibited significantly high antioxidant activity 
towards the linoleie aeid peroxidation.
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Figure 2.6 The time-dependent lipid peroxidation inhibition activity of egg albumen 
peptide fractions (1 mg/ml) by the thiobarbiturie acid (TBA) assay based on the linoleie 
acid system. Butylated hydroxytoluene (BHT) (0.01 %) and trolox (0.01 %) were 
assayed as positive controls and distilled water as the negative control. Values (n=3) 
presented as mean±S.D.
The lipid oxidation inhibition of the three peptide fractions compared to those of 
negative and positive controls is shown in figure 2.7. The percentage peroxidation 
inhibition of the 2, 5, and 10 kDa peptides, BHT and trolox was 39, 27, 17, 78 and 70 
%, respectively. The 2 kDa peptide fractions exhibited the highest lipid peroxidation 
inhibition activity when compared to the higher molecular weight fractions (5 and 10 
KDa). In general, it appears that the lipid oxidation inhibition activity detected by the 
TBARS method (figure 2.7) was slightly lower when compared to the FTC method 
(figure 2.4) probably due to the presence of chemical kinetic factors not favouring 
MDA formation from the primary hydroperoxides (Pawar et al., 2013). This was 
consistent with the lipid peroxidation inhibition activity values of aqueous and 
alcoholic Roth plant (Gardenia resinifera) extracts measured recently by Pawar et al. 
(2013) using both FTC and TBA assays.
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Figure 2.7 Lipid peroxidation inhibition activity of egg albumen hydrolysate (EAH) 
fractions (1 mg/ml). The antioxidant activities were tested against linoleie acid oxidation 
by the TBARS method. The control contained distilled water alone instead of sample. 
The degree of linoleie acid oxidation was assessed by measuring absorbance at 532 nm 
at day 5. Butylated hydroxytoluene (BHT) (0.01 %) and trolox (0.01 %) were used as 
positive controls. Values (n=3) presented as mean±S.D.
2.3.3.2 Gel filtration
The 2 kDa egg albumen peptide fraction, which exhibited the highest antioxidant 
activity, was selected as a candidate for further purification by the Fast-Protein Liquid 
Chromatography (FPLC) gel filtration on a 2.0 x 90 cm column of Sephadex G-25 
column. The gel filtration chromatogram of the 2 kDa peptide along with its elution 
peaks were detected at a wavelength of 250 nm, which exhibited 13 different peaks 
(GF 12, 17, 23, 26, 29, 33, 35, 39, 41, 44, 47, 57 and 59) as shown in figure 2.8. 5 ml 
aliquots of the 13 sub-fractions collected from GF-FPLC elution peaks were 
lyophilized and tested for further in vitro antioxidant activity with BHT and trolox as 
positive controls. The GF26 sub-fraction exhibited the highest antioxidant activity (80 
%) based on the FTC method (Fig 2.9). The percentage of antioxidant activities of the 
GF26 sub-fraction, BHT and trolox were 80, 95 and 82 %, respectively (Fig 2.10).
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Figure 2.8 Gel filtration chromatoghraphy of the 2 kDa egg albumen peptides on the 
Sephadex G-25 column and detected at 250 nm. Separation was performed at a flow 
rate of 1 ml/min and collected at a fraction volume of 5 ml.
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Figure 2.9 Antioxidant activities of egg albumen peptides (1 mg/ml) separated on a G 25 
column and tested for antioxidant activity by the ferric thiocyanate (FTC) assay based 
on the linoleie acid model system. Butylated hydroxytoluene (BHT) (0.01 %) and trolox 
(0.01 %) were assayed as positive controls. Values (n=3) presented as mean±SD.
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Figure 2.10 Antioxidant activity of gel filtration fraction 26 (1 mg/ml) determined by the 
ferric thiocyanate (FTC) assay based on the linoleie acid model system. Butylated 
hydroxytoluene (BHT) (0.01 %) and trolox (0.01 %) were assayed as positive controls. 
Values (n=3) presented as mean±SD.
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2.3.4 Inhibitory effects of peptides on peroxide formation
The observed lipid oxidation inhibition aetivities of different eoneentrations (0.2, 
0.4, 0.8 and 1 mg/ml) of egg albumen peptides (GF26) were 42, 65, 54 and 78 %, 
respectively indicated a dose-dependent anti oxidant activity. The BHT and trolox 
assayed as positive controls exhibited a significantly high lipid oxidation inhibition 
activity as compared to egg albumen (p<0.05) as shown in figure 2.11.
Trolox
Lipid oxidation inhibition (%)
Figure 2.11 Lipid oxidation inhibition activity of egg albumen gel filtration peptide 
(GF26) (0.2, 0.4, 0.8 and 1 mg/ml) deterrmiend by the ferric thiocyanate (FTC) assay 
based in the linoleie acid system, based on peroxide equivalents (mg/ml FeC12) 
measured after 72 hours of incubation. Butylated hydroxytoluene (BHT) (0.01 %) and 
trolox (0.01 %) were assayed as positive controls. Values (n=3) presented as mean±SD.
There was a linear correlation between the concentration of the egg albumen 
fraction (GF26) and the corresponding lipid oxidation inhibition activity (R^= 
0.97864) as shown in figure 2.12. This gave 0.373 mg/ml as the concentration of the 
egg albumen GF26 fraction that can inhibit 50 % of the lipid oxidation in the linoleie 
aeid system (IC50).
6 3
90
80
y = 42x + 34.3 
= 0.9786
0.2 0.4 0.6 I
Concentration (m g/m l)
1.2
Figure 2.12 Concentration-dependent lipid peroxidation inhibition activity of egg
albumen gel filtration peptide (GF26) (0.2, 0.4, 0.8 and 1 mg/ml) in a linoleie acid system 
and based on peroxide equivalents (mg/ml FeC12) measured after 72 hours of 
incubation. Butylated hydroxytoluene (BHT) (0.01 %) and trolox (0.01 %) were assayed 
as positive controls. Values (n=3) presented as mean±SD.
These data indieate that the egg albumen GF26 fraction contained antioxidant 
peptides with radical scavenging activity (Sakanaka et ah, 2004). The antioxidant 
activities are inversely related to the size of the peptide and may be attributed to 
peptide hydrophobieity (Davalos et al., 2004; Wang et al., 2009; Li and Li, 2013). 
Therefore, the antioxidant GF26 peptide was further analysed to identify the amino 
acids with the putative antioxidant activity.
2.3.5 Determination of amino acids in antioxidative egg albumen peptides
The GF26 fraction obtained by chromatography on Sephadex G-25, which 
exhibited the highest antioxidant activity contained a high proportion of Glu (14.9 %) 
>Asp (8.5 %) >Val (8.3 %) > Leu (7.7 %) > Phe (7.2 %) > Lys (6.5 %) > lieu (6.2 
%)>Arg (5.8 %) >Ala (5.6 %)>Met (5.3 %). Cys was present in very low level (0.83 
%). The presence of the hydrophobic amino residues such as Phe (7.2 %), Val (8.3 
%), Leu (7.7 %) and Met (5.3 %) of the GF26 peptides enhanced antioxidant activity 
through ROS scavenging activities (Davalos et al, 2004; Amarowiez, 2008) as the 
hydrophobic amino acids are reported to target hydrophobic radicals.
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Table 2.3 Amino acid composition of egg albumen gel filtration peptide fraction (GF26).
Amino acid residue Amino acid composition (%)
Asp 8.5 ± 0.03
Glu 14.9 ± 0.05
Ser 4.7 ±0.01
Gly 3.2 ±0.03
His 1.46 ±0.06
Arg 5.8 ±0.10
Thr 4.2 ± 0.04
Ala 5.6 ± 0.02
Pro 3.9 ±0.12
Tyr 3.8 ±0.08
Val 8.3 ± 0.04
Met 5.3 ± 0.00
Cys 0.83 ± 0.03
lieu 6.2 ± 0.23
Leu 7.7 ± 0.05
Phe 7.2 ± 0.09
Trp 1.7 ±0.01
Lys 6.5 ± 0.02
* Values (n=3) presented as mean±SD.
2.4 CONCLUSION
The present study measured the putative antioxidant activity of peptides isolated 
from egg albumen protein hydrolysate prepared using pepsin and pancreatin enzymes. 
The crude egg albumen hydrolysate and the UF and GF peptides exhibited significant 
antioxidant activity as evidenced by enhanced lipid peroxidation inhibition activity in 
a linoleie aeid system. This activity was attributed to amino acid residues with 
hydrogen bonding or electron donation activity towards the radical species, therefore 
quenching their reactivity. Upon fractionation and purification, the 2 kDa and GF26 
peptide fractions exhibited enhanced antioxidant activity, which were similar to the 
synthetic antioxidant trolox but less than BHT at the conentrations used. The 
antioxidant activity shown by the GF26 peptide fraction was mainly due to the 
presence of Glu, Asp, Val, Leu, Phe, Lys, lieu, Arg, Ala and Met. The hydrophobic 
amino acid residues (Phe, Met, Leu, lieu, Val and Ala) may target free radicals by 
acting as hydrogen atom donors, which stabilize the reactive potential of free radicals.
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CHAPTER 3
3. ANTIOXIDANT MECHANISMS OF EGG ALBUMEN 
HYDROLYSATES
3.1 INTRODUCTION
During normal metabolic processes, both plant and animal cells produce metabolic 
by-products, particularly reactive oxygen species (ROS), known to be highly 
oxidative (Rahman, 2007; Valerie et al, 2007; Ray et al, 2012). The radical cellular 
ROS include hydroxyl radicals (OH'), superoxide radical (O2 ' ), nitric oxide radical 
(NO*), peroxyl radical (ROO ) and alkoxyl radicals (R0‘). The non-radical cellular 
ROS include hydrogen peroxide (H2O2) and singlet oxygen (^ 0 2 ) (Kohen and Nyska, 
2002; Lee, et al, 2007; Rahman, 2007). The O2*, OH’, and H2O2 are the most 
abundant forms of ROS in all metabolieally active cells, particularly in aerobic 
biological systems (Wan and Liu, 2008). While low-levels of cellular ROS is 
important in cell signalling (especially for apoptotie and necrotic cell deaths), 
excessive accumulation of ROS underlies oxidative stress in all metabolieally active 
cells (Ray et al, 2012).
Oxidative stress causes oxidative damage of important cellular components, 
particularly functional biomolecules and cellular macromolecules, particularly, the 
genomic DNA (Barzilai and Yamamoto, 2004). For instance, accumulation of ROS is 
largely implicated in oxidative damage of membrane phospholipids (through lipid 
peroxidation) (Wu and Cederbaum, 2003; Rizvi and Maurya, 2007). Irreparable DNA 
damage and associated mutations are also largely induced by cellular oxidative stress 
(Salmon et al, 2004). Oxidative stress-induced DNA damage is largely implicated in 
various metabolic and degenerative disorders such as diabetes mellitus, myocardial 
infarction, heart failure and neuro-degeneration, atherosclerosis, arthritis, and cancer 
(Dworakowski et al, 2006; Ray et al, 2012). Unchecked oxidative stress is also 
thought to accelerate cellular senescence and the ageing process (Kurz et al, 2004; 
Chen et al, 2007).
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There is a variety of natural and synthetic antioxidants usefiil for scavenging 
cellular ROS. For instance, butylated hydroxytoluene (BHT) and butylated 
hydroxyanisole (BHA) are synthetic phenolic antioxidants previously demonstrated to 
be anti-carcinogenic by inhibiting iV-acetylating and DNA-adduct formation by 
carcinogens (Chung, 1999; Lu et al, 2002). Therefore, BHT and BHA have been 
extensively used in the past as dietary antioxidant supplements (Patil et al, 2010). 
However, some studies have claimed that both BHT and BHA can induce tumors in 
the gastrointestinal tract and the liver. Following these controversies regarding the 
safety of the two synthetic antioxidants, their use has declined over the last two 
decades (Kahl and Kappus, 1993; Williams et al, 1999). Therefore, there is 
increasing interest in natural antioxidants such as ascorbic acid, tocopherols and beta- 
earotenes (You et al, 2010). Surprisingly, bioaetive peptides derived from proteolytic 
digests of plant and animal protein sources have been extensively studied for their 
antioxidant activities based on in vitro systems. While bioaetive peptides generally 
contain 3-20 amino acid residues, those containing 5-16 amino acid residues have 
been shown to exhibit in vitro antioxidant activity (Elias et aï., 2008; Bougatef et al., 
2010; Puchalska et al., 2014). Various studies have fractionated and purified peptides 
with putative antioxidant activities from egg albumen hydrolysates (Davalos et al, 
2004; Chen era/., 2012).
While numerous studies have demonstrated the antioxidant activity of bioaetive 
peptides containing 5-16 amino acid residues, the underlying antioxidant mechanisms 
have remained poorly described (Davalos et al, 2004; Udenigwe and Aluko, 2011; 
Chen et al, 2012; Wiriyaphan et al, 2012). It has been suggested that the antioxidant 
activities of some bioaetive oligopeptides are due to the presence of hydrophobic 
amino acid residues (Udenigwe, and Aluko, 2011; Sarmadi et al, 2011). However, 
His, Tyr, Trp, Val, Leu, Met, Lys, Cys, Phe and Pro amino acid residues exhibit 
antioxidant activities through ROS scavenging activities (Davalos et al., 2004). Some 
of these amino acid residues contain non-bonded side chain groups, which serve as 
hydrogen atom donors (Udenigwe and Aluko, 2011; Wiriyaphan et al, 2012). 
However, the antioxidant activity of bioaetive peptides depends on the content and 
specific sequence of the antioxidant amino acid residues (Wiriyaphan et al, 2012). 
For instance, the nonapeptide Tyr-Ala-Glu-Glu-Arg-Tyr-Pro-Ile-Leu isolated from
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egg albumen contains two Tyr and Pro amino acid residues with putative antioxidant 
activity. The nonapeptide was demonstrated to exhibit not only a strong inhibitory 
activity of the angiotensin converting enzyme (ACE), but also a high oxygen radical 
scavenging activity (Davalos et ah, 2004).
The aim of the current study was to investigate the antioxidant mechanisms of egg 
albumen hydrolysate based on its reducing power, free radical scavenging activity and 
metal chelating capacity.
3.2 MATERIALS AND METHODS
3.2.1 Materials
The egg albumen protein, pepsin and pancreatin enzymes, were obtained from 
Sigma-Aldrieh Company Ltd., Poole, Dorset, United Kingdom. All chemicals and 
reagents, which include 1,1 -diphenyl-2-picrylhydrazyl (DPPH), ferrous chloride 
(FeCb), ferrozine, 1,10-phenanthroline, phosphate buffer, hydrogen peroxide, 
phosphate, potassium hexaeyanoferrate (KsFe(CN)6), tris-HCl, nitroblue tétrazolium 
(NET), trichloroacetic aeid (TCA), non-enzymatie phenazine methosulfate- 
nicotinamide adenine dinucleotide (PMS-NADH) and tetraethoxypropane (TEP) 
were purchased from Sigma-Aldrich Company Ltd. (Poole, Dorset, UK). All these 
reagents were of analytical grade.
3.2.2 Methods
3.2.2.1 Enzymatic hydrolysis of egg albumen
Enzymatic hydrolysis of the egg albumen protein was carried out as described in 
sections 2.2.2.1.
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3.22.2 Mechanisms of antioxidative activity assays
3.2.2.2.1 Determination of reducing power assay
The antioxidant mechanism of the bioaetive peptides present in egg albumen 
hydrolysate was determined based on the ferric reducing/antioxidant power assay as 
described previously (Benzie and Strain, 1999; Pulido et al., 2000). This assay was 
based on the putative ability of the egg albumen hydrolysate to reduce ferric iron 
(Fe^ )^ to ferrous ions (Fe^ )^ as described previously by Yildirim et al. (2001) with 
slight modifications. One ml aliquots of different concentrations of the egg albumen 
hydrolysate (0.5, 1.0, 5.0, 10.0 and 20.0 mg/ml) were mixed with 2.5 ml aliquots of 
0.2 M phosphate buffer (pH, 6.6) and 1 % (w/v) potassium ferricyanide. The mixtures 
were incubated at 50 °C for 30 min. Afterward, 2.5 ml aliquots of 10 % (w/v) TCA 
were added to the mixtures and then centrifuged at 1650 x g for 10 min. In clean test 
tubes, 2.5 ml aliquots of the supernatants from each reaction mixture was mixed with
2.5 ml of distilled deionized water and 0.5 ml aliquots of 0.1 % (w/v) ferric chloride 
solution. After 10 min of incubation, the absorbance of each reaction mixture was 
determined at a wavelength of 700 nm using a spectrophotometer (UNICAM 
Speetronic, Speetronic Tudor House, Leeds, UK). The absorbance readings were 
recorded in triplicates. A higher absorbance reading indicated high reducing power. 
The absorbance readings were recorded in triplicate. BHT, trolox and ascorbic acid 
solutions were used as standards.
3.2.2.2.2 Ferrous ion (Fe^ )^ chelating activity
The ability of the peptides present in egg albumen hydrolysate to chelate 
transition metals was tested based on the Fe^  ^ ion chelation. The Fe^^-ehelating 
activity of egg albumen hydrolysate was determined by measuring the formation of 
the Fe^^-ferrozine complex using similar methods described previously by Dinis et al. 
(1994) with slight modifications. One ml aliquots of different concentrations of the 
egg albumen hydrolysate (0.5, 1.0, 5.0, 10.0 and 20.0 mg/ml) were mixed with 1.6 ml 
of distilled deionized water followed by addition of 0.05 ml aliquots of the 2 mM 
FeCl2 solution. The reaction mixtures were allowed to stand for 30 seconds where 0.1 
ml aliquots of the 5 mM ferrozine were added and allowed to stand for 10 min at 
room temperature for complexation reaction to complete. The absorbance of the
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formed Fe^^-ferrozine complex in each reaction mixture was measured at a 
wavelength of 562 nm using a spectrophotometer (UNICAM Spectronic, Spectronic 
Tudor House, Leeds, UK). BHT, trolox and ascorbic acid solutions were used as 
standards. The absorbance readings were recorded in triplicates, where the mean 
chelating activity of the egg albumen hydrolysate for Fe^  ^ was calculated using 
equation below.
Iron chelating activity (%) = (Ao-Ai/Ao) xlOO
Where, Ao is the absorbance of the control (with no peptide solution), Ai the 
absorbance of the peptide solutions treated with 2 mM FeCl2 .
3.2.2.2.3 DPPH free radical scavenging activity
Free radical scavenging activity of the egg albumen hydrolysate was measured 
using 1, 1 -diphenyl-2-picryl-hidrazyl (DPPH) radical. The DPPH radical-scavenging 
activity of the egg albumen hydrolysate was determined according to methods 
described previously by Bersuder et al. (1998). In clean test tubes, 500 pi aliquots of 
different concentrations of the egg albumen hydrolysate (0.5, 1.0, 5.0, 10.0 and 20.0 
mg/ml) were mixed with 500 pi aliquots of the 99.5 % ethanol and 125 pi aliquots of 
the 0.02 % DPPH. The mixtures were then kept at room temperature in a dark 
cupboard for 60 min. The reduction of the DPPH radical was determined at a 
wavelength of 517 nm using a UV-Visible spectrophotometer (UNICAM Spectronic, 
Spectronic Tudor House, Leeds, UK). Distilled deionized water was tested as a 
negative control while BHT, trolox and ascorbic acid were tested as positive controls. 
The absorbance readings were recorded in triplicates. The putative DPPH radical- 
scavenging activity of the egg albumen hydrolysate was calculated using equation 
below.
DPPH radical scavenging activity (%) = (Ac-As/Ac) xlGQ
Where: Ac and As are the absorbance values of the control and samples, 
respectively.
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3.2.2.2.4 Superoxide anion scavenging activity
The superoxide anion radical scavenging activity of the egg albumen hydrolysate 
was measured using similar methods described previously by Liu et al (1997) with 
slight modifications. The superoxide anion radicals were generated through chemical 
reactions involving PMS, NADH, and molecular oxygen in the non-enzymatic 
phenazine methosulfate-nicotinamide adenine dinucleotide (PMS-NADH) system. 
The superoxide anion scavenging activity of the egg albumen hydrolysate was based 
on the ability of superoxide scavengers to reduce nitroblue tétrazolium (NET) into 
formazan at pH 7.8 and room temperature. The superoxide anion was generated in the 
PMS-NADH system constituted with 3 ml of 100 mM Tris-HCl buffer (pH 7.4) 
containing 0.75 ml of 300 pM NET solution and 0.75 ml of 936 pM NADH solution. 
0.3 ml aliquots of different concentrations of the egg albumen hydrolysate (0.5, 1.0, 
5.0, 10.0 and 20.0 mg/ml) were tested for superoxide anion scavenging activity in the 
constituted PMS-NADH system. The reaction in the PMS-NADH system was 
initiated by adding 0.75 ml of 120 pM PMS and incubated at room temperature for 5 
min. After incubation, the absorbance values of the samples and control (without egg 
albumen peptides) were determined at a wavelength of 560 nm using a UV-Visible 
spectrophotometer (UNICAM Spectronic, Spectronic Tudor House, Leeds, UK). The 
absorbance readings were recorded in triplicates. The superoxide anion scavenging 
activity was estimated mathematically using equation below.
The superoxide anion scavenging activity (%) = (Ao-Ai/Ao) *100
Where; Ao and Ai are the absorbance values of the control and egg albumen 
hydrolysate, respectively.
3.2.2.2.5 Hydroxyl radical scavenging activity (HRSA)
The putative hydroxyl radical scavenging activity of the egg albumen hydrolysate 
was based on the Fenton reaction and was determined using similar methods 
described previously by Li et al (2008) with slight modifications. Reaction mixtures 
containing 60 pi of 1.0 mM FeCl], 90 pi of ImM 1,10- phenanthroline, 2.4 ml of 
sodium phosphate buffer (0.2 M, pH 7.8), and 60 pi of 15 mM EDTA, and 1.5 ml
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aliquots of egg albumen hydrolysate at different concentrations (0.5, 1, 5, 10 and 20 
mg/ml) were prepared in separate test tubes. The reactions were initiated by adding 
150 pi of 0.17 M H2O2 (0.01 %) and the mixtures were incubated at room temperature 
for 5 min. Next, the absorbance of the reaction mixtures was measured at 560 nm 
using a spectrophotometer (UNICAM Spectronic, Spectronic Tudor House, Leeds, 
UK). Distilled deionized water was assayed as a negative control, while trolox, BHT, 
and ascorbic acid were assayed as positive controls. All the absorbance readings were 
recorded in triplicate. The hydroxyl radical scavenging activity was estimated 
mathematically using equation below.
The hydroxyl radical scavenging activity (%) = (Ac-As/Ac) xlOO
Where, Ac and As are the absorbance readings of the control solution (distilled 
water as control) samples, respectively.
3.2.3. Statistical Analysis
All assays were carried out in triplicate where values were expressed as a mean± 
SD. Statistical analyses were performed using the SPSS statistical package. To 
determine if the difference between mean pairs of samples was statistically 
significant, a one-way analysis of variance (ANOVA) was performed. The confidence 
intervals using a post-hoc test coupled with a t-test were used to assess the difference 
between mean pairs, where a P-value of < 0.05 was considered a significant.
3.3 RESULTS AND DISCUSSION
3.3.1 Antioxidant mechanisms of egg albumen hydrolysatc
The putative antioxidant activity of egg albumen hydrolysate has been extensively 
documented (Davalos et al, 2004; Chen et al, 2012). However, the proposed 
antioxidant mechanisms of antioxidant peptides have remained speculative. The 
proposed mechanisms for the antioxidant activity of some bioactive peptides include 
radical scavenging, multivalent metal chelation, quenching chain reaction, reductive 
activity and decomposition of peroxides (Yildrim et al, 2000). Therefore, the present 
study investigated the scavenging activities of egg albumen hydrolysate towards
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hydroxyl, superoxide anion and DPPH radicals and its reducing power and metal 
chelation.
3.3.1.1 Reducing power
The reducing power assay determines the ability of an antioxidant to donate an 
electron or hydrogen to stabilize the oxidative potential of an oxidant molecule or ion 
radical (Benzie and Strain, 1999; Davalos et al., 2004). The ferric 
reducing/antioxidant power (FRAP) assay used in the present study determines the 
"total antioxidant power" of egg albumen hydrolysates to reduce the Fe^Vferricyanide 
complex to the more stable ferrous form (Benzie and Strain, 1999; Yildirim et al, 
2000; Amie et al, 2007; Pokora et al, 2013;). The ferrous form, which has an intense 
blue colour, can be monitored spectrophotometrically at its maximum absorption 
wavelength of 700nm {Amax 700). The reducing power of an antioxidant of interest is 
therefore, directly proportional to the absorbance at Amax 700 (Benzie and Strain, 
1999; Yildirim et al, 2000).
In the present study, the egg albumen hydrolysate resulted in the reduction of the 
yellow-coloured Fe^Vferricyanide complex in the reaction mixture to various shades 
of blue-green to blue-coloured ferrous forms (Fe^ )^ depending on the reducing power 
of the antioxidant sample tested (Beyhan et al, 2010). The ferric reducing power of 
the different concentrations of the egg albumen hydrolysate is shown in figure 3.1. 
There was a strong linear relationship between the hydrolysate concentration and 
reducing power (R^>0.957). It is clearly evident that as the concentration of the egg 
albumen hydrolysate increased from 0.5 to 20.0 mg/ml, the ferric reducing power 
increased from 0.02 to 0.08. This strongly suggests that the reducing power of the egg 
albumen hydrolysate was dose-dependent (Pokora et al, 2013).
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Figure 3.1 The ferric reducing power (ATOOnm) for different concentrations of egg
albumen protein hydrolysates.Values presented as mean ± SD (n=3).
This reducing power activity can be attributed to the increasing concentration of 
specific oligopeptides and free amino acid residues with antioxidant activity, which 
reacted with the free radicals to form products with more stable oxidative potential 
(Sun et al, 2012). It has been suggested that bioaetive oligopeptides containing one or 
more of His, Tyr, Met, Lys, Trp, Cys, Phe and Pro amino aeid residues exhibit 
antioxidant activity (Jung et al, 1995; Davalos et al, 2004; Udenigwe and Aluko, 
2011; Wiriyaphan et al, 2012). For instance, the nonapeptide, Tyr-Ala-Glu-Glu-Arg- 
Tyr-Pro-Ile-Leu, isolated from egg albumen protein hydrolysates eontain two Tyr and 
Pro amino acid residues with putative antioxidant aetivity (Davalos et al, 2004). 
While the Tyr and Pro amino acid residues act as electron donors, the Lys, Arg amino 
residues act hydrogen-bonding donors, which stabilize the oxidative potential of 
oxidants (Rapp et al, 2013).
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Figure 3.2 The ferric reducing power (Avoonm) of 1 mg/ml egg albumen protein compared 
to 0.01 % of synthetic antioxidants BHT, trolox, and ascorbic acid. Values presented as 
mean ± SD (n=3).
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However, the reducing power of the 1 mg/ml egg albumen hydrolysate was 
significantly low (p<0.05) when compared to those of synthetic antioxidants (0.01 % 
BHT, 0.01 % trolox and 0.01 % ascorbic acid) as shown in figure 3.2. Therefore, 
isolation and purification of the oligopeptides and free amino acid residue from the 
crude egg albumen hydrolysates is likely to enhance bioavailability and therefore, 
enhance the reducing power.
3.3.I.2. Ferrous (Fe^ )^ ion chelating activity
In biological systems, metals such as iron (Fe), copper (Cu), zinc (Zn), chromium 
(Cr), manganese (Mn), cobalt (Co), and many other transition metals are important 
catalytic elements required for the proper functioning of many enzymes (Kleczkowski 
and Gamcarz, 2012). However, these metals are pro-oxidant catalysts owing to their 
redox cycling reactions and when present in excess they can catalyze the generation 
of the reactive hydroxyl radicals (OH*), superoxide radical (O2*') and nitric oxide 
radical (NO*) in biological systems (Jomova and Valko, 2011). For instance, excess 
iron (II) and copper (I) in biological systems can catalyse the reduction of hydrogen 
peroxide via the Fenton reaction to generate the highly aggressive OH* radical 
according to equation below (Leopoldini et al, 2006; Amie et al, 2007). Where, M is 
the transition metal and n the valent state of the metal.
H2 O2  +  ► HO* + OH
However, antioxidant ligands can form stable complexes (metal chelates) with a 
variety of transition metal ions, therefore blocking or reducing their pro-oxidant 
actions (Leopoldini et al, 2006; Amie et al, 2007). Metal chelation is one of the 
antioxidant mechanisms, which can inhibit or slow down the generation of reactive 
radicals in biological systems (Leopoldini et al, 2006).
In the present study, the putative antioxidant properties of the egg albumen 
hydrolysate were also evaluated based on their degree of ferrous (Fe^ )^ ion chelation. 
This assay was based on the complexation reaction between aqueous solutions of
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ferrozine and FeCb to form the ferrozine-Fe "^  ^ complex. In the presence of an 
antioxidant, some Fe^  ^ ions will be chelated and, therefore, reducing ferrozine-Fe^"  ^
complex formation. Figure 3.3 shows the degree of Fe^  ^ chelation of different 
concentrations of egg albumen hydrolysates. It is evident that the Fe^”^ chelating 
capacity (% chelation) of the egg albumen hydrolysates increased with increasing 
concentrations of hydro lysates (0.5-20 mg/ml), from 4.5 % to 43.2 %. These results 
demonstrated that the egg albumen hydrolysate possesses a dose-dependent metal 
chelation activity. This strongly indicates that consumption of egg albumen proteins 
may enhance chelation of excess transition metal ions, known to catalyse lipid 
peroxidation reactions.
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Figure 3.3 Ferrous ion chelating activity for different concentrations of egg albumen
hydroIysates.Value (n=3) presented as mean ± SD.
The metal chelating potency of egg albumen hydrolysate was also compared with 
those of well-established synthetic antioxidants (trolox, BHT and ascorbic acid) as 
positive controls. Figure 3.4 shows the Fe^ "^  chelating activity of 10 mg/ml egg 
albumen hydrolysates, 0.01 % trolox, 0.01 % BHT and 0.01 % ascorbic acid. The 
percentage Fe^  ^ chelating activity was 30.82, 34.9, 29.87 and 24.89 % for egg 
albumen hydrolysate, trolox, BHT and ascorbic acid, respectively. This data strongly 
indicates that the egg albumen hydrolysate has superior Fe^  ^chelating activity over 
the well-established synthetic antioxidants at the concentrations used (p<0.05).
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Various in vitro studies have demonstrated metal chelation activity of bioactive 
peptides chelate metal ions such as iron (II) and copper (I), which are known to 
catalyse formation of hydroxyl radical from hydrogen peroxide, which initiate lipid 
peroxidation reaction (Leopoldini et al, 2006; Amie et al, 2007; Sarmadi, and Ismail, 
2010). The putative métal scavenging peptides chelate these metals and therefore, 
mask their catalytic activity on hydrogen peroxide. Metal scavenging peptides as 
ligands are also thought to form insoluble metal complexes, which sterically hinders 
the metal interaction with hydrogen peroxide and the dispersed lipids (Barkia et al, 
2010).
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Figure 3.4 Ferrous ion chelating activity of egg albumen hydrolysates (10 mg/ml), 0.01 
% trolox, 0.01 % BHT and 0.01 % ascorbic acid. Value (n=3) presented as mean ± SD.
The hydrophobic amino acid residues have been linked to both metal-chelating and 
radical-scavenging activities (Nalinanon et al, 2011; Ao and Li, 2012). Antioxidative 
peptides derived from porcine skin collagen were found to contain high proportion of 
hydrophobic amino residues such as Pro and Gly. The antioxidant peptides exhibit 
excellent metal-chelating activity (Ao and Li, 2012). The positively charged and basic 
His residue has also been suggested to contribute to the metal-chelating effect when 
present in protein hydrolysates in low concentrations. About 10 % by proportion of 
His has been frequently observed in antioxidant peptides with metal-chelating activity 
(Chen et al, 1998; Rajapakse et al, 2005). This strongly suggests that the egg 
albumen hydrolysates exhibiting the metal-chelating activity contain bioactive 
peptides with Pro, Gly and His amino acid residues, warranting isolation, purification 
and characterisation of the putative antioxidant peptides.
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3.3.3.3 D PPH  free radical scavenging activity
It is widely accepted that self-propagating lipid peroxidation chain reactions are 
initiated by free radicals. Therefore, scavenging for free radicals is one of the key 
antioxidant mechanisms. Radical scavengers react directly with free radicals 
therefore, quenching and terminating their peroxidation chain reactions. This explains 
why high-fat food products are preserved with antioxidants with radical scavenging 
activity to enhance food quality and stability (Beyhan et al., 2010). The 1, 1-diphenyl- 
2-picrylhydrazyl (DPPH*) free radical scavenging assay is a widely used 
spectrophotometric technique for determination of the radical scavenging capacity of 
antioxidants in food, beverages, vegetable extracts and protein hydrolysates (Beyhan 
et al, 2010). The DPPH’ radical scavenging assay is relatively rapid, sensitive, and 
reproducible but a simple method for evaluating the antioxidant activity of 
compounds (Ozcelik et ah, 2003).
The DPPH* radical absorbs at 517 nm and is widely used for studying the radical 
scavenging activities of some natural antioxidants such as phenolic compounds 
(Beyhan et al, 2010). When the DPPH* radicals are treated with antioxidant analytes, 
the radicals are quenched by accepting protons (hydrogen) donated by the 
antioxidants. The DPPH* radicals are therefore, reduced to stable, yellow-coloured 
diphenyl-picrylhydrazine (DPPH-H) and thus scavenged. Increased concentration of 
the non-radical form DPPH-H reduces absorbance of the reaction mixture at 517 nm, 
and this provides a spectrophotometric means for measuring the radical-scavenging 
activity of the antioxidant analyte (Shimada et al, 1992; Beyhan et al, 2010). 
Therefore, the present study measured the DPPH radical-scavenging activity of 
different concentrations (0.5, 1.0, 5.0, 10.0 and 20.0 mg/ml) of the egg albumen 
hydrolysate. The reaction mixture of egg albumen and DPPH changed from purple to 
yellow, indicating that the DPPH* radicals were scavenged characterised by reduced 
absorbance value at 517 nm. Figure 3.5 clearly indicates that the DPPH* radical 
scavenging activity of the egg albumen hydrolysate increased significantly with 
concentration (p<0.05).
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Figure 3.5 The 1,1- diphenyl-2- picrylhydrazyl (DPPH) free radical scavenging activity
of different concentrations of egg albumen hydrolysates (0 - 20 mg/ml). Value (n=3) 
presented as mean ± SD.
The scavenging activity was determined based on the inhibitory concentration of 
the egg albumen hydro lysate that scavenged 50 % of the initial concentration of 
DPPH (IC50). In this case, IC50 of the egg albumen hydrolysate was inversely 
proportional to its radical scavenging activity where; a lower IC50 value indicates a 
higher free-radical scavenging activity. The IC50 value of the egg albumen 
hydrolysate obtained from the linear regression equation was found to be 23,46 mg/ml 
and there was a strong linear relationship between peptide concentration and the 
percentage DPPH radical scavenging activity (j^>0.99). This strongly indicates that 
the DPPH radical scavenging activity of the egg albumen hydrolysate was dose- 
dependent as observed in a similar recent in vitro study by Sun et al. (2013).
These data strongly indicate that the egg albumen hydrolysate confers its putative 
antioxidant activity through radical scavenging activity of the peptides which acted as 
good electron and/or hydrogen donors when interacting chemically with the free 
radicals (Sarmadi and Ismail, 2010; Sun et al, 2013). It has been suggested that the 
radical scavenging activity of protein hydrolysates or peptides is influenced by the 
overall hydrophobicity (Rajapakse et al, 2005; Li et al, 2008). Peptide 
hydrophobicity enhances its bioavailability to the hydrophobic targets (Kim et al.,
2007).
Furthermore, the proportions of certain amino acid residues in hydrolysates or 
bioaetive peptides have been correlated with the overall antioxidant power of 
peptides. For instance, hydrophobic, branched and aromatic amino acid residues such
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as Phe, Tyr, He and Val have unique structural features that enhance the radical 
scavenging activity of antioxidant peptides (Jung et al, 1995; low, and Gan, 2013).
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Figure 3.6 The l,l-diphenyl-2- picrylhydrazyl (DPPH) free radical scavenging activity 
of 10 mg/ml egg albumen hydrolysates, compared to those of 0.01 % trolox, 0.01 % BHT 
and 0.01 % ascorbic acid used as positive controls. Value (n=3) presented as mean ± SD.
The DPPH radical scavenging potency of the egg albumen hydrolysate was also 
compared with those of well-established synthetic antioxidants (0.01 % trolox, 0.01 % 
BHT and 0.01 % ascorbic acid) as positive controls (Fig 3.6). It is clearly evident that 
the egg albumen hydrolysate exhibited a slightly higher DPPH radical scavenging 
activity (22.94 %) when compared to BHT (18.69 %) and ascorbic acid (10.70 %). 
However, trolox exhibited the highest DPPH radical scavenging activity (65.55 %). 
This can be attributed to the high proportion of bioaetive peptides with electron- or 
hydrogen-donating capacity in the egg albumen hydrolysate (Beyhan et al, 2010). 
Amino acid residues that act as electron- or hydrogen-donors react with the free 
DPPH radicals, therefore quenching their reactivity by forming stable non-radical 
forms of the DPPH (Beyhan et al, 2010; Sun et al, 2013). Furthermore, the electron- 
donating peptides can scavenge free reactive radicals through terminating the 
propagation steps of radical-initiated chain reaction (Sun et al, 2013).
It has been suggested that the radical scavenging activity of antioxidant peptides is 
also contributed by the hydrogen donated by the hydroxyl groups of aromatic amino 
acid residues as Phe, Typ, His and Tyr (Jung et al., 1995). Indeed, recent in vitro 
studies have demonstrated that egg protein hydrolysates contain bioaetive peptides 
with a significant proportion of hydrophobic amino acid residues particularly, Tyr,
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Pro, Met, Val, and His. These amino residues enhance accessibility (bioavailability) 
of the bioaetive peptides to the hydrophobic targets, particularly, free radicals. This 
enhances radical scavenging capacity of the bioaetive peptides (Jung et al, 1995; low, 
and Gan, 2013).
3.3.3.4. Superoxide anion radical scavenging activity
Superoxide anion radical is a highly reactive oxygen species in biological systems 
known to initiate lipid peroxidation. It also acts as a precursor for additional ROS 
such as hydroxyl radicals and singlet oxygen, which are known to cause oxidative 
damage to cells and tissues (Rahman, 2007; Covarrubias et al, 2008; Sun et al, 
2013). Therefore, studying superoxide anion radical scavenging activity antioxidants 
is of great importance from a nutritional perspective (Covarrubias et al, 2008; Sun et 
al, 2013). In the present study, the superoxide anion scavenging activity of the egg 
albumen hydrolysate, which is known for its putative antioxidant activity, was 
studied. The non-enzymatic PMS/NADH-NBT system is widely used for generating 
superoxide anion radical through oxidation of the PMS, NADH, and molecular 
oxygen (Sannigrahi et al, 2010; Sun et al, 2013).
The superoxide anion radical scavenging activity of different concentrations of the 
egg albumen hydrolysates is presented in figure 3.7. The egg albumen protein 
hydrolysate exhibited considerable scavenging activity over superoxide anion radical 
(Sun et al, 2013), which clearly increased with hydrolysate concentrations fi-om 0 to 
20 mg/ml. The IC50 value calculated from the linear regression equation was found to 
be 11.96 mg/ml. This strongly indicates that the scavenging activity of the egg 
albumen hydrolysate towards superoxide anion was dose-dependent as observed 
previously by Sun et al (2013).
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Figure 3.7 The superoxide anion scavenging activity of different concentrations of egg 
albumen hydrolysates (0-20 mg/ml). Value (n=3) presented as mean ± SD.
The superoxide anion radical scavenging potency of 10 mg/ml egg albumen 
hydrolysate was also compared with those of well-established synthetic antioxidants 
(0.01 % trolox, 0.01 % BHT and 0.01 % ascorbic acid) as positive controls as shown 
in figure 3.8. Superoxide radical scavenging activity of the 10 mg/ml egg albumen 
hydrolysatc was significantly high (49.78 %), when compared to the synthetic 
antioxidants: 0.01 % trolox (16.33 %), 0.01 % BHT (19.13 %) and 0.01 % ascorbic 
acid (9.90 %) (p<0.05). These data indicate that the egg albumen hydrolysatc was a 
strong scavenger of superoxide anion radical and therefore, protects cells from 
superoxide anion-initiated lipid peroxidation and associated cellular damage 
(Sannigrahi et al, 2010; Sun et al, 2013).
îl
2 =
0  b£
1
60.00
50.00
40.00
30.00
20.00 
10.00
0.00 I ■
EAH BHT Trolox
Antioxidants
Ascorbic acid
Figure 3.8 The superoxide anion scavenging activity of 10 mg/ml egg albumen 
hydrolysates, compared with those of 0.01 % trolox, 0.01 % BHT and 0.01 % ascorbic 
acid used as positive controls. Value (n=3) presented as mean ± SD.
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3.3.3.5 H ydroxyl radical scavenging activity
The hydroxyl radical is another endogenously generated free radical in 
metabolically active biological systems (Rahman et al, 2010). Just like the 
superoxide radicals, hydroxyl radicals can react with lipids, proteins, amino acids and 
the genomic DNA, therefore causing cellular and DNA damage (Jackson, et al, 1987; 
Malins et al, 1996). Therefore, antioxidants with scavenging capacity for the reactive 
hydroxyl radicals are protective to body cells from oxidative damage and lipid 
peroxidation. The in vitro hydroxyl radical scavenging capacity of the different 
concentration of the egg albumen hydro lysates is presented in figure 3.9.
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Figure 3.9 The hydroxyl radical scavenging activity of different concentrations of egg 
albumen hydrolysates (0-20 mg/ml). Values (n=3) presented as mean ± SD.
The results clearly show that the egg albumen hydrolysatc exhibited hydroxyl 
radical scavenging activity, which increased with concentration and is therefore, dose- 
dependent. These results indicate that the egg albumen hydrolysatc contained 
bioaetive peptides with hydroxyl radical scavenging aetivity. The peptides contained 
amino acid residues, which acted as hydrogen atom donors, therefore stabilizing the 
hydroxyl radicals (Jung et al, 1995; low, and Gan, 2013).
The hydroxyl anion radical scavenging activity of 10 mg/ml of the egg albumen 
hydrolysatc was also compared with those of well-established synthetic antioxidants 
(0.01 % trolox and 0.01 % BHT) as positive controls as shown in figure 3.10. The 
scavenging capacity of the egg albumen hydrolysatc was significantly high (70.67 %) 
when compared with that of BHT (58.33 %) and trolox (40 %) (p<0.05). The results
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clearly indicate that the egg albumen hydrolysatc has a superior hydroxyl radical 
scavenging activity over BHT and trolox at the concentrations used. This can be 
attributed to the presence of bioaetive peptides containing high proportion of 
hydrophobic amino acid residues such as Tyr, Pro, Met, Val, and His, which 
enhanced peptide accessibility to the hydrophobic hydroxyl radical targets, where 
they donate hydrogen to stabilize the radicals (Jung et al, 1995; low, and Gan, 2013).
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Figure 3.10 The hydroxyl radical scavenging activity of 10 mg/ml of the egg albumen 
hydrolysatc, compared to those of 0.01 % trolox and 0.01 % BHT as positive controls. 
Value (n=3) presented as mean ± SD.
3.4 CONCLUSION
The present study attempted to study the anti oxidant mechanisms of egg albumen 
protein hydrolysatc. Radical scavenging aetivity, metal chelation capacity and 
reducing power of the egg albumen hydrolysatc were evident. The hydrolysatc 
scavenged hydroxyl, superoxide anion and DPPH radicals in a dose-dependent 
manner. The ferric ion (Fe^ )^ reducing power and Fe (11) metal chelation capacity of 
the egg albumen hydrolysatc were also dose-dependent.
Antioxidant peptides contain amino aeid residues that act as electron donors, and 
which reduce and stabilize divalent and multivalent metal ions. The metal chelation 
activity of the peptides can be attributed to the presence of amino residues acting as
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hydrogen donors. Such peptides act as ligands that chelate metal ions, thereby 
masking their catalytic activity towards the generation of ROS. The radical 
scavenging activity of the peptides can be attributed to the presence of peptides with 
hydrophobic amino residues such as Tyr, Pro, Met, Val, and His, some of which also 
act as hydrogen donors. The hydrophobicity of the antioxidant peptides enhances their 
access to the hydrophobic radical targets, thus donating protons (hydrogen) to 
stabilize the radicals.
The above findings demonstrate that egg albumen hydrolysate prepared using 
pepsin and pancreatin, contain bioaetive peptides with antioxidant activities that are 
comparable to the well-established synthetic antioxidants such as ascorbic acid, BHT 
and trolox at the doses used.
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CHAPTER 4
4. ANGIOTENSIN-I CONVERTING ENZYME (ACE) 
INHIBITORY PEPTIDES DERIVED FROM EGG ALBUMEN 
HYDROLYSATE
4.1 INTRODUCTION
An estimated 30 percent of the adult populations worldwide have high blood 
pressure (hypertension); where hypertension is defined as blood pressure (BP) 
exceeding 140/90 mm Hg (Chow et ah, 2013). Hypertension is extensively associated 
with cardiovascular disease (CVD) as the leading risk factor for coronary heart 
disease (CHD), stroke, arteriosclerosis, myocardial infarction and kidney failure, 
worldwide (Alper et al., 2001; Chow et al., 2013). Consequently, hypertension is 
estimated to cause more than 7.6 million CVD-related deaths each year, globally 
(Chow et al., 2013). While the risk of developing hypertension is highest in 
individuals older than 60 years, important risk factors for hypertension include family 
history, obesity, smoking, excessive consumption of alcohol, high dietary salt intake 
and high serum cholesterol (Buttar et al., 2005; Goldstein et al., 2008). Therefore, 
lifestyle moderation has remained an important patient self-management approach to 
hypertension control (Scisney-Matlock et al., 2009; Bray et al., 2013).
Although the aetiology of hypertension is multifaceted while its pathophysiology 
is highly complex, angiotensin I-converting enzyme (ACE) underpins homeostatic 
blood pressure and regulation. ACE is a dipeptidyl carboxypeptidase enzyme (EC. 
3.4.15.1) encoded by the ACE gene, initially isolated from horse blood (Meng and 
Berecek, 2001; Wijesekara and Kim, 2010). The ACE gene encodes the downstream 
components of the renin-angiotensin system (RAS) and therefore increasing 
enzymatic conversion of the inactive decapeptide (angiotensin I) to the highly potent 
vasoconstrictor octapeptide (angiotensin II hormone), which results in antagonistic 
inactivation of the vasodilator bradykinin in kallikrein-kinin system (Morshed et al., 
2002; Wijesekara and Kim, 2010). The angiotensin II is also involved in the 
stimulation of the release of sodium-retaining steroids and aldosterone from the 
adrenal cortex, which contribute to increase blood pressure (Wijesekara and Kim, 
2010). In hypertensive individuals and those with CVD, the levels of angiotensin II
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hormone circulating in their peripheral blood are abnormally high resulting in 
induction and sustained vasoconstriction of blood vessels. This results in increased 
resistance of blood flow through most of the blood vessels and therefore increasing 
the energy the heart has to expend to pump blood through the body’s main arteries 
(Sweitzer, 2003).
Consequently, inhibition of the ACE reverses hypertension by blocking production 
of angiotensin II hormone and reactivation of the protective vasodilator bradykinin 
(Sweitzer, 2003; Wijesekara and Kim, 2010). Most antihypertensive drugs belong to 
two main drug classes; ACE inhibitors and angiotensin II receptor blockers 
(angiotensin II receptor antagonist). Both have comparable efficacy in the treatment 
of cardiovascular diseases, kidney disease and type 2 diabetes (Kaplan, 1999; Terra, 
2003; Abuissa et al., 2010; Verdecchia et al., 2010). ACE inhibitors (ACEIs) induce 
their antihypertensive effects by reversing the angiotensin Il-induced vasoconstriction 
of blood vessels through blockade of the RAS. RAS blockade results in the inhibition 
of enzymatic conversion of angiotensin I to angiotensin II hormone (Verdecchia et 
al., 2010). In contrast, the angiotensin II receptor blockers (ARBs), selectively 
inhibits angiotensin II activity by binding competitively to the angiotensin II 
receptors. Furthermore, ARBs selectively displace angiotensin II from their 
corresponding angiotensin I receptors, therefore reversing vasoconstriction of blood 
vessels induced by angiotensin II hormone (Barreras and Gurk-Turner, 2003; 
Verdecchia et al., 2010).
Synthetic ACEIs include captopril, benazepril, enalapril, lisinopril and 
trandolapril, among others. On the other hand, synthetic ARBs include candesartan, 
losartan, telmisartan, eprosartan, irbesartan, and valsartan. The use of ACE inhibitors 
and ARBs as monotherapy or as ACEIs/ARBs combination therapy confer 
comparable antihypertensive efficacy (Makani et al., 2013). However, the 
antihypertensive benefits of these drugs are often accompanied by multiple 
undesirable side effects. For instance, all ACEIs may induce undesirable hypotension 
(characterized by weakness and dizziness), persistent dry cough, acute renal failure, 
skin rashes, angioneurotic edema, increased potassium retention (hyperkalemia), and
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complications during pregnancy (Yusuf et al., 2008; Wijesekara and Kim, 2010; Izzo 
and Weir, 2011).
Following the undesirable side effects of the synthetic ACEIs and ARBs, there is 
increasing interest of ACEIs derived from bioaetive phytochemicals, food proteins, 
and microbial sources, which confer antihypertensive benefit with fewer or no side 
effects (Wijesekara and Kim, 2010). Plant flavonoids, phlorotannins, bioaetive 
peptides, and chitooligosaccharide derivatives, derived from marine organisms 
particularly seaweeds have shown remarkable ACE inhibition activity. Such natural 
ACEIs can be developed as antihypertensive pharmaceuticals and nutraceuticals 
(Wijesekara and Kim, 2010; Cian et al., 2014). Bioaetive peptides with the putative 
ACE inhibition can be obtained from food proteins containing bioaetive peptide 
sequences. However, the short chains of amino acids within the bioaetive peptide 
proteins are usually inactive. Such amino acids can be mobilized through 
gastrointestinal digestion, food processing, and microbial fermentation (Wijesekara 
and Kim, 2010; Kim, 2013; Zambrowicz et al., 2013). For instance, bioaetive 
peptides have been derived from fish and marine proteins by enzymatic hydrolysis of 
marine proteins, in vitro, using various proteolytic enzymes under appropriate 
hydrolytic conditions (Raghavan and Kristinsson, 2009; Kim, 2013). Enzymatic 
hydrolysis through microbial fermentation has been successfully used to mobilize 
bioaetive peptides from seafood particularly oyster and blue mussel sauces (Je et al.,
2005).
Recent studies have demonstrated that egg-white proteins, particularly ovalbumin 
and ovotransferrin, have ACE-inhibitory activity when degraded with pepsin 
(Abeyrathne et ah, 2013; Zambrowicz et ah, 2013). It is possible to mobilize ACE 
inhibitor peptides from chicken egg albumin proteins through in vitro digestion using 
lysozyme hydrolysate (Rao et ah, 2012). However, hydrolysis of egg-white proteins 
with gastrointestinal proteases yields ACE-inhibitory peptides that can resist digestive 
action when administered orally. Furthermore, it is also possible to hydrolyze the egg 
albumin using gastrointestinal proteases in vitro through simulated gastrointestinal 
digestion (Zambrowicz et ah, 2013). Therefore, the aim of the present study was to
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mobilize and characterize ACE-inhibitor peptides from egg albumen hydrolysate 
using pepsin and pancreatin enzymes, in vitro.
4.2 MATERIALS AND METHODS
4.2.1 Materials
Egg albumin, pepsin and pancreatin enzymes, hippuryl-L-histidyl-leucine (Hip- 
His-Leu) substrate, rabbit lung ACE 4 units/mg, phenylisothiocyanate (PITC), 
Sephadex G-25, triethylamine (TEA), captopril, and amino acid standard solution 
were obtained from Sigma-Aldrich Company Ltd. (Poole. Dorset, UK). High-quality 
2 kDa, 5 kDa and 10 kDa ultrafiltration membranes were obtained from Vivaspin, 
Epsom, UK. Acetonitrile used was of HPLC grade quality while sodium hydroxide, 
sodium acetate, and sulphuric acid were of analytieal grade. All these chemicals were 
purchased from Fisher Scientific Holding UK Ltd. (Loughborough, UK).
4.2.2 Methods
4.2.2.1 Enzymatic hydrolysis of egg albumen hydrolysatc
Enzymatic hydrolysis of the egg albumen protein was carried out as described in 
sections 2.2.2.1.
4.2.2.2 Purification of antihypertensive peptide
4.2.2.2.1 Ultrafiltration
Ultrafiltration of the egg albumen hydrolysate was carried out as described in 
sections 2.2.2.2.
4.2.2.2.2 Gel Filtration chromatography
Gel Filtration chromatography of the egg albumen hydrolysate was carried out as 
described in sections 2.2.2.3.
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4.2.2.2.3 R everse Phase-H igh Perform ance Liquid Chrom atography (RP-H PLC )
The RP-HPLC analysis of the peptide fraetions was carried out using a liquid 
chromatography system assembled in tandem with a P2000 pump for HPLC 
autosampler (Thermoseparation Products), Spectra Physics AS 1000 HPLC 
autosampler and a detector (Thermoseparation Products UV6000LP). The HPLC 
system was also equipped with user interface integration software (Chromoquest, 
2004).
The most bioaetive ACE inhibitory peptide fraction as fraetioned by gel filtration 
on Sephadex G-25 according to their relative MWCO was further purified through 
Partisil 10 pm ODS (1) C l8 EC Column (9.5 x 500 mm) using preparative RP-HPLC 
(Whatman pic, UK). A 5 ml aliquot of the sample containing TEA soluble peptides 
(10 mg/ml) was loaded onto a RP-HPLC column and eluted at a flow rate of 1 ml/min 
with the linear gradient system from 0.1 % TEA in water (eluent A) to 0.1 % TEA in 
acetonitrile (eluent B). The specific linear gradient system for acetonitrile was 0-70 % 
in 70 min (Table 4.1). The elution peaks were monitored at a wavelength of 250 nm 
where 2 ml fractions were collected and pooled. The fraction from the peak 
corresponding to the highest ACE inhibitory activity was collected, pooled, and 
lyophilized pending further tests (Sarbon, 2011).
Table 4.1 Gradient profile for the ehromatographie separation of peptides by RP-HPLC
Time (min) Elution flow rate Eluent A (%) Eluent B (%)
(ml/min)
0 1 100 0
50 1 30 70
60 1 30 70
65 1 100 0
70 1 100 0
4.2.2.3 ACE inhibitory activity assays
ACE inhibitory activity was measured according to methods described previously 
by Wu et al. (2002) as slightly modified by Gupta et al. (2013). This method was
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based on the ACE catalyzed liberation of hippuric acid from the hippuryl -L-histidyl- 
L-leucine (Hip-His-Leu) residue. 10 pi of the sample peptide fraction was added to 50 
pi of substrate (2.17 mM Hip-His-Leu in 0.1 M borate buffer containing 0.3 M NaCl, 
pH 8.3) and then incubated at 37 °C for 10 min. 10 pi aliquot of ACE (2 mU) was 
incubated separately for 10 min where the two were then mixed and incubated further 
for 30 min at 37 °C with continuous agitation. The reaction was terminated by the 
addition of 85 pi of 1 M HCl and votexed. The positive control was prepared by 
adding ACE to Hip-His-Leu, while the blank solution was prepared by reconstituting 
Hip-His-Leu substrate in buffer.
High-performance liquid chromatography
The HPLC analysis was carried out as initially described in section 4.2.2.2.3. 
Sample aliquots of 10 pi were loaded onto a C l8 column (3.0 x 150 mm, 5 pm) and 
eluted at a flow rate of 1 ml/min with a two-eluent system; eluent A (0.05 % (v/v) 
TEA in deionized water) and eluent B (acetonitrile with 0.05 % (v/v) TEA). The 
elution was carried out using a linear gradient where, for the first 10 min acetonitrile 
gradient was 5-60 %, and then switched to 60 % acetonitrile gradient for 2 min and 
then switched back to 5 % acetonitrile for 1 min. Finally, the samples were 
isocratieally eluted for 4 mins at a flow-rate of 1 ml/min. The elution peaks of the 
hippuric acid and Hip-His-Leu were spectrophotometrically monitored at a 
wavelength of 228 nm.
The ACE inhibitory activity of the peptide factions were estimated using the 
equation below (Li et al., 2005; Li et al., 2007).
ACE inhibitory activity (%) = 100-[(S-B)/(C-B) x 100]
Where C is the control peak area (buffer alone), B is the reaction blank peak area 
(sample with ACE), and S is the sample peak area. The inhibitory concentration (IC50) 
value was defined as the concentration of the inhibitory peptides in mg/ml required to 
decrease ACE activity by 50 % under the assayed conditions. This was determined by 
regression analysis of % ACE inhibition versus the logarithm of peptide concentration 
(mg/ml).
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4.2.2.4 ACE inhibition mechanism
The ACE inhibitory peptide was prepared in two different strengths, which were 
added separately to each reaction mixture (4 and 10 mg/ml). ACE inhibitory activity 
was determined with different coneentrations of the Hip-His-Leu substrate (0- 21.7 
pM) for different times (0-40 min). The reaction mixtures were analysed for strength 
of peaks of the liberated hippuric acid using the same HPLC analysis procedure 
described initially in section 4.2.2.S. Lineweaver-Burk plots were used to determine 
the ACE kinetics in the presence of the ACE inhibitory peptide (Kasase, 2009).
4.2.2.5 Amino acid analysis of ACE inhibitory peptides
Amino acid analysis of ACE inhibitory peptides was carried out as described in 
sections 2.2.2.5.
4.2.3 Statistical analysis
All assays were carried out in triplicate where values were expressed as a mean± 
SD. Statistical analyses were performed using the SPSS statistical package. To 
determine if the difference between mean pairs of samples was statistically 
significant, a one-way analysis of variance (ANOVA) was performed. The confidence 
intervals using a post-hoc test coupled with a t-test were used to assess the difference 
between mean pairs, where a P-value of < 0.05 was considered a significant.
4.3 Results and Discussion
4.3.1 In vitro enzyme hydrolysis of egg albumen hydrolysate
The egg albumen was hydrolysed with two commercially obtained proteases 
(pepsin and pancreatin enzymes) which are similar to those produced by humans. 
Stepwise hydrolysis of the egg albumen carried out under optimal hydrolysis 
conditions, particularly enzyme-specific temperature and pH conditions, to optimise 
mobilization of the ACE inhibitory peptides (Chel-Guerrero et ah, 2012; Pokora et al. 
2013). Pepsin enzyme found in the human gastric juice catalyses hydrolytic cleavage 
of protein peptide bonds linking the amino termini of tyrosine and phenylalanine 
(Jung et al., 2006). On the other hand, pancreatin enzyme hydrolyses peptide bonds
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linking amino ends of arginine, lysine, trypsin and leucine (Adamson and Reynolds, 
1995). Therefore, stepwise digestion of the egg albumen using the two proteases 
permitted the hydrolysis of nearly all peptide bonds in the egg albumen and was 
useful. This strongly demonstrates that ACE inhibitory peptides can be mobilized 
from egg albumen in an in vitro digestion model system simulating the 
gastrointestinal digestive system of humans.
To determine the ACE inhibitory activity of the peptides, the egg albumen 
hydrolysates were treated with ACE obtained from rabbit lung. The rabbit lung ACE 
is similar to that purified from human plasma and therefore suitable for demonstrating 
the antihypertensive activity of egg albumen hydro lysate (Bull et al., 1985; Xiao et 
al., 2006). The ACE inhibitory activity of the hydrolysate produced by the two 
proteases was 59±0.33 % with a corresponding IC50 value of 8.79±0.56 mg/ml. This 
strongly indicates that the hydrolytic activity of the two proteases (pepsin and 
pancreatin) was efficient in liberating and mobilizing the ACE inhibitory peptides, in 
vitro. Most bioaetive ACE inhibitory peptides are inactive when bonded by peptide 
bonds within sequences of the parent protein molecules (Sharma et al., 2011; Bah et 
al., 2013). However, various studies have demonstrated that useful bioaetive peptides 
can be liberated and mobilised through food processing, microbial fermentation and 
during enzymatic digestion (Meisel 1997; Bah et al., 2013). The bioaetive short- 
chained peptides in protein hydrolysates produced from gastrointestinal digestion are 
easily absorbable through gastrointestinal walls into the body where they needed 
(Robert e/a/. 1999).
It is has been demonstrated that hydrolysates of egg white or egg-yolk proteins 
digested with proteolytic enzymes exhibited both ACE-inhibitory and antioxidant 
activities. However, egg-protein hydrolysate obtained from stepwise hydrolysis of 
egg-proteins using thermolysin and alcalase proteases exhibited markedly higher 
ACE-inhibitory activity than egg-protein hydrolysate obtained using pepsin and 
pancreatin. However, the two egg-protein hydrolysates exhibited comparable 
antioxidative activity (Davalos et al., 2004; You and Wu, 2011). This strongly 
indicates that gastrointestinal and non-gastrointestinal proteolytic enzymes can
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liberate peptides with dual protective benefits; antioxidation and ACE-inhibitory 
activities (Davalos et al., 2004).
Previous studies have shown that the short-chained ACE inhibitory peptides are 
low molecular weight dipeptides or oligopeptides consisting of 2 - 1 2  amino acids 
(Byun and Kim 2002; Zambrowiez et al., 2013). In a previous study, Iroyukifujita and 
Eiichiyokoyama (2000) prepared chicken muscle and ovalbumin hydrolysate using 
thermolysin and peptic digestive enzymes, respectively. The protein hydrolysate 
produced contained a total of eight ACE inhibitory peptides with varying IC50 values. 
However, ACE inhibitory peptides that were not altered after pre-ineubation with 
ACE and those converted into true ACE-inhibitors by ACE or gastrointestinal 
proteases, exhibited superior inhibitory activity with a IC50 value of 29 pg/ml. 
Surprisingly, one of the eight peptides (with amino acid sequence LKPNM) with 
moderate ACE inhibitory activity (IC50 =2.4 pM), was found to be hydrolysable by 
ACE to produce a shorter inhibitory peptide (LKP), which exhibited markedly strong 
ACE inhibitory activity with a corresponding IC50 value of 0.32 pM) (Iroyukifujita 
and Eiichiyokoyama, 2000). Similarly, a recent study has demonstrated that shark 
meat hydrolysate produced by the protease SM980I1 exhibited superbly strong ACE 
inhibitory activity with a corresponding IC50 value of 0.4 mg/ml (Wu et al., 2008). 
This IC50 value was markedly higher than the IC50 value of 10.5 mg/ml exhibited by 
undigested shark slurry (He et al., 2007).
Apart from animal proteins, it is also possible to hydrolyse soy protein using 
pepsin and panereatin enzymes to produce soy protein hydrolysate containing ACE 
inhibitory peptides. In this ease low-moleeular weight dipeptides and oligopeptides 
and those with higher hydrophobicity were the most bioactive peptides (Lo and Li- 
Chan, 2005). This strongly suggests that dipeptides and oligopeptides with higher 
hydrophobicities are the typical high-active ACE inhibitory peptides (Zhu et al., 
2010; Wu et al., 2013). While food-grade proteolytic enzymes from microbial 
cultures, animal, and plant sources may have comparable hydrolytic activities, these 
enzymes have different specific optimal temperature and pH ranges for optimal 
hydrolysis of various types of peptide bonds (Panyam and Kilara, 1996). Therefore, it 
is evident that ACE inhibitory peptides can be liberated from their parent protein
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sequence by proteolytic enzymes under optimal hydrolyzing conditions. Importantly, 
the bioactive dipeptides and the short-chained oligopeptides released from the protein 
hydrolysate are usually of low molecular weight and therefore can be separated by 
ultrafiltration. In the present study, the egg albumen hydrolysates were ultrafiltered 
through 2, 5 and 10 kDa ultrafiltration membranes to separate the peptides according 
to molecular size.
4.3.2 Purification of antihypertensive peptide
4.3.2.1 U ltrafiltra tion  separation of active peptide fractions
The egg albumen hydrolysates were filtered through 2, 5 and 10 kDa ultrafiltration 
membranes to separate the peptides according to molecular weights (Chiang et al.,
2006). The three step ultrafiltration process yielded three molecular weight peptides 
fractions of 2, 5 and 10 kDa with recovery yields of 57, 28 and 15 %, respectively 
(Table 4.3). The yield of peptide fraction (2 kDa) with the shortest peptide chains and 
lowest molecular weights was the highest (57 %) as compared to other short-chained 
peptide fractions (28 and 15 %). In this case, the 2 kDa peptide fraction exhibited the 
highest ACE inhibitory activity, followed by 5 kDa and 10 kDa peptide fractions. 
This is consistent with ACE inhibitory activity of peptide fractions described in other 
similar studies (Byun and Kim, 2001; Jung et al., 2006; Vastag et al., 2010; Forghani 
et al., 2012).
Table 4.2 Yield recovery of egg albumen hydrolysate fractions.
Short-chain Peptide Yield recovery (%)
Fractions
2 KDa 57
5 KDa 28
10 KDa 15
It is evident that peptide molecular size (kDa), which corresponds to the peptide 
molecular weight, has a direct influence on the ACE inhibitory activities of the egg 
albumen hydrolysate. Under in vitro conditions, it is plausible that the small low- 
molecular weight peptides have higher ACE inhibitory activity owing to their 
mobility and effective adsorbability to the active sites of ACE, therefore inducing 
ACE inhibition (Tidona et al., 2009; Tavares et al., 2011). Similarly, the low-
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molecular weight peptides have enhanced biological activity in vivo due to their 
enhanced absorbability through gastrointestinal walls into blood as compared to the 
higher molecular weight peptides. This strongly indicates that low-molecular weight 
ACE inhibitory peptides have enhanced bioavailability after oral administration 
(Vermeirssen et al., 2004; Tavares et al., 2011). Figure 4.1 below shows differential 
% ACE inhibitory activities of the three peptide fractions (2, 5 and 10 kDa) of the egg 
albumen hydrolysate produced by two proteases (pepsin and panereatin). Captopril, a 
synthetic ACE inhibitor used for the treatment of hypertension was included as a 
positive control. 2, 5 and 10 kDa ACE inhibitory peptides exhibited % ACE 
inhibitory activities of 78, 71 and 62 %, respectively. The positive control (captopril) 
exhibited ACE inhibitory activity of 96 %.
B 80
I
10 kDa 
Fractions
Hydrolysate Captopril2kO a 5 kDa
Figure 4.1 ACE inhibitory activity (%) of egg albumen hydrolysate and 2,5,10 kDa 
(MWCO) ultrafiltration fractions. Value (n=3) presented as mean ± SD.
Table 4.4 shows % ACE inhibitory activity of the three ACE inhibitory peptide 
fractions with corresponding concentrations required to inhibit 50 % of the ACE 
activity (IC50). The presented data shows that % ACE inhibitory activity increased 
with reducing ACE inhibitory peptide factions. It is also evident that the smaller the 
ACE inhibitory peptide faction the lower the concentration needed to inhibit 50 % of 
the ACE activity (IC50). The ACE inhibitory peptide factions 2, 5 and 10 kDa 
exhibited IC50 values of 6.01, 6.86 and 7.93 mg/ml respectively. A low IC50 value 
indicates a high ACE inhibitory activity as extensively demonstrated in the literature 
(Hai-Lun et al., 2006; Vercruysse et al., 2010; Eau et al., 2013). In the present study, 
captopril included as a positive control exhibited a markedly lower IC50 value of 
0.016 mM indicating its high antihypertensive potency.
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Table 4.3 ACE inhibitory activity of egg albumen hydro lysate fractions.
Fraction of EAR ACE Inhibition ICso (mg/ml)
(%)
10 kDa 62±0T6 7.93±0.07
5 kDa 71±0.07 6.86±0.15
2 kDa 78±0.02 6.01±0.02
Captopril 96±0.04 0.016±0.19 mM
It is extensively observed that ACE-inhibitory activities of peptides with 6 or less 
amino acids at the C-termini are influenced significantly by the hydrophobicity, the 
degree of positive charge, and the bulk density of the amino acids adjacent to the C- 
termini (Pripp et ah, 2005; Hayes et al., 2007). The hydrophobicity of ACE 
inhibitory peptides is due to the hydrophobic C-termini end of the peptides (Segura- 
Campos et al., 2013). In contrast, hydrophilic nature of peptides with hydrophilic 
amino acids at the C-termini underpins weak or no ACE inhibitory activity. This is 
due to the incompatibility nature of the hydrophilic amino acids with the active sub­
sites of the ACE. These strongly indicate that the overall hydrophobicity of the 
peptides is an important feature for the antihypertensive potency of ACE inhibitory 
peptides (Wijesekara and Kim, 2010; He et al., 2011). Jung et al. (2006) 
demonstrated that hydrolysis of proteins with a-chymotrypsin enzyme can only yield 
bioactive peptides with C-termini of various amino acids but not the highly 
hydrophobic amino acids Pro, Val and Phe. This warrants the need to indentify 
digestive enzymes that can yield ACE inhibitory peptides with the high ratios of the 
hydrophobic amino acids at the C-termini (Jung et al., 2006).
However, while ACE inhibitory peptides from protein hydrolysates exhibit 
markedly lower ACE inhibitory activity as compared to synthetic ACE inhibitors, the 
former is readily obtained through in vivo digestion of proteins and should have 
additional antioxidation activity with no undesirable side effects (Lau et al., 2013).
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4.3.2.2 Separation of ACE inhibitory peptide fractions by gel filtration
The ACE inhibitory peptide fraction (2 kDa) from the egg albumen hydrolysate 
exhibited the highest ACE inhibitory activity, compared with the 5 and 10 kDa 
peptide fractions was chosen to further fractione by FPLC gel filtration on a 2.0 x 90 
cm column of Sephadex G-25 column. The 2 kDa ACE inhibitory peptide exhibited 
13 different peaks (GF 12, 17, 23, 26, 29, 33, 35, 39, 41, 44, 47, 57 and 59) as shown 
in figure 4.2. When these sub-fractions collected from GF-FPLC were further tested 
for ACE inhibition activity, they exhibited different ACE inhibitory activities. The 
GF29 sub-fraction exhibited the highest ACE inhibitory activity (84.49 %) with the 
lowest 1C50 value of 5.76 mg/ml suggesting high antihypertensive potency (Fig 4.3). 
This strongly indicates that the 2 kDa ACE inhibitory peptide fraction contained 13 
different smaller peptides which are less than 2 kDa in size. However, while ACE 
inhibitory peptides with lower kDa imply high ACE inhibitory activity, this may not 
always be the case since the overall hydrophobicity of the peptide determines their 
true ACE inhibitory potential (Saiga et al., 2003; Wijesekara and Kim, 2010).
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Figure 4.2 Separation of the 2 kDa egg albumen peptides by gel filtration 
chromatography using a Sephadex G-25 column and detection at 250 nm.
98
100.00
c 80.00
0
5 60.00
!E
c 40.00
LU
u 20.00
<
0.00
12 17 23 26 29 33 35 39 41 44 47 57 59
Fractions
Figure 4.3 In vitro ACE inhibitory activity of the 2 kDa egg albumen peptide sub­
fractions. The GF29 peptide sub-fraction exhibited the highest ACE inhibitory activity 
with a corresponding ICso value of 5.76 mg/ml. Values (n=3) presented as mean ± SD.
4.3.2.3 Reverse-Phase High Performance Liquid Chromatography (RP-HPLC)
The GF29 sub-fraction exhibiting the highest ACE inhibitory activity was further 
purified and eluted by reverse phase high performance chromatography (RP- HPLC) 
on column ODS C l8 based on the aeetonitrile linear gradient. The GF29 ACE 
inhibitory peptide exhibited 2 different peaks as shown in figure 4.4. The two peptides 
sub-fractions exhibited different ACE inhibitory activities. One peptide sub-fraction 
exhibited significantly higher ACE inhibitory activity (85.64 %) with a corresponding 
I C 5 0  value of 5.13 mg/ml than the other peptide sub-fraction, which exhibited a lower 
ACE inhibitory activity of (51.35 %). Figure 4.5 shows differential ACE inhibitory 
activity of the two peptides sub-fractions with captopril as the positive control.
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Figure 4.4 Separation of ACE inhibitory peptides from the gel filtration (GF 29) peptide
fraction, by RP-HPLC. Two peaks of most active ACE inhibitory peptides in the GF 29 
peptide sub-fraction.
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Figure 4.5 ACE inhibition of the HPLC purified GF29 peptide fractions. Peptide sub­
fraction 17 exhibited the highest ACE inhibitory activity of 85.64 % with a 
corresponding ICso value of 5.13 mg/ml as compared to peptide sub-fraction 25. Value 
(n=3) presented as mean ± SD.
Consequently, the peptide sub-fraction with the highest ACE inhibitory activity 
was further lyophilized and then characterized for amino acid composition.
Table 4.4 Comparison of ACE inhibition and inhibitory concentration (IC50) between 
egg albumen hydrolysate and peptide fractions, obtained by ultrafiltration (2 kDa), gel 
filtration and HPLC, and captopril.
Sample ACE Inhibition (%) ICso (mg/ml)
Hydrolysate 59±0.33 8.79±0.56
Ultrafiltration (2 kDa) 78±0.02 6.01±0.02
Gel filtration (29) 84.49±0.02 5.76±0.34
HPLC (17) 85.64±1.9 5.13±0.21
Captopril 96±0.04 0.016±0.19 mM
4.3.3 Inhib itory  kinetics o f an A C E -inhibitory peptide from  egg album en
The putative mechanism of the ACE-inhibitory peptides from the egg albumen 2 
kDa fraction was evaluated based on the ACE-inhibitory kinetics. The ACE- 
inhibitory kinetics of the egg albumen peptides was determined based on the 
Lineweaver-Burk plot. From figure 4.6, it is evident that the rate of ACE-catalyzed 
liberation of hippuric acid from the HHL residue in the absence of the ACE-inhibitory 
peptides was significantly high, compared to samples containing the peptides. This 
strongly indicates that the ACE-inhibitory peptides reduced the rate of the ACE- 
catalyzed liberation of hippuric acid from the HHL residue. It is also evident that the
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ACE-inhibitory activity of the peptides was dose-dependent, since 10 mg/ml of the 
peptide solution significantly inhibited the ACE activity rate compared to that of 4 
mg/ml peptide solution.
The slopes of the graphs were determined based on Km/Vmax. The three graphs for 
the negative control (HHL substrate), and the peptides (4 and 10 mg/ml) appear to 
intersect almost at the same point along the Y-axis, indicating that increasing inhibitor 
concentration increased the Km values for the three graphs at a constant Vmax value. 
These results confirm that the ACE-inhibitory 2 kDa peptide is a competitive inhibitor 
(Mallikarjun-Gouda et al. 2006; Yu et al, 2006); this suggests that the ACE- 
inhibitory peptides competitively bind to the HHL thereby reducing the rate of ACE- 
catalyzed liberation of hippuric acid from the HHL residue. Lysozyme protein from 
hen egg albumen was recently demonstrated to exert a strong competitive ACE- 
inhibitory activity with a corresponding I C 5 0  value of 12.6 pg/ml (Rao et al, 2012). 
Competitive inhibition of ACE is the basis for the pharmacological action of the 
common synthetic antihypertensive drugs particularly, captopril, enalapril, and 
lisinopril, which compete with the HHL substrate for binding to the active site of 
ACE enzyme (Tsai et al., 2006).
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Figure 4.6 Lineweaver-Burk plot of ACE-inhibitory of the 2 kDa peptides (4 and 10 
mg/ml) from egg albumen hydrolysate.
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4.3.4 Amino acid profiles of the purified ACE inhibitory peptides
Purified A CE inhibitory peptide w as further separated to obtain separate am ino 
acid residues using RP-HPLC. Table 4.6 shows the am ino acid profile o f  purified 
ACE inhibitory peptide (peptide 17). Peptide 17 contained higher proportions Asp, 
Glu, Gly, Ala, Pro, Val and Lys as shown in table 4.6.
Table 4.5 Amino acid composition of inhibitory purified peptides.
Amino acids Inhibitory purified peptides (%)
Asp 10A5±0TW
Glu 13.23 ±0.06
Hyp -
Ser 2.59 ±0.08
Gly 7.65 ±0.05
His 2.03 ± 0.06
Arg 2.56 ±0.02
Thr 3.66 ±0.04
Ala 6.97 ± 0.09
Pro 6.08 ±0.16
Tyr 2.45 ±0.10
Val 8.20 ± 0.24
Met 5.33 ±0.01
Cys -
lieu 5.85 ± 0.09
Leu 4.41 ±0.04
Phe 5.65 ± 0.08
Trp 1.93 ±0.08
Lys 19.34 ±0.10
*Values a re  in m eans ± SD o f th ree  ACE inhibitory  peptide determ inants.
The com position o f  Lys in the peptide fraction 17 was the highest (19.34 ±  0.10 
%) while that o f  Trp was the lowest (1.93 ± 0.08 %). The peptide lacked Cys and Hyp 
am ino acid residues. B ioactive peptides from protein hydrolysates are usually 
dipeptides or oligopeptides m ade o f  2 -2 0  amino acid residues in length. However, the 
true ACE inhibitory activity o f  such bioactive peptides is determ ined by the specific 
profile o f  am ino acids (Zhao et al., 2007; Ryan et al., Kim ;201 land  Byun, 2012). 
Previous studies have also dem onstrated that bioactive peptides from food protein 
hydrolysates are com posed o f  a variety o f  a-am ino acids with characteristic am ino 
acid profiles (Kim et al., 1999; Chen et al., 2002; Ryan et al., 2011).
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Hydrophobicity is the key molecular characteristic of highly bioactive peptides. 
ACE-inhibitory activity of peptides with 6 or less amino acids residues at the C- 
termini is determined by the hydrophobic amino acids adjacent to the C-termini 
(Pripp et al., 2005; Hayes et al., 2007). Hydroxyproline (Hyp) is a key determinant of 
the binding affinity of short-chained ACE inhibitory peptides (less than 6 amino 
acids) to the active sites of ACE to induce the ACE inhibition (Saiga et al., 2003; 
Wijesekara and Kim, 2010). In the present study, while the highly bioactive peptide 
17 lacked Hyp, its amino acid profile was characterised by high composition of other 
amino acids (Gly, Ala, Pro and Val), which enhanced the hydrophobicity of the 
peptide 17 and therefore high ACE inhibitory activity. These amino acids have been 
fi-equently observed in other highly bioaetive peptides from food protein hydrolysate 
with high ACE inhibitory activity (Miguel and Aleixandre 2006; Ryan et al., 2011; 
Zambrowiez et al., 2013). For instance, peptides with the amino acid sequence of 
Arg-Ala-Asp-His-Pro-Phe, Asp-Leu-Pro and Val-Pro-Pro, have been previously 
characterised in marine microalgae (Wijesekara and Kim, 2010), soybean protein (Lo 
and Li-Chan, 2005) and skimmed milk hydrolysate (Pan et al, 2005), respectively. 
Furthermore, bioactive peptides with aromatic amino acids at the C-termini also 
contribute to the competitive binding to the angiotensin II receptors, thereby blocking 
the ACE activity (Je et al., 2004; Pripp et al., 2005; Ryan et al., The binding of .(2011 
sites (two domains) of the ACE or -the ACE inhibitory peptides to the active sub 
competitive binding to the angiotensin II receptors is predominantly mediated by the 
carboxy terminal tripeptide residues (Zhao, 2007).
In the present study, the amino acid profile of the bioactive peptide 17 was 
characterised by high Lys value (19.34±0.10 %). While ACE preferably binds to the 
hydrophobic amino acid residues at the three C-termini of the ACE inhibitory 
peptides, the electronic charge of the amino aeid residue at the C-terminus also 
influences the binding affinity. In the present study, the high proportion of the C- 
termini lysine which has a net positive charge appears to enhance the ACE inhibitory 
activity of peptides (Pripp et al., 2005). Consequently, it is quite evident that the ACE 
inhibitory peptides fi’om egg albumen hydrolysate induce ACE inhibition largely 
through the positively charged C-termini lysine amino acid.
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4.4 C O NC LUSIO N
The aim of the present study was to extract and characterise ACE inhibitory 
peptides from egg albumen hydrolysate. Enzymatic hydrolysis of food proteins by 
stepwise digestion using various proteolytic enzymes yields a variety of bioaetive 
peptides with varying ACE inhibitory strength. Pepsin and panereatin proteases 
exhibited remarkable hydrolysis activity of the egg albumen. Bioaetive peptides in 
hydrolysates produced by pepsin and panereatin, which are similar to those secreted 
by humans, are less likely to undergo degradation when administered orally and can 
be absorbed rapidly through gastrointestinal walls. The present study has 
demonstrated that it is possible to isolate peptides with the highest ACE Inhibitory 
activity through multistep purification process. The egg albumen hydrolysate 
exhibited an initial ACE Inhibitory activity of 59 % with a corresponding IC50 value 
of 8.79 mg/ml. After initial ultrafiltration and purifieation of the egg albumen 
hydrolysate the short-ehained peptides (2 kDa in size) exhibited a marked increase in 
ACE Inhibitory activity of 78 % with a corresponding IC50 value of 6.01 mg/ml. 
Further purification of crude 2 kDa peptides by gel filtration increased ACE 
Inhibitory activity to 84.49 % with an IC50 value to 5.79 mg/ml. Through multistep 
purifieation, peptide 17 was obtained and exhibited the highest ACE inhibitory 
activity of 85.64 % with a IC50 value of 5.13 mg/ml. The amino acid profile of the 
peptide 17 was characterised by high proportions of Asp, Glu, Gly, Ala, Pro, Val and 
Lys, where Lys was in the highest proportion (19.34 ±0.10 %). The ACE inhibitory 
peptides from the egg albumen hydrolysate induced ACE inhibition largely through 
the positively charged C-termini lysine. It is also evident that the competitive ACE- 
inhibitory mechanism of the peptides is through competitive-binding to the HHL 
substrate, therefore reducing kinetics of the ACE-catalysed liberation of the hippuric 
acid from the HHL residue.
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CHAPTER 5
5. ANTIOXIDANT ACTIVITY OF EGG ALBUMEN PEPTIDES IN 
CACO-2 CELLS AND ABSORPTION OF THE PEPTIDES IN A 
CACO-2 MONOLAYER MODEL.
5.1 INTRODUCTION
Biological systems are constantly exposed to both radieal and non-radical reactive 
oxygen species (ROS) such as superoxide radical (O2 '), hydroxyl radical (OH), nitric 
oxide radical (NO), peroxyl radical (ROO), alkoxyl radicals (RO ), hydrogen 
peroxide (H2O2) and the singlet oxygen (^ 0 2 ), which are endogenously generated 
during normal metabolic processes (Kohen and Nyska, 2002). Exposure of cells to 
UV light radiation and medieally significant doses of ionizing radiations (X-rays and 
gamma rays) can also induce mitochondrial-dependent generation of radical and non­
radical ROS (Lee et al, 2007; Rahman, 2007; Valerie et al, 2007). Cellular 
accumulation of ROS often overwhelms the antioxidant mechanisms of cells, 
therefore, resulting in oxidative stress. Prolonged oxidative stress results in oxidative 
damage of critical cellular components, particularly the DNA and structural and 
functional biomolecules (proteins and lipids), whieh culminates in cell death (Lee et 
al, 2007; Rahman, 2007). For instance, aecumulation of ROS results in oxidative 
attaek of the polyunsaturated fatty acids within cell membranes, which often initiate 
self-propagating lipid peroxidation chain reactions that yield a variety of cytotoxic 
low-molecular weight organic molecules such as ethane, pentane, and aldehydes (eg. 
malondialdehyde) (Mylonas and Kouretas, 1999). Accumulation of lipid peroxidation 
products impairs the fluidity and barrier function of cell membranes (Pawlak et al, 
1998). Therefore, cellular accumulation of ROS is extensively implicated in the 
pathogenesis of metabolic disorders, degenerative diseases, carcinogenesis and rapid 
aging process (Rahman, 2007; De Moraes Mourao et al, 2009).
Biological systems are equipped with defence mechanisms comprising complex 
antioxidant systems, which involve a variety of endogenous antioxidant enzymes (Lee 
et al, 2007). The endogenous antioxidant enzymes particularly, glutathione 
peroxidase (GPX), superoxide dismutase (SOD), and catalase (CAT) are collectively 
involved in reducing and quenching the oxidative potential of both radical and non-
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radical ROS in cells. These endogenous antioxidant enzymes moderate cellular 
oxidative stress and are, therefore, important in the stabilization of cellular redox 
potential (Pawlak et al, 1998; Lee et al, 2007; De Moraes Mourao et al, 2009). 
However, due to additional ROS generation induced by environmental factors such 
ionizing radiation and chemical pollution, the endogenous antioxidant enzymes do not 
confer full protection against the deleterious effects of ROS. Therefore, in order to 
maintain redox poise, biological systems require exogenous non-enzymatic 
antioxidants, such as vitamin C (ascorbic acid), vitamin E (a-tocopherols), ^-carotene, 
natural flavonoids and thiol-based antioxidants such as glutathione, lipoic acid and 
thioredoxin (May, 1999; Deneke, 2000; Rahman, 2007).
Surprisingly, dietary protein hydrolysates contain a variety of free amino acid 
residues and short-chained bioaetive peptides with antioxidant activity when 
assimilated in their intact forms into cells (Korhonen, 2009; Li et al, 2010; Aloglu 
and Oner, 2011; Ngo and Kim, 2013). Various cell-lines cultured with protein 
hydrolysates have shown enhanced viability and longevity, due to the putative 
antioxidant activity of the bioaetive peptides (Hartshorn et al, 2010). Microbial, cell 
and tissue culture physical-chemical conditions are characterised by oxidative stress 
due to the accumulation of ROS. The free amino acids and oligopeptides in protein 
hydrolysates have side chains with antioxidant and ROS scavenging activities. This 
explains why protein hydrolysates are widely used in microbiological growth media 
and as supplements in cell/tissue culture media to enhance culture performance and 
longevity (Vasileva-Tonkova et al, 2007; Hartshorn et al, 2010). For instance, the 
human eolon carcinoma caco-2 cell lines treated with hydrolysates from hen’s egg 
yolk were protected from oxidative damage caused by H2O2 present in the cell 
culture; the antioxidant activity was attributed to phosvitin phosphopeptides present in 
egg yolk hydrolysates (Udenigwe and Aluko, 2011).
The caco-2 cell line is one of the conditionally immortalized epithelial cell lines 
frequently used for the in vitro study of the physiological response of epithelial cells 
exposed to drugs, nutrients and other chemicals. Caco-2 cell lines have excellent 
growth rate in cell cultures, since they ean attain a high level of confluence when 
grown in semi-permeable filters (Tavelin et al, 1999). Importantly, caco-2 confluent
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monolayers are increasingly being used for studying drug adsorption/absorption 
parameters and transcellular drug transport (Tavelin et al, 1999; Sambuy et al, 2005; 
Sun et al, 2008; Roger et al, 2012).
The aim of the present study was to study the antioxidant activity of the 2 kDa 
ffaetion of the egg albumen peptides on eaco-2 epithelial cell line cultures. The study 
also assessed the adsorption and absorption properties of the 2 kDa peptide on the 
caco-2 monolayer model.
5.2. MATERIALS AND METHODS
5.2.1 Materials
Egg albumen protein was obtained from Sigma-Aldrich Company Ltd. (Poole. 
Dorset, UK). The human coloreetal carcinoma (caco-2) cells lines stored in liquid 
nitrogen (-196 °C) were obtained from the European Collection of Cell Cultures 
(ECACC). The Dulbecco's Modified Eagle's Medium (DMEN), glutamine, non- 
essential amino acids, purified trypsin, penicillin antibiotic, and heat-inactivated fetal 
bovine serum (FBS) were commercially obtained from Invitrogen (Paisley, UK). The 
3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tétrazolium bromide salt (MTT) dye, 
dimethyl sulfoxide (DMSO) and tert-butyl hydroperoxide (tBHP) were obtained 
commercially from Sigma-Aldrich Company Ltd. (Poole. Dorset, UK). Phosphate- 
buffered saline (PBS) tablets, ethanol and chloroform were purchased from Fisher 
Scientific Holding UK Ltd. (Loughborough, UK). Caspase-Glo® 3/7 Reagent 
(DEVD-aminoluciferin substrate) was obtained from Promega (Southampton, UK). 
All these chemicals and reagents were of analytical grade.
5.2.2 Methods
5.2.2.1 Isolation and purification of egg albumen peptides
5.2.2.1.1 Enzymatic hydrolysis of egg albumen
Enzymatic hydrolysis of the egg albumen protein was carried out as described in 
sections 2.2.2.1.
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5.2.2.1.2 Ultrafiltration
Ultrafiltration of the egg albumen hydrolysate was carried out as described in sections 
2.2.2.2.
5.2.2.2 Antioxidant activity of peptide in caco-2 cells
5.2.2.2.1 Cell culture
The caco-2 cells stored in liquid nitrogen (-196 °C) were removed and thawed out 
in a 37 °C water bath and then centrifuged at 352 x g for 3 min. The caco-2 cell 
concentrate was homogenized in DMEN cell culture media supplemented with 5 % 
non-essential amino acids, 5 % L-glutamine, 5 % penicillin antibiotic and 20 % heat- 
inactivated FBS. The cells were then grown in a 25 cm  ^culture flask (Cell; Sarstedt, 
Leicester, UK), in an incubator at 37° C, in 95 % air and 5 % CO2 . The cell cultures 
were allowed to grow up to a 100 % confluent monolayer, and the cells were then 
trypsinized with 2 ml trypsin and incubated further for 2 min at 37 °C to dissociate 
them. Trypsin was deactivated using 5 ml of the DMEN cell culture media and then 
centrifuged at 1500 x g for 3 min to remove trypsin. Trypsin-free caco-2 cells were 
then sub-cultured in 75 cm  ^ cell culture flasks until they reached a 100 % confluent 
monolayer.
5.2.2.2.2. MTT assay
The 100 % confluent trypsin-free caco-2 cells were rinsed with 5 ml PBS and the 
cells counted using a hemocytometer and seeded in a 96-well plate at the rate of 2 x 
10^  cells per well. The cells were incubated for 24 hours, and then rinsed with PBS 
followed by treatment with 5 pi of MTT dye (10 mg/ml MTT) per well then re­
incubated further at 37° C for 4 hours. Caco-2 cells in eaeh well were treated with 150 
pi of DMSO with constant shaking while maintaining the temperature at 37 °C for 10 
min. The absorbance of the cells was determined using a multi-well scanning 
spectrophotometer (ELISA plate reader) at a wavelength of 492 nm as described by 
Zonouzi et al. (2013).
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5.2.2.2.3. Cell viability o f  caco-2 cells treated w ith egg album en peptides
Caco-2 cells were seeded in a 96-well plate at a seeding rate of 2 x 10"^  cells per 
well as described in section 5.2.2.2.2 and incubated at 37°C. After 24 hours of 
incubation, the eells were sub-cultured in DMEM culture media treated with different 
concentrations of the 2 kDa fraction of egg albumen peptides and then re-incubated 
further for 24 hours. The DMEM culture media was aspirated out of the wells, and the 
cells rinsed with PBS. The viability of the DMEM-free cells was determined using the 
MTT assay as described in section 5.2.2.2.2 (Zonouzi et al, 2013).
5.2.2.2.4 Cell viability of caco-2 cells treated with tert-butyl hydroperoxide 
(tBHP)
Tert-butyl hydroperoxide (tBHP) is a highly oxidizing synthetic oxidant for 
inducing oxidative stress in cell/tissue eultures (Sardao et al, 2007). To investigate 
the oxidative effect of the tBHP on epithelial cells, the harvested caco-2 cells were 
seeded in 96-well plates at a seeding rate of 2 x 10"^  cells per well and ineubated at 37 
°C for 24 hours. After 24 hours of incubation, the cells were rinsed with PBS, treated 
directly with tBHP at different concentrations and then re-incubated further for 2.5 
hours. After incubation, the tBHP was aspirated from the wells and the cells re-rinsed 
with PBS. The viability of the tBHP-treated cells was determined using the MTT 
assay as described in seetion 5.2.2.2.2 (Zonouzi et al 2013).
5.2.2.2.5 Treatment of caco-2 cells with peptides and tert-butyl hydroperoxide 
(tBHP)
The effect of oxidative stress on epithelial cell viability upon the uptake of tBHP 
in the presence or absence of the 2 kDa egg albumen peptides was analysed using 
caco-2 cells. The caco-2 cells were seeded in 96-well plates at a rate of 2 x 10"^  cells 
per well. After 24 hours of incubation at 37 °C, the cells were rinsed with PBS, 
treated with the 2 kDa egg albumen peptides and then incubated further for 24 hours. 
After 24 hours of incubation at 37 °C, the cells were rinsed with PBS, treated with 3 
mM tBHP and then ineubated further for 2.5 hours. The viability of the cells was
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determined by MTT assay as described in section 5.2.2.2.2 above (Zonouzi et al, 
2013).
5.2.2.2.6 Lipid peroxidation and TEARS formation in caco-2 cells
Total thiobarbituric acid reactive substances (TEARS) and malondialdehyde 
(MDA) are formed as secondary products following free radieal indueed lipid 
peroxidation, and used as a measure of the degree of lipid peroxidation in cells. The 
TEARS in tBHP oxidized and the control caco-2 cells were assessed using methods 
described by Gomez-Monterrey et al (2010) with slight modifications. Caco-2 cells 
were seeded in 25 cm  ^cell eulture flasks at a rate of 1x10  ^per culture flask. The cells 
were incubated until they reached at least 80 % confluent monolayer, after which the 
cells were treated with the 2 kDa egg albumen peptides at a dosing rate of 0.1 mg/ml 
and then incubated further for 24 hours. The DMEN media was aspirated from the 
cell culture flasks and the cells rinsed twice with PBS. The cells were harvested and 
lysed with 20 % TCA, treated with 2 ml of TEA and then warmed at 100 °C for 1 
hour. The cell suspension was then cooled and centrifuged at 1500 x g for 10 min and 
the supernatant recovered. The absorbance of the recovered cell supernatant was 
determined at a wavelength of 532 nm using a spectrophotometer (UV mini 1240 
Shimadzu Europa, Milton Keynes, UK). The concentration of MDA (pmol) was 
determined using 1,1,3,3 tetramethoxypropane as the standard solution.
5.2.2.3. Caspase-Glo 3/7 assay
Caco-2 cell suspension prepared as deseribed in section 5.2.2.2.1 was seeded in a 
96-well plate at a seeding rate of 2 xlO"^  cells per well. The seeded cells were then 
treated with the 2 kDa egg albumen peptides (0.1 mg/ml) and incubated for 24 hours. 
Each well was then treated with tBHP and incubated further for 2.5 hours. 100 pi of 
caspase 3/7 reagent was added to 100 pi of the tBHP-treated caeo-2 cells and 
reincubated further for 30 min. The luminescence activity of the cell was determined 
using GloMax®96- luminometer (Promega, Southampton, UK) with DEVD- 
aminoluciferin substrate.
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5.2.2.4. M orphological changes in caco-2 cells treated w ith  egg album en peptides
Caco-2 cell suspension was seeded in 25 cm  ^cell culture flasks at a seeding rate of 
1x10  ^per culture flask. The cells were incubated at 37 ”C until they reached a 80-100 
% confluent monolayer, where the eells were treated with the 2 kDa egg albumen 
peptide (0.1 mg/ml) and then incubated further for 24 hours. After incubation, the 
DMEN media was removed from the cells and the cells rinsed twice with PBS, 
followed by 2.5 mM tBHP treatment then ineubated for 2.5 hours. The tBHP-treated 
caco-2 cells were rinsed off with PBS and then morphological and cytological 
changes examined with the aid of a phase contrast microscope (Zeiss Telaval 
microscopy) incorporated with a camera (Nikon, Japan).
5.2.2.5 Peptide transport in caco-2 monolayer model
5.2.2.5.1 Caco-2 monolayer preparation
Caco-2 cells were cultured in 25 cm  ^ cell culture flasks as described in section 
5.2.2.2.I. When sub-cultures of the caco-2 cells were 80-100 % confluent, the cells 
were rinsed with 5 ml PBS and harvested from the culture flasks by trypsinization 
with 1 ml trypsin followed by re-suspension in EDTA. The suspended cells were 
loaded onto 0.3 pm Millipore, 1.2 cm diameter polycarbonate cell culture inserts with 
filters (Transwell, coster) at a seeding rate of 1.0x10^ cells/cm^ 12-well plates. The 
eaco-2 cells loaded onto the culture inserts were incubated at 37 °C in a humidified 
atmosphere of an incubator (5 % CO2 and 95 % air). During incubation, the DMEN 
media was changed after every 48 hours after seeding. Caco-2 cell confluence of 
barrier forming eells was monitored with the aid of an Evon epithelial volt-ohm 
TEER (Trans Epithelial Electric Resistance) meter (World Preeision Instrument, 
USA). The caco-2 cells were 100 % confluent after six days of cell culture and were, 
therefore, suitable for trans-cellular transport experiments.
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Figure 5.1 Trans Epithelial Electric Resistance (TEER) meter and the 0.3 pm Millipore,
1.2 cm diameter polycarbonate cell culture inserts with filters (Transwell, coster).
S.2.2.5.2 Peptide transport in a caco-2 monolayer model
The transport of the 2 kDa egg albumen peptide fraction across the epithelial 
membrane was investigated using the eaeo-2 monolayer model with PBS as the 
transport medium. The confluent monolayers of the eaeo-2 eells were rinsed twice 
with PBS, where the apical (A) and basalateral (B) chambers of the filter inserts were 
filled with 0.75 ml PBS as the transport medium. Caco-2 eells were then equilibrated 
by incubating in a humidified incubator atmosphere of 5 % CO2 and 95 % air at 37 °C 
for 60 min. 0.1 mg/ml stock solution of the 2 kDa egg albumen peptides was loaded 
onto the apical or basalateral chamber and ineubated further at 37 °C for 3 hours in a 
humidified incubator atmosphere of 5 % CO2 and 95 % air. The TEER value across 
eaeh monolayer was determined before and after 3 hours of incubation. The apparent 
permeability coefficient (Papp, em/s) of the 2 kDa egg albumen peptides was 
estimated using the equation below.
Papp=Vr X (dC/dt) X (1/ACo)
Where; Vr is the volume of the loading chamber (0.75 ml); dC/dt is the solute 
transfer rate, A is the surface area of the membrane (corresponding to 1.2 em  ^surface 
area of the Trawell filter), and Co is the initial peptide (solute) concentration.
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5.2.2.5.3 HPLC of absorbed peptide in a caco-2 monolayer model
Aliquots (300 pi) of the peptides were sampled from both apieal and basalateral 
chambers of the inserts from each well. The peptide samples were then run separately 
on a Reverse-Phase High Performance Liquid Chromatography (RP-HPLC) using a 
Phenomenex C18 (3.0 x 250mm) column, with a linear gradient of aeetonitrile (0-70 
% in 50 min) and milli-Q water premixed with 0.1 % trifluoroaeetie aeid (TFA) at a 
flow rate of 1 ml/min. The RP-HPLC analysis was carried out on an HPLC system 
comprising a P2000 pump for HPLC autosampler (Thermoseparation Products), 
Spectra Physics AS 1000 HPLC autosampler and a detector (Thermoseparation 
Products UV6000LP). The HPLC system was also equipped with user interface 
integration software (Chromoquest, 2004).
5.2.3 Statistical analysis
All assays were carried out in triplicate where values were expressed as a mean± 
SD. Statistical analyses were performed using the SPSS statistical package. To 
determine if the difference between mean pairs of samples was statistically 
significant, a one-way analysis of variance (ANOVA) was performed. The confidence 
intervals using a post-hoc test coupled with a t-test were used to assess the difference 
between mean pairs, where a P-value of < 0.05 was considered a significant.
5.3 RESULT AND DISCUSSION
5.3.1 Antioxidant activity of peptide in caco-2 cells
Balanced cellular redox poise protects cells from oxidative stress and damage. Cell 
viability is largely influenced by cellular oxidative poise, because increased oxidative 
stress results in genomic DNA damage and oxidant-induced mutation (Jones and Go, 
2010). Cell viability is a good measure of cellular oxidative poises using in vitro 
model systems. Caeo-2 eells is a conditionally immortalized epithelial cell line 
frequently used as an in vitro system for studying physiological response of epithelial 
cells subjected to drugs, nutrients and other chemicals (Tavelin et al, 1999). In the 
present study, the antioxidant activity of the 2 kDa egg albumen peptides was 
analysed based on the viability of caco-2 cell line treated with a synthetic oxidizing 
agent in the presence or absence of the peptides.
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5.3.1.1 Cell v iability  o f  caco-2 cells treated w ith egg album en peptides
The caco-2 epithelial cell-line can attain 80-100 % confluence when cultured in 
semi-permeable filters and is, therefore, suitable for studying viability of epithelial 
eells (Tavelin et al, 1999). The viability assessment of caeo-2 cells was based on the 
MTT eolorimetric assay whieh, is based on the speetrophotometric principle as 
described by Zonouzi et a l (2013). Viable cells are metabolically active and, 
therefore, contain active NAD(P)H-dependent oxido-reductases and succinate 
dehydrogenases, which catalyze electron transfer from the electron donor to an 
electron acceptor (Berridge et al, 2005). Therefore, when the yellow MTT (3-[4,5- 
dimethylthiazol-2-yl]-2,5 diphenyl tétrazolium bromide) salt is absorbed by viable 
cells, the mitochondrial oxido-reductases and sueeinate dehydrogenases reduee the 
tétrazolium salt to form the dark blue/purple insoluble formazan dye crystals. The 
formazan dye crystals are impermeable to cell membranes and therefore, accumulate 
in the cytosols of viable cells (Berridge et al, 2005; Sylvester, 2011). The advantage 
of the MTT eolorimetric assay is that the enzymatic conversion of the tétrazolium salt 
to formazan dye crystals occurs only in living cells with functional mitochondria. 
Therefore, the quantity of formazan dye crystals formed in exposed cells in 96-well 
plates is directly proportional to the number of viable and metabolieally active cells 
per well (Sylvester, 2011).
The formazan dye crystals in the cytosol of viable cells in 96-well plates can be 
solubilized in DMSO. When solubilized, the formazan dye crystals can absorb 
maximum electromagnetic radiation at a wavelength of 492 nm on an ELISA plate 
reader. The absorbance of the formed formazan dye crystals in DMSO is directly 
proportional to the number of viable cells with functional mitochondria per well in a 
96-well plate (Sylvester, 2011; Van Meerloo, et al, 2011). In the present study, the 
pereentage cell viability of caco-2 cells was directly proportional to concentration of 
the cells per well. The highest caco-2 cell viability was observed when cell 
eoncentration was 50,000 per well (Fig 5.2).
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Figure 5.2 Viability of caco-2 cells at different cell concentrations (per well) after 24 
hours of incubation at 37 °C. Values (n=3) presented as mean ± SD.
Caco-2 cells at a eoneentrations of 20,000 cells/well were treated with different 
concentrations of the 2 kDa egg albumen peptides, the cells exhibited excellent 
viability (>80 %), suggesting that the peptides were not cytotoxic. Peptides at a 
concentration of 0.1 mg/ml resulted in 99 % cell viability in relation to the control (no 
treatment) (Fig 5.3). This data strongly supports the view that the egg albumen 
peptides possess antioxidant activity, whieh protects eells from ROS-induced 
oxidative damage and therefore, enhance cell viability and survival.
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,3 Cell viability of caco-2 cells treated with different concentrations of egg 
peptides. Values (n=3) presented as mean ± SD.
The 0.1 mg/ml peptide concentration that supported 99 % cell viability was the 
optimal peptide concentration selected for further antioxidant analyses. The 
pereentage viability of caeo-2 eells treated with 0.1 mg/ml of the 2 kDa egg albumen 
peptides was compared with similar cells treated with two proven natural
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antioxidants: 0.01 % ascorbic acid and 0.01 % trolox and control cells (no treatment). 
The water-soluble vitamin C and trolox (vitamin E analogue a-toeopherol) are natural 
antioxidants extensively known for their excellent antioxidant activities as ROS 
scavengers and therefore, confer protection of cells from oxidative damage (Arellano 
et al, 201; Arrigoni and De Tullio, 2002; Padayatty et al, 2003). From figure 5.4, 
eaeo-2 eells treated with 0.1 mg/ml of 2 kDa peptides exhibited 99.45 % viability, in 
relation to the control followed by 0.01 % ascorbic aeid (95.31 %) and 0.01 % trolox 
(92.74 %). The ANOVA test showed that the difference in cell viability between the 
three antioxidant treatments was statistically significant (p<0.05). This data strongly 
supports the fact that the bioaetive peptides derived from egg albumen proteins have 
good antioxidant activity comparable to that of proven natural antioxidants at the 
concentrations used.
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Figure 5.4 Cell viability of caco-2 cells treated with 0.1 mg/ml of egg albumen peptide, 
0.01 % ascorbic acid and 0.01 % trolox. Values (n=3) presented as mean ± SD.
Previous in vitro studies have demonstrated antioxidant activity of peptides from 
whole egg, yolk and albumen protein hydrolysates (Park et al, 2001; Davalos et al, 
2004; Sakanaka et al, 2004; Chen et al, 2012). The 2 kDa fraction of the egg 
albumen peptides contain free amino aeid residues such as His, Tyr, Met, Lys, Trp, 
Cys, Phe and Pro whieh are known for their antioxidant and free radical scavenging 
activities. Importantly, the oligopeptides present in the 2 kDa egg albumen have side 
chain groups, whieh act as hydrogen donors and therefore capable of reducing the 
oxidative potential of ROS (Udenigwe and Aluko, 2011; Wiriyaphan et al, 2012). 
For instance, oligopeptides Tyr-Leu-Gly-Ala-Lys and Tyr-Ala-Glu-Glu-Arg-Tyr-Pro- 
lle-Leu containing Tyr/ Lys and Tyr/Tyr amino aeid residues, respectively were
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isolated from egg albumen hydrolysates and exhibited independent antioxidant 
activity (Davalos et al, 2004; Chen et al, 2012).
5.3.1.2 Cell viability of caco-2 cells treated with tert-butyl hydroperoxide (tBHP)
Organic hydroperoxides such as tBHP are widely used to induce oxidative stress in 
a variety of cell lines and tissue cultures (Prasad et al, 2007). As a strong synthetic 
oxidizing agent, tBHP generates highly reactive hydroxyl and t-butoxyl radicals 
through Fenton’s reaction (Prasad et al, 2007; Chappie et al, 2013). The tBHP- 
generated radicals are highly cytotoxic to epithelial cells. The present study 
investigated the in vitro oxidative effect of tBHP on the viability and survival of eaco- 
2 eells using MTT viability assay. Figure 5.4 shows the pereentage viability of caeo-2 
cells treated with different concentrations of tBHP as compared to the control eells 
(no treatment).
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Figure 5.5 Cell viability of caco-2 cells treated with different concentrations of tert-butyl 
hydroperoxide (tBHP). Values (n=3) presented as mean ± SD.
From figure 5.5, it is evident that the oxidative effect of tBHP on the viability of 
caco-2 cells is dose-dependent. As the concentration of tBHP increased the viability 
of caeo-2 cells reduced to 45.45 % at the maximum concentration of 40 mM. 
Increasing the concentration of tBHP, increased the kinetics of Fenton's reaction, 
yielding a high concentration of the highly reactive hydroxyl and /-butoxyl radicals 
that affect polysaturated fatty acids present as membrane phospholipids (Prasad et al.
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2007; Chappie et al, 2013). Further, increased accumulation of the cytotoxic ethane, 
pentane and malondialdehyde can alter fluidity and impair the barrier function of cell 
membranes and therefore, reduced cell function and viability (Pawlak et al, 1998; 
Mylonas and Kouretas, 1999). The 3 mM tBHP was selected for further oxidative 
analyses on caco-2 cells.
5.3.1.3 The effect of tBHP on the caeo-2 cells pre-treated with egg albumen 
peptides
It was important to test the in vitro antioxidant effect of egg albumen peptides, as 
shown in 5.3.1.1, on caco-2 cells exposed to the cytotoxic tBHP. Figure 5.6 shows 
percentage viability of caco-2 cells treated with 3 mM tBHP in the presence or 
absence of 0.1 mg/ml of the egg albumen peptides in relation to the control (no 
treatment). As expected, caco-2 cells treated with 3 mM tBHP alone exhibited low 
cell viability (63.32 %) while cells treated with peptides alone exhibited high viability 
(99.25 %) in relation to the control. Caco-2 cells exposed to 3 mM tBHP in the 
presence of 0.1 mg/ml of peptides exhibited improved viability (84.91 %). The 
ANOVA test shows that the cell viability difference between treatments was 
statistically significant (p<0.01).
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Figure 5.6 Cell viability of caco-2 cells incubated with tcrt-butyl hydroperoxide (tBHP) 
in the presence of egg albumen peptides. Values (n=3) presented as mean ± SD.
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This data strongly support the fact that the 2 kDa fraction of egg albumen peptides 
have antioxidant activity. The peptides possessed both antioxidant and ROS 
scavenging activity, therefore protecting cells from oxidative stress. ROS are known 
for their role in cell signalling of necrotic and apoptotic death as a cellular defence 
mechanism. Therefore, the presence of the 2 kDa egg albumen peptides protected 
cells from ROS-induced apoptotic and necrotic cell deaths (Wiriyaphan et al., 2012; 
Udenigwe and Aluko, 2011).
5.3.1.4 Formation of TEARS in caco-2 cells
TEARS particularly MDA and isoprostanes (IsoPs) are formed due to ROS- 
induced lipid peroxidation and are the principle markers for cellular oxidative stress 
(Kolagal et al, 2009; Gomez-Monterrey et al, 2010; Ho et al, 2013). Therefore, 
cellular levels of TEARS can be used to measure cellular oxidative stress and the 
degree of lipid peroxidation in a variety of cell lines (Gomez-Monterrey et al, 2010). 
In the present study, formation of MDA in caco-2 cells treated with tBHP was 
measured. Figure 5.7 shows the concentration of MDA produced from caco-2 cells 
treated with 0.1 mg/ml egg albumen peptides alone and 3 mM tBHP in the presence 
or absence of the egg albumen peptides.
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Figure 5.7 TEARS (malondialdehyde) concentration in caco-2 cells treated with 3 mM 
tert-butyl hydroperoxide (tBHP) in the presence or absence of 0.1 mg/ml egg albumen 
peptide. Values (n=3) presented as mean ± SD.
Cells treated with 3 mM tBHP produced the highest concentration of MDA 40.23 
pg/ml). However, cells treated with 3 mM tBHP in the presence of egg albumen 
peptides exhibited significantly reduced MDA concentration (37.78 pg/ml) (p<0.05).
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These data indicate that the oxidative reactivity of the hydroxyl and /-butoxyl radicals 
generated from tBHP through Fenton’s reaction, which yield the cytotoxic MDA 
(Prasad et al., 2007; Chappie et al. 2013), was significantly quenched by the egg 
albumen peptides. The antioxidant peptides contain amino acid residues with side 
chains that act as hydrogen donors that quench/reduce the oxidising free radicals 
(Wiriyaphan et al. 2012; Udenigwe and Aluko, 2011).
5.3.1.5 Caspase-3/7 activities in caco-2 cells trea ted  w ith tB H P
Apoptosis and necrosis are two distinct types of cell death in animals. Apoptotic or 
programmed cell death is an energy-dependent mode of cell death mediated by 
multiple signalling pathways involving an array of biochemical events that result in 
depletion of intracellular ATP and eventual cell death characterised by cell shrinkage, 
karyolysis and pyknosis (Elmore, 2007). On the other hand, necrosis is an energy- 
independent mode of cell death involving cell swelling, degradation of cell membrane 
and karyolysis. Unlike necrosis, apoptosis also occurs as a cellular defence 
mechanism induced by autoimmune reactions and cell injury due to noxious agents 
(Elmore, 2007). The energy-dependent apoptotic cell death involves cellular 
activation of caspases (cysteine proteases) and cascade of events that lead to cell 
shrinkage, karyolysis and pyknosis.
In the present study, A caspase-glo 3/7 assay was performed to assess the caspase- 
3/7 activities and therefore, the apoptotic status of caco-2 cells treated with tBHP in 
the presence or absence of egg albumen peptides. Table 5.1 shows the percentage 
activity of caspases 3/7 in caco-2 cells. Cells treated with 3 mM tBHP alone exhibited 
significantly high caspase 3/7 activities (134.69 %) compared with cells treated with 3 
mM tBHP in the presence of egg albumen peptides (p<0.05). Caco-2 cells treated 
with egg albumen peptide exhibited the lowest caspase 3/7 activities (21.16 %). The 
difference in caspase 3/7 activities between the three treatments of caco-2 cells was 
statistically significant (p<0.01).
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Table 5.1 Caspase-3/7 activities of caco-2 cells treated with 2 kDa egg albumen peptides 
in the presence or absence of tert-butyl hydroperoxide (tBHP). Values (n=3) expressed 
as means±%CV.
Treatment Caspase 3/7 activity (%)
Egg albumen peptide 21.16 ±1.35
Peptide + tBHP 43.26 ±3.74
tBHP 134.69 ± 1.24
This data strongly supports the fact that caspase 3/7 activities are dependent on 
cellular redox poise such that increasing oxidative stress activated and enhanced 
caspase 3/7 activities, cell shrinkage, karyolysis and pyknosis (Elmore, 2007).
5.3.1.6 M orphological changes in caco-2 cells trea ted  w ith  egg album en peptides
The morphological and cytological changes of caco-2 cells treated with egg 
albumen peptide and tBHP in the presence or absence of egg peptides were 
investigated using phase-contrast microscopy. Morphological alteration was observed 
in confluent monolayer of caco-2 cells treated with 3 mM tBHP alone (Fig 5.8 D). 
The tBHP-injured cells appeared detached from the confluent monolayer of the 
cell/tissue culture flask indicating tBHP-induced necrotic and apoptotic cell death. 
However, tBHP treated cells in the presence of egg albumen peptides (Fig 5.8 C) 
exhibited normal morphology similar to the control (Fig 5.8 A) and cells treated with 
egg albumen peptides alone (Fig 5.8 B). These data indicate that egg albumen 
peptides protected cells from oxidative damage.
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Figure 5.8 Phase-contrast microscopy images of caco-2 cells: (A) No treatm ent (control) 
(B) Cells treated with egg albumen peptide alone (C) Cell treated with tBHP in the 
presence of egg albumen peptide (D) Cells treated with tBHP alone.
5.3.2 Peptide tra n sp o rt in a caco-2 m onolayer
Caco-2 cells grown to 100 % confluent monolayers are used as epithelial 
monolayer models for studying drug adsorption/absorption parameters and 
transcellular drug transport (Tavelin et al, 1999; Sambuy et al., 2005; Sun et al., 
2008; Roger et al., 2012). The present study investigated the trancellular transport of 
the 2 kDa egg albumen peptides using caco-2 monolayer cultured on semipermeable 
filter inserts. After 6 days of culturing, the epithelial integrity of the caco-2 monolayer 
was determined based on the transepithelial electrical resistance (TEER). The 
confluent caco-2 monolayer formed was found to have a TEER value greater than 
200D cm  ^as desired.
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The calculated apparent permeability coefficients (Papp) of the 2 kDa egg albumen 
peptides are shown in table 5.2. The cumulative apical to basalateral transport of the 
peptides was 0.81 ± 0.16 cms'  ^which was significantly lower than 0.97 ± 0.14 cm s’^  
observed for the basalateral to apical transport (p<0.01).
Table 5.2 Apparent permeability coefficients (Papp) of peptide transport across a caco-2
Peptide transport PapD (cm s‘^ ) % ratio of peak areas
Apical-to-basalateral 0.81 ±0.16* 11.62
Basalateral-to-apical 0.97 ±0.14* 12.33
Permeation of the 2 kDa egg albumen peptides across the caco-2 monolayers 
(apical-to-basalateral and basalateral-to-apical) did not result in the drop of TEER 
value below 900fl cm  ^ suggesting that the egg albumen peptides did not alter the 
physiological integrity of the caco-2 monolayers. From table 5.2, the ratio of peak 
areas for the apical-to-basalateral (11.62 %) and basalateral-to-apical (12.33 %) 
peptides transport appear quite close, suggesting that the transepithelial peptide 
transport in caco-2 monolayers is bidirectional rather than unidirectional.
Transepithelial transport of oligopeptides involves three main transport pathways, 
which include the transporter (PepTl)-mediated flux of the di- and tri-peptides, 
paracellular pathway via intracellular junctions (tetrapeptides and peptides of more 
than 4 amino residues) and the intracellular pathway (adsorptive transcytosis) as 
described by previously by Shimizu et al (1997). The rate of transepithelial transport 
of oligopeptides is multifaceted because it is influenced by a variety of the brush- 
border peptidases.
Dietary peptides susceptible to the brush-border aminopeptidases would have 
reduced rate of transepithelial peptide transport (Miguel et al, 2008). This strongly 
suggests that peptides that are resistant to cellular aminopeptidases have high 
bioavailability and therefore, high rate of transepithelial peptide transport (Shimizu et
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al, 1997). It also appears that the rate of the apical-to-basolateral transport is 
dependent on the hydrophobic properties of the oligopeptides (Shimizu et al., 1997).
Transport of intact ovokinin (FRADHPFL), an antihypertensive peptide, across 
caco-2 cell epithelium was observed recently by Miguel et al (2008), suggesting that 
egg albumen peptides could be formulated as fiinctional foods. This implies that some 
peptides derived from egg albumen were resistant to cellular aminopeptidases and 
were therefore, absorbed through the caco-2 cell epithelium in their intact forms. This 
strongly supports that the 2 kDa egg albumen peptides can confer antioxidant activity 
in vivo.
5.4 CONCLUSION
The present study investigated the antioxidant activity of the 2 kDa egg albumen 
peptides using caco-2 cell lines. The adsorption/absorption and transcellular transport 
of the bioactive peptides was also probed using confluent monolayers of caco-2 cell 
lines. Data from the present study supports the antioxidant and ROS scavenging 
activity of the 2 kDa fraction of egg albumen peptides. Based on MTT colorimetric 
assay, the egg albumen peptides enhanced cell viability in the presence of tBHP, a 
highly potent synthetic oxidizing agent. The antioxidant activity of the egg albumen 
peptides, at the concentrations used was similar to well established natural 
antioxidants, particularly ascorbic acid and trolox. TBARS particularly MDA is a 
good indicator of the level of lipid peroxidation in cells. It is evident that the 
production of the cytotoxic MDA was reduced by the antioxidant and ROS 
scavenging activity of egg albumen peptides. The caspase-3/7 activities of cells 
treated with tBHP in the presence of the peptides was significantly low, suggesting 
that the peptides protected cells from apoptosis. The morphological characteristics of 
caco-2 cells treated with tBHP in the presence of the peptides, was slightly changed 
due to the antioxidant activity of the peptides. The 2 kDa egg albumen peptides 
contained peptides with His, Tyr, Met, Lys, Trp, Cys, Phe and Pro amino acid 
residues, with side chains that act as hydrogen donors and therefore, exhibiting both 
ROS scavenging and antioxidant activity. Importantly, data from the present study 
shows that a significant proportion on the 2 kDa egg albumen peptides are resistant to 
cellular aminopeptidases present in caco-2 cell epithelium and were therefore,
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absorbed in their intact forms. This strongly suggests that the 2 kDa egg albumen 
peptides can confer antioxidant activity in vivo.
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CHAPTER 6
6. EFFECT OF PEPTIDES DERIVED FROM EGG ALBUMEN ON 
THE ENDOGENOUS ANTIOXIDANT ENZYMES
6.1 INTRODUCTION
Both plants and animals are constantly exposed to oxidative stress induced by 
radical and non-radical reactive oxygen species (ROS) endogenously generated 
during normal metabolic processes (Kohen and Nyska, 2002; Rahman, 2007; Valerie 
et aL, 2007). Oxidative stress in both animal and plant systems is moderated by the 
endogenous antioxidant system comprising complex antioxidant enzyme systems 
including superoxide dismutase (SOD), glutathione peroxidase (GPx), glutathione 
reductase (GRx) and catalase (CAT) enzyme. These enzymes collectively terminate 
chain reactions initiated by radical ROS by donating hydrogen (electron) and 
therefore, quenching or stabilizing their electron affinities (Pawlak et aL, 1998; Lee et 
al., 2007; De Moraes Mourao et al., 2009). For instance, SOD (EC 1.15.1.1) is 
abundantly present in aerobic cells such as muscle cells, which are constantly at risk 
of increased oxidative stress. In aerobic cells, SOD catalyzes the simultaneous redox 
reaction (dismutation) of two superoxide radicals (O2 ' ) to yield the less reactive H2O2 
molecules and molecular oxygen (De Moraes Mourao et al, 2009). Similarly, the 
selenium-containing, GPx (EC 1.11.1.9), confers its antioxidant activity by 
terminating the self-propagating lipid peroxidation chain reaction by catalysing the 
reduction of lipid peroxides and free peroxides in aerobic cells such as animal 
muscles (Symons and Gutteridge 1998). Lastly, the CAT enzyme; also called H2O2 
oxidoreductase (EC 1.11.1.6) is also abundant in aerobic cells. It catalyzes 
simultaneous redox reaction (dismutation) of two H2O2 molecules (from SOD 
dismutation of two superoxide radicals) to water and oxygen molecules (De Moraes 
Mourao et aL, 2009).
The effectiveness of these endogenous antioxidant enzymes depends on the level 
of activation. However, due to environmental factors such ionizing radiation and 
chemical pollution, the total antioxidant capacity of these endogenous enzymes is 
usually not sufficient for complete antioxidant protection of cells from oxidative 
damage (De Moraes Mourao et aL, 2009). Therefore, the importance of increased 
daily intake of dietary antioxidants has been extensively emphasised in the literature
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from a nutritional point of view. Vitamin C, vitamin E, y9-carotene and natural 
flavonoids are phytochemicals well known for their excellent antioxidant activity 
(May, 1999; Deneke, 2000; Rahman, 2007). Surprisingly, various in vitro studies 
have shown that some bioactive peptides from protein hydrolysates have antioxidant 
activity that can supplement the endogenous antioxidant enzymes (Peng et al, 2009; 
Powers/nr/., 2013).
A recent study has shown that Z-taurine, a non-essential amino acid abundantly 
present in muscle cells and inflammatory cells is cytoprotective (Yu and Kim, 2009). 
This could be attributed to its putative antioxidant activity suggested recently (Jong, 
2010; Jong, 2012). The MTT colorimetric assay of B16F10 mouse melanoma cells 
grown in culture medium supplemented with taurine showed that taurine increased 
both levels and enzymatic activities of the endogenous SOD, GPx and CAT. 
Consequently, taurine reduced cellular ROS generation in a dose-dependent manner 
(Yu and Kim, 2009). However, a recent study has pointed out that taurine is neither a 
typical ROS scavenger nor a modulator of the endogenous antioxidant system (Jong, 
2012). This raises uncertainties regarding the specific effects of antioxidants on the 
antioxidant activity of exogenous antioxidants.
While the antioxidant activity of bioactive peptides involves ROS scavenging 
activity, little is known about their effect on the endogenous antioxidant enzymes. 
This led to the question, as to whether antioxidant peptides enhance the levels and 
activity of these endogenous antioxidant enzymes. Therefore, the aim of the present 
study was to investigate the effect of egg albumen peptides on the antioxidant activity 
levels of the endogenous enzymes. This study also investigated the comparative effect 
of other well-known antioxidants such ascorbic acid and trolox on the activity levels 
of the endogenous enzymes and whether they have a similar effect as the 2 kDa egg 
albumen peptides.
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6.2 MATERIALS AND METHODS
6.2.1 Materials
The human colorectal carcinoma (caco-2) cells lines stored in liquid nitrogen (-196 
®C) were obtained from the European Collection of Cell Cultures (ECACC). Egg 
albumen powder, 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tétrazolium bromide salt 
(MTT) dye, dimethyl sulfoxide (DMSG), potassium phosphate buffer (pH 7.5), and 
ethylenediaminetetraacetic acid (EDTA) disodium salt dihydrate were obtained from 
Sigma-Aldrich Company Ltd. (Poole. Dorset, UK). Dulbecco's Modified Eagle’s 
Medium (DMEN), heat inactivated fetal bovine serum (FBS), trypsin, glutamine, non- 
essential amino acids and penicillin antibiotic were obtained from Invitrogen (Paisley, 
UK). The OxiSelect™ superoxide dismutase activity assay kit (colorimetric) and 
OxiSelect™ catalase activity assay kit (colorimetric) were obtained commercially 
from Cell Biolabs, Inc (Cambridge Bioscience Ltd., Cambridge, UK). The glutathione 
peroxidase activity assay kit was commercially obtained from Cayman Chemical 
Company (Cambridge Bioscience, Ltd., Cambridge, UK). Phosphate-buffered saline 
(PBS) tablets were purchased from Fisher Scientific Holding UK Ltd. 
(Loughborough, UK). All these chemicals were of analytical grade quality.
6.2.2 Methods
6.2.2.1 Isolation and purification of egg albumen peptides
6.2.2.1.1 Enzymatic hydrolysis of egg albumen
Enzymatic hydrolysis of the egg albumen protein was carried out as described in 
sections 2.2.2.1.
6.2.2.1.2 Ultrafiltration
Ultrafiltration of the egg albumen hydrolysate was carried out as described in 
sections 2 2 2 2 .
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6.2.2.2 Cell viability  o f  endothelial cells (caco-2 cells)
6.2.2.2.1 Cell cultures
As described in chapter 5 section 5.2.2.2.I.
6.2.2.2.2 MTT colorimetric assay for cell viability
As described in chapter 5 section 5.2.2.2.2.
6.2.2.2.3 Viability of caco-2 cells treated with egg albumen peptides
As described in chapter 5 section 5.2.2.2.2.
6.2.2.3 Measurement of endogenous antioxidant enzyme activities of caco-2 cells
6.2.2.3.1 Preparation of caco-2 cell lysates and supernatants
Lysates of caco-2 cells pre-incubated with different concentration of the 2 kDa egg 
albumen peptides (0.01, 0.03, 0.05, 0.1, 0.2, and 0.5 mg/ml) and the control (no 
treatment) were prepared. The cells were harvested by scraping off the cells as pellets 
and then re-resuspended in 2 ml of ice-cold PBS containing 1.0 mM EDTA. The cells 
were lysed by sonication and then centrifuged at 10,000 x g for 15 min while 
maintaining the cells at 4 °C. The supernatants of the cell lysates were recovered and 
stored at -80 °C pending SOD, CAT and GPx activity assays. A similar procedure 
was followed to prepare lysates of caco-2 cells pre-incubated with 0.01 % ascorbic 
acid, 0.01 % trolox, 3 mM tBHP (in the presence or absence of the 0.1 mg/ml 
peptide). The concentrations of protein in the recovered supernatants were determined 
using a multi-well seanning spectrophotometer (ELISA plate reader).
6.2.2.3.2 Storage and preparation of reagents
Upon receipt, the OxiSelect™ assay kits for measuring SOD, CAT and GPx, the 
components were stored according manufacturer’s instructions until use to ensure 
maximum stability. The reagents were diluted immediately before use where 
appropriate assay standards prepared according to respective manufacturer’s 
instructions.
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6.2.2.5.3 Superoxide dismutase (SOD) activity assay of caco-2 cell supernatants
The superoxide dismutase (SOD) activity of caco-2 cell supernatants was 
measured using Cell Biolabs’ OxiSelect™ SOD activity assay kit (colorimetric). The 
supernatants of caco-2 cell lysates (which contains superoxide dismutase enzyme 
extract) prepared as described in section 6.2.2.3.1 above were defrosted and 
immediately plated into a 96-well microtiter plate (70 pi). 5 pi xanthine solution, 5 pi 
chromagen solution, 10 pi SOD assay buffer and 10 pi aliquots of the diluted xanthine 
oxidase solution was added into each well, mixed thoroughly and incubated for 60 
min at 37 °C. The SOD activity was estimated by measuring eolour development
using the absorbance microplate reader at wavelength of 490 nm. The SOD activity 
was estimated as the percentage inhibition rate as shown in the equation below.
SOD activity (AU/mg protein) = (SOD activity (Inhibition rate)/l-SOD activity
(Inhibition rate))
6.2.2.3.4 Glutathione peroxidase (GPx) activity assay of caco-2 cell supernatants
The glutathione peroxidase (GPx) activity was measured using the Cayman 
Chemical’s GPx assay kit (colorimetric). The GPx assay was performed according to 
the respective manufacturer’s instructions. Supernatants of caco-2 cell lysates as 
prepared in section 6.2.2.3.1 above were defrosted and immediately plated into a 96- 
well microtiter plate. An aliquot (25 pi) of the diluted NADPH solution was added to 
each well to be tested, followed by 20 pi of the glutathione peroxidase standards or 
samples at 25 °C. Next, a 20 pi aliquot of the assay buffer solution was added to each 
well and mixed briefly. The plate reader for the kinetic assay was set at wavelength of
340 nm, and then a 20 pi aliquot of the glutathione reductase solution was added to 
each well and mixed briefly. The absorbance readings were recorded immediately at 1 
min intervals for 10 min. The concentrations for GPx assays were expressed in 
nmoles GPx/min/mg protein, respectively. The GPx assay was performed in triplicate.
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6.2.2.3.S C atalase activity assay o f  caco-2 cells
The catalase (CAT) activity of caco-2 cells was determined using the Cell Biolabs’ 
OxiSelect CAT activity assay kit (colorimetric method) according to the 
manufacturer’s instructions (Wei et aL, 2014). Supernatants from lysates of caco-2 
cells as prepared in section 6.2.2.3.1 were defrosted and immediately plated into a 96- 
well microtiter plate. Similarly, 20 pi aliquots of the diluted catalase standards or 
samples were plated into a 96-well microtiter plate, followed by the addition of 50 pi 
of the working solution of H2O2 (12 mM) in each well. The solutions in the wells 
were then mixed thoroughly and incubated for exactly 60 seconds. Catalase activity in 
the 96-well microtiter plate was terminated by adding of 50 pi of the catalase 
quencher into each well and mixed thoroughly. A 5 pi aliquot from each reaction well 
was transferred to fresh wells followed by the addition of 250 pi of the previously 
prepared chromogenic working solution into each well. The 96-well microtiter plate 
was then incubated for 40-60 min while mixing vigorously. The absorbance of the 
plate was determined at wavelength of 520 nm using UV/ visible spectrophotometer. 
The CAT assay was performed in triplicate. The measured CAT activity was assumed
to be equal to the total amount of CAT enzyme(s) that decomposed 1.0 pmole of 
H2O2 per minute at 25 °C. Therefore, CAT activity was calculated and expressed as 
activity units (AU) per mg protein.
6.2.3 Statistical analysis
All assays were carried out in triplicate where values were expressed as a mean± 
SD. Statistical analyses were performed using the SPSS statistical package. To 
determine if the difference between mean pairs of samples was statistically 
significant, a one-way analysis of variance (ANOVA) was performed. The confidence 
intervals using a post-hoc test coupled with a t-test were used to assess the difference 
between mean pairs, where a P-value of < 0.05 was considered a significant.
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6.3 R ESU LTS AND D ISC U SSIO N
6.3.1 The viabilities of caco-2 cells treated with egg albumen peptides
Based on the MTT colorimetric assay, it was demonstrated in the previous chapter 
(5) that caco-2 cells exhibit optimal viability at a cell concentration of 20,000 per 
well. In the present study, we confirmed this where caco-2 cells treated with the 2 
kDa egg albumen peptides have a good viability (>80 %). Therefore, a 0.1 mg/ml egg 
albumen peptide concentration, which exhibited 99 % cell viability, was selected.
6.3.2 Effect of the 2 kDa egg albumen peptides on the antioxidant enzyme 
activities in caco-2 cells
The total antioxidant capacity of cells is largely contributed by the endogenous 
antioxidant enzymes, particularly SOD, GPx and CAT enzymes (Ismail et ah, 2010). 
These enzymes collectively moderate cellular oxidative stress by maintaining cellular 
redox poise, therefore protecting cells from oxidative damage. Using caco-2 cells, the 
in vitro antioxidant activity of the 2 kDa egg albumen peptides (0.1 mg/ml) in the 
presence of the organic hydroperoxides such as tBHP was demonstrated in the 
previous chapter (5). The 2 kDa egg albumen peptides (0.1 mg/ml) exhibited 
antioxidant activity that was similar to two well-established natural antioxidants (0.01 
% ascorbic acid and 0.01 % trolox). In the present study, it was important to measure 
the individual antioxidant activities of SOD, GPx and CAT enzymes in caco-2 cells 
treated with the 2 kDa egg albumen peptides (0.1 mg/ml) in the presence of the 3 mM 
tBHP, 0.01 % ascorbic acid and 0.01 % trolox.
6.3.3 Superoxide dismutase (SOD) activity of caco-2 cells treated with the 2 kDa 
egg albumen peptides
Superoxide dismutase (SOD) is one of the key endogenous cellular antioxidant 
enzymes which protect cells from the cytotoxic effects of the endogenously generated 
superoxide radicals (O2" ). SOD catalyses the dismutation of two O2*' into H2O2 and 
molecular O2 (Yim et al, 1990; Ismail et al., 2010; Ungvari et al, 2011). SOD is 
therefore, a key antioxidant defence component in nearly all aerobic cells (Lynch and 
Kuramitsu, 1999; Patil et al, 2010). The OxiSelect™ SOD activity assay is based on
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the xanthine/xanthine oxidase (XOD) system, which generates superoxide anions 
(O2 '’) (Miwa et al, 2000; Mitsuta, 2010). The xanthine oxidase catalyzes the 
oxidation of the xanthine where molecular oxygen is reduced to O2 into H2O2 
(Wassmann et al, 2004). The generated O2 ' in ions react with the chromagen solution 
to form a water-soluble red formazan dye that can be measured colorimetrically 
(Nebot et aL, 1993; Berridge et al, 2005). However, the concentration of O2 ' in ions 
reduces with increasing SOD enzyme (as the colorimetric signal reduces). SOD 
activity is therefore, determined as the level of inhibition of the chromagen reduction 
(Kovaceva et aL, 2007).
In the present study, the SOD activity of caco-2 cells treated with different 
concentrations of the 2 kDa egg albumen peptides with respect to the control was 
investigated (Fig 6.1). Caco-2 cells treated with the egg albumen peptides exhibited 
significantly reduced SOD activity when compared with the control cells. The 
peptide-moderated SOD activity reduced in a dose-dependent manner up to an 
optimal concentration of 0.1 mg/ml of the peptides. The ANOVA test showed that the 
SOD activity difference between treatments was significant (p<0.0001). However, the 
SOD activity difference in caco-2 cells treated with 0.1, 0.2, and 0.5 mg/ml of the 
peptides was not significant (p>0.05), suggesting that SOD activity in the caco-2 cells 
was optimally inhibited at these three peptide concentrations. Therefore, the 0.1 
mg/ml peptide concentration was selected for subsequent SOD activity analyses.
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Figure 6.1 Superoxide dismutase (SOD) activity of caco-2 cells treated with different 
concentrations of the 2 kDa egg albumen peptides compared to control cells (no 
treatment). Values (n=3) presented as mean±SD.
These data strongly indicate that the 2 kDa egg albumen peptides confer ROS- 
scavenging activity. It appears that the peptides scavenge the O2 released from the 
xanthine/xanthine oxidase (XOD) system and therefore, reduce cellular 
concentrations of the O2 '* available to react with the chromagen solution to form the 
water-soluble red formazan dye. Therefore, reduced cellular concentration of O2 
would imply reduced SOD activity and this could explain why SOD activity of caco-2 
cells reduced with increasing peptide concentration. At high peptide concentration 
(0.1-0.5 mg/ml), the O2 released from the XOD system is efficiently scavenged and 
therefore, reduced SOD activity.
6.3.4 Superoxide dismutase (SOD) activity of caco-2 cells treated with the 2 kDa 
egg albumen peptides compared with 0.01 % ascorbic acid and trolox
Ascorbic acid and trolox are well-characterised antioxidants known for their 
excellent antioxidant activities as ROS scavengers and therefore, protect cells from 
oxidative damage (Arrigoni and De Tullio, 2002; Padayatty et aL, 2003; Zaidi et aL, 
2005; Arellano et al, 2011). In the present study, the SOD activity of caco-2 cells 
treated with 0.1 mg/ml of the 2 kDa egg albumen peptides was compared to that of 
cells treated with 0.01 % ascorbic acid and 0.01 % trolox in relation to the control 
cells. From figure 6.2, it is evident that cells treated with 0.1 mg/ml of the egg 
albumen peptides, 0.01 % ascorbic acid and 0.01 % trolox exhibited significantly
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reduced SOD activity when compared to the control cells (p<0.05). The 2 kDa (0.1 
mg/ml) egg albumen peptides had good ROS scavenging activity, which was higher 
than ascorbic acid (0.01 %) and trolox (0.01 %). This finding is consistent with data 
from a previous in vivo study, which demonstrated that antioxidant supplementation 
(vitamins C and E) in male volunteers decreased their plasma SOD activity by 17 % 
(p<0.05) (Tomoeda et aL, 2013). Therefore, it appears that the antioxidant activity of 
the endogenous SOD is inversely related to cellular concentration of O2 '.
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Figure 6.2 Superoxide dismutase (SOD) activity of caco-2 cells treated with 0.1 mg/ml 
peptides, 0.01 % ascorbic acid and 0.01 % trolox compared to control cells (no 
treatment). Values (n=3) presented as mean±SD.
6.3.5 Superoxide dismutase (SOD) activity of caco-2 cells treated with the 2 kDa 
egg albumen peptides in the presence or absence of tert-butyl hydroperoxide 
(tBHP)
In the previous chapter (5), it was demonstrated good antioxidant activity of the 2 
kDa egg albumen peptides in caco-2 cells treated with tert-butyl hydroperoxide 
(tBHP), a highly oxidizing synthetic oxidant. In the present study, therefore, 
investigated the SOD activity of caco-2 cells treated with the egg albumen peptides in 
the presence or absence of 3 mM tBHP (Fig 6.3). The SOD activity of cells treated 
with 0.1 mg/ml of the egg albumen peptides was significantly reduced while that of 
cells treated with 3 mM tBHP in the absence of the peptides exhibited significantly 
high SOD activity in relation to the control (p<0.05). On the other hand, the tBHP- 
treated cells in the presence of the peptides exhibited SOD activity that was slightly 
higher than that of control cells but not significant (p>0.05). The ANOVA test shows
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that the SOD activity difference between treatments and control was significant
(p<0.0001).
These data strongly indicate that tBHP-treated cells had increased oxidative stress 
due to accumulation of the highly reactive hydroxyl radical (OH*) and t-butoxyl 
radicals generated by the tBHP through Fenton's reaction (Prasad et aL, 2007; 
Chappie et aL, 2013; Lemire et al, 2013). The hydroxyl radical and t-butoxyl radicals 
initiated self-propagating peroxidation chain reactions in polyunsaturated fatty acids 
of membrane phospholipids, thereby generating O2 ' and enhancing cellular SOD 
activity in an attempt to moderate tBHP-induced oxidative stress.
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Figure 6.3 Superoxide dismutase (SOD) activity of eaco-2 cells treated with 0.1 mg/ml 
peptides in the presence or absence of 3 mM tert-butyl hydroperoxide (tBHP) compared 
to control cells (no treatment). Values (n=3) presented as mean±SD.
6.3.6 Glutathione peroxidase (GPx) activity in caco-2 cells treated with the 2 kDa 
egg albumen peptides
Glutathione peroxidase (GPx) is among the key endogenous anti oxidant enzymes 
present in nearly all aerobic cells (Wassmann et al, 2004). The selenium-dependent 
GPx plays a critical role in the reduction of lipid hydroperoxides and hydrogen 
peroxides to lipid alcohols and water, respectively (Arthur, 2000; Wassmann et al, 
2004). Rapid ageing processes have been correlated with declining GPx activity and 
the accumulation of free radicals (Espinoza et al, 2008). Inadequate GPX activity 
results in the accumulation of hydrogen peroxide and lipid peroxides, which may 
undergo conversion to hydroxyl radicals (OH*) and lipid peroxyl radicals by oxidative 
transition metals such as Fe^  ^(Wassmann et aL, 2004).
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Given the good antioxidant activity of the 2 kDa egg albumen peptide fraction 
demonstrated in the previous chapter (5) using caco-2 cells, it was important to 
investigate the effect of these peptides on the GPx activity. In the present study, the 
GPx activity in caco-2 cells was determined using the Cayman Chemical’s GPx assay 
kit (colorimetric). The assay is based on the colorimetric monitoring of the rate of 
NADPH oxidation to NADP+ per minute at 25°C (Wei et aL, 2014). GSH is a 
tripeptide (L-glutamyl-L-cysteinyl-glycine), which maintains the appropriate redox 
poise of the sulfhydryl groups (Lushchak, 2012). In this case, GSSG reduction can be 
indirectly determined from the rate of NADPH consumption, which is directly related 
to the decrease in the NADPH absorbance at a wavelength of 340 nm as a function of 
time (Ayaz and Turan, 2006). The NADPH oxidation rate also allows 
spectrophotometric determination of GPx enzyme activity using NADPH extinction 
coefficient of 0.00373 (after adjusting for 0.6 cm as the path length of the 
solution in the well), at a wavelength of 340 nm (Ayaz and Turan, 2006; Wei et aL, 
2014).
Figures 6.4 shows the GPx activity (nmoles GPx/min/mg protein) of caco-2 cells 
treated with different concentrations of the 2 kDa egg albumen peptides with respect 
to the control. It is evident that the peptides enhanced GPx activity in a dose- 
dependent manner up to an optimal peptide concentration of O.I mg/ml. The GPx 
activity difference between treatments and the control was significant (p<0.05). 
However, GPx activity difference between cells treated with O.I, 0.2 and 0.5 mg/ml 
peptide concentrations was not significant (p>0.05), suggesting that GPx activity was 
optimized at these three peptide concentrations. Therefore, the O.I mg/ml peptide 
concentration was selected for subsequent GPx activity analyses.
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Figure 6.4 Glutathione peroxidase (GPx) activity of caco-2 cells treated with different 
concentrations of the 2 kDa egg albumen peptides compared to control cells (no 
treatment). Values (n=3) presented as mean±SD.
6.3.7 Comparative Glutathione peroxidase (GPx) activity of caco-2 cells treated 
with the 2 kDa egg albumen peptides, 0.01 % ascorbic acid and 0.01 % trolox
As shown in figure 6.5, the GPx activity o f  caco-2 cells treated w ith 0.1 m g/m l o f  
the 2 kD a egg album en peptide was significantly higher when com pared w ith those 
treated w ith 0.01 % ascorbic acid and 0.01 % trolox in relation to the control 
(p<0.05). In a recent in vivo study, it was dem onstrated that while the antioxidant 
supplem entation (vitam ins C and E) in male volunteers reduced their plasm a SOD 
activity by 17 % (p<0.05) and increased G Px activity by 13 % (p<0.05) (Tom oeda et 
al,  2013). However, a recent in vivo study dem onstrated that antioxidant 
supplem entation (o f vitam ins C and E) in female volunteers using oral contraceptives 
(OCs), w hich cause an oxidative stress effect, had significantly increased plasm a GPx 
and reduced lipid peroxidation marked by reduced plasm a M DA  levels (Zal et a l ,
2012). This strongly indicates that GPx and SOD activities are antagonistie since 
antioxidant conditions enhancing GPx activity result in reduced SOD activity. It has 
been suggested that the activities o f  the enzym e com ponents o f  the endogenous 
antioxidant systems should be well balanced to shield cells from oxidative dam age 
(Am stad et a l,  1994; de Haan et a l,  1996).
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The enzymatic antioxidant pathway involves essentially two steps; the SOD- 
catalysed dismutation of two O2"' to H2O2 and molecular oxygen; and the GPx- 
catalysed conversion of H2O2 to H2O (de Haan et al, 1996). Therefore, the balance of 
antioxidant enzymes involved in the first and second step is important in moderating 
cellular oxidative stress. This strongly suggests that significantly reduced SOD 
activity relative to the GPx activity can result in accumulation of O2 and therefore, 
increase cellular oxidative stress. Similarly, significantly increased SOD activity 
relative to GPx could result in accumulation of the H2O2 intermediate, which in itself 
contributes to cellular oxidative stress (de Haan et al, 1996). This could partly 
explain why SOD activity of caco-2 cells reduced while the GPx activity increased 
with increasing concentration of the antioxidant egg albumen peptides.
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Figure 6.5 Glutathione peroxidase (GPx) activity of caco2-ceIIs treated with 0.1 mg/ml 
peptides, 0.01 % ascorbic acid and 0.01 % trolox compared to control cells (no 
treatment). Values (n=3) presented as mean±SD.
6.3.8 G lutath ione peroxide (GPx) activity o f caco-2 cells trea ted  w ith the 2 kDa 
egg album en peptides in the presence o r absence of tert-bu ty l hydroperoxide 
(tBHP)
In the present study, we also investigated the GPx aetivity of caeo-2 cells treated 
with tBHP oxidant in the presence or absence of the 0.1 mg/ml of the 2 kDa egg 
albumen peptides (Fig 6.6). The tBHP-treated cells exhibited significantly reduced 
GPx activity when compared with the control (p<0.05). However, the tBHP-treated 
eells in the presenee of the 0.1 mg/ml peptides exhibited signifieantly inereased GPx
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activity, suggesting that the egg albumen peptides are potent ROS scavengers. 
However, the meehanism and kinetics by which the egg albumen peptides enhance 
the GPx activity are not elear.
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Figure 6.6 Glutathione peroxidase (GPx) activity of caco2-cells treated with 0.1 mg/ml 
peptides in the presence or absence of 3 mM tert-butyl hydroperoxide (tBHP) compared 
to control cells (no treatment). Values (n=3) presented as mean±SD.
6.3.9 C atalase activity of caco-2 cells trea ted  w ith egg album en peptides
Figure 6.7 shows the CAT aetivity (AU/mg protein) of caeo-2 cells treated with 
different concentrations of the 2 kDa egg albumen peptides in relation to the eontrol. 
It is evident that the peptides redueed the eatalase activity of caco-2 cells eompared 
with the eontrol eells. This can be attributed to the ROS scavenging aetivity of the 2 
kDa egg albumen peptides, which reduced the substrate for catalase enzyme, 
particularly hydrogen peroxide. CAT activity was minimal at 0.1 mg/ml peptide 
concentration and therefore, this eoncentration was selected for further CAT activity 
analyses.
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Figure 6.7 Catalase (CAT) activity of caco-2 cells treated with different concentrations 
of the 2 kDa egg albumen peptides compared to control cells (no treatment). Values 
(n=3) presented as mean±SD.
6.3.10 C om parative catalase activity o f Caco-2 cells trea ted  w ith the 2 kD a egg 
album en peptides, 0.01 %  ascorbic acid and 0.01 % trolox
The CAT activity of caco-2 cells treated with 0.01 mg/ml of the egg albumen 
peptide was compared with that of cells treated with 0.01 % ascorbic acid and 0.01 % 
trolox in relation to that of control cells (no treatment) (Fig 6.8). It is evident that the 
2 kDa egg albumen peptides redueed CAT activity of the eells, which was 
significantly lower than that of eontrol eells (p<0.05). Similarly, the eells treated with 
0.01 % ascorbic acid and 0.01 % trolox also exhibited a significant drop CAT activity 
(p<0.05).
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Figure 6.8 Catalase (CAT) activity of caco2-ceIIs treated with 0.1 mg/ml peptides, 0.01 
% ascorbic acid and 0.01 % trolox compared to control cells (no treatment). Values 
(n=3) presented as mean±SD.
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6.3.11 Catalase activity of caco-2 cells treated with the 2 kDa egg albumen
peptides in the presence or absence of tert-butyl hydroperoxide (tBHP)
Caco-2 cells treated with 3 mM of the oxidizing tBHP alone exhibited significantly 
increased CAT activity in relation to that of the eontrol eells (p<0.05). Through 
Fenton’s reaction the tBHP generates hydroxyl and Tbutoxyl radicals, which initiate 
self-propagating lipid peroxidation chain reactions that may yield superoxide radieals 
(O2 '*) (Prasad et al, 2007; Chappie et al. 2013). Aceumulation of superoxide radicals 
enhances the activity of SOD, which catalyzes the dismutation of the two superoxide 
radicals (O2 ’) to yield less H2O2 molecules and molecular oxygen (De Moraes 
Mourao et al. 2009). Cellular accumulation of H2O2 subsequently inereases the CAT 
aetivity. However, tBHP-treated cells in the presence of the egg albumen peptides 
exhibited significantly reduced CAT activity in relation to the control (p<0.05). The 
CAT activity difference between treatments was significant (p<0.0001) (Fig 6.9). This 
data strongly suggests that the egg albumen peptides have exeellent H2O2 scavenging 
aetivity, therefore moderating CAT aetivity.
I
0.1 mg/mL peptide 0.1 mg/mL peptide + 
3mMtBHP
Contro 3mMtBHP
Figure 6.9 Catalase (CAT) activity of caco2 ceils treated with 0.1 mg/ml peptides in the 
presence or absence of 3 mM tert-butyl hydroperoxide (tBHP) compared to control cells 
(no treatment). Values (n=3) presented as mean±SD.
6.4 CONCLUSION
The effect of these exogenous antioxidants on the activity of the endogenous 
enzymes is poorly known; this has been shown in a elinical trial but not in caco-2 
cells (Zal et al., 2012). In the present study, it is evident that SOD and CAT activities 
in caco-2 cells treated with the 2 kDa egg albumen peptides were significantly
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reduced in a dose-dependent manner. However, the GPx activity increased in a dose- 
dependent manner. It appears that the antioxidant activity of the 2 kDa egg albumen 
involves direct ROS scavenging, thereby, reducing the enzymatic activities of SOD 
and CAT enzymes. This view was supported by the significantly increased enzymatic 
activities of SOD and CAT, in cells treated with tBHP oxidant. Both SOD and CAT 
activities were also reduced in caco-2 cells treated with 0.01 % ascorbic acid and 0.01 
% trolox in relation to that of control cells, suggesting that the exogenous antioxidants 
also directly scavenge for ROS, therefore reducing substrates for SOD and CAT 
enzymes. On the other hand, the increased enzymatic activity of GPx in caco-2 cells 
treated with the 2 kDa egg albumen peptides suggests increased accumulation of lipid 
hydroperoxides and hydrogen peroxides. GPx catalyzes the reduction of lipid 
hydroperoxides and hydrogen peroxides to lipid alcohols and water, respectively. It 
appears that the enzymatic activity of GPx increased to compensate for the reduced 
activities of SOD and CAT in cells (especially in the presence of tBHP) treated with 
the 2 kDa egg-albumen peptides, with the putative antioxidant properties. These 
confounding data warrant further studies to delineate the mechanisms used by 
exogenous antioxidants, particularly, the 2 kDa egg albumen peptides, to alter the 
endogenous antioxidant enzyme system.
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CHAPTER 7
7. EFFECT OF PEPTIDES DERIVED FROM EGG ALBUMEN ON 
REACTIVE OXYGEN SPECIES (ROS) IN ENDOTHELIAL 
CELLS (Ea.hy926 CELLS)
7.1 INTRODUCTION
Both radical and non-radical reactive oxygen species (ROS) are endogenously 
produced during mitochondrial oxidative metabolism (Ray et al, 2012). Most 
biological systems, both in animals and in plants have endogenous antioxidant 
systems comprising enzymes particularly, superoxide dismutase (SOD), glutathione 
peroxidases (GPx), and catalase (De Moraes Mourao et al, 2009). However, the total 
antioxidant capacity of these enzymes is not always sufficient to prevent cellular 
accumulation of ROS. This strongly indicates that most biological systems experience 
oxidative stress due to imbalanced cellular redox (reduction/oxidation) potential, 
following unchecked accumulation of ROS over the cellular antioxidant capacity 
(Dworakowski et al, 2006; Ray et al, 2012). Oxidative stress may cause irreversible 
cellular DNA damage, which is implicated in various degenerative and metabolic 
disorders such as atherosclerosis, neurodegeneration, diabetes mellitus, myocardial 
infarction, heart failure, cancer and aging (Dworakowski et al, 2006; Ray et al, 
2012).
It was originally thought that ROS is only generated in phagocytotic cells in 
response to pathogen invasion, xenobiotics and cytokines. It is now well-described 
that cellular ROS have important physiological cell signalling roles in both plant and 
animal cells (Ray et al, 2012). It is extensively recognized that high concentrations of 
ROS can oxidize cell membrane lipids to deleterious lipid peroxidation products. 
Importantly, ROS coupled with the reactive lipid peroxidation products can induce 
apoptotic or necrotic cell death by silencing the activity of many genes involved in 
maintaining cellular metabolism. More recent evidence strongly suggests that ROS 
can regulate various cellular functions by inducing reversible oxidative post- 
translational modification (PTM) of structural, functional, and signalling proteins 
(Kuster et al, 2006; Finkel, 2012).
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The vascular endothelial growth factor (VEGF) is known to re-model vascular 
cells by enhancing microvascular permeability. However, the exact signalling 
mechanisms involved have been poorly understood (Monaghan-Benson and Burridge, 
2009). Recent evidence suggests that cellular ROS is involved in the re-modelling of 
vascular cells by promoting permeability of microvascular endothelial cells and is, 
therefore, central to the pathophysiology of atherosclerotic disease (Schachinger and 
Zeiher, 2000; Pacurari et ah, 2012; Wang et al, 2013).
Blood pressure is physiologically modulated by the renin-angiotensin system 
(RAS) coupled with the kinin-nitric oxide system (KNOS). The KNOS involves the 
endothelium-released nitric oxide (NO) radical, which has vasodilative effect on 
smooth muscle cells, by restricting platelet aggregation, leukocyte adhesion and 
smooth muscle cell migration. The bioactive NO also inhibits oxidation of low- 
density lipoprotein and, therefore, protects against endothelial dysfunction 
(Schachinger and Zeiher, 2000; Davignon and Ganz, 2004).
Bioactive peptides from dietary proteins exhibit antioxidative activity and 
antihypertensive effects by promoting the NO-mediated vasodilation in the KNOS 
(Udenigwe and Aluko, 2012). Recent studies have demonstrated that antioxidants 
inhibit ROS production, inhibiting lipid peroxidation, and enhance production of the 
endogenous antioxidants, particularly GSH and SOD, in the human umbilical vein 
endothelial cell lines (HUVECs), particularly EA.hy926 HUVEC (Huang et al, 2004; 
Huang et al, 2013; Yu et al, 2013). The human EA.hy926 endothelial cell line 
exhibits properties that are similar to those of the vascular endothelial cells (Ahn et 
al, 1995; Bonis et al, 2001). The aim of the present study was to investigate the in 
vitro effect of bioactive peptides derived from the egg albumen hydrolysates on 
cellular ROS in the Ea.hy926 cells.
7.2 MATERIALS AND METHODS
7.2.1 Materials
The Ea.hy926 cells in liquid nitrogen (-196 °C) were generously donated by the 
Department of Microbial and Cellular Science. Heat-inactivated foetal bovine serum
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(FBS), purified trypsin, penicillin antibiotic, Dulbecco's modified Eagle's medium 
(DMEN) and the Griess reaction kit were commercially obtained from Invitrogen 
(Paisley, UK). The 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tétrazolium bromide salt 
(MTT) dye, methyl sulfoxide (DMSO) and egg albumen powder were commercially 
obtained from Sigma-Aldrich Company Ltd. (Poole. Dorset, UK). Phosphate-buffered 
saline (PBS) tablets were purchased from Fisher Scientific Holding UK Ltd. 
(Loughborough, UK). All these chemicals were of analytical grade.
7.2.2 Methods
7.2.2.1 Isolation and purification of egg albumen peptides
Enzymatic hydrolysis of egg albumen protein and fractionation were carried out 
using a similar protocol to that described in chapter 2.
1.2.2.2 Cell viability of endothelial cells (Ea.hy926 Cells)
7.2.2.2.1 Cell culture
The Ea.hy926 cells were removed from liquid nitrogen (-196 °C), thawed out in a 
water bath at 37 °C and then centrifuged at 352 x g for 3 min. The Ea.hy926 cell 
concentrate was homogenized in DMEN culture media supplemented with 10 % heat 
inactivated FBS and treated with 5% penicillin antibiotic and 5 % non-essential amino 
acids. The Ea.hy926 cells homogenates were incubated in a 25 cm  ^culture flask in an 
incubator at 37 °C with 95 % air and 5 % CO2 . When the cells reached a 100 % 
confluent monolayer, the eells were dissociated by treating with 2 ml trypsin and 
incubated further for 2 min at 37 °C. The trypsin was deactivated by treating the 5 ml 
of the culture media, and centrifuged at 3000 rpm (1500 x g) for 3 min to remove 
trypsin. The trypsin-free Ea.hy926 cells were then subcultured in 75 ml culture flasks 
until 80-100 % confluent.
1.2.2.2.2 MTT colorimetric assay
In the present study, when the Ea.hy926 cell subcultures were 80-100 % confluent, 
they were trypsinized and rinsed with 5 ml of PBS, and a cell count was performed 
using a hemocytometer. The cells were then seeded in a 96-well plate at seeding rate
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of 2x10"^  cells per well. After the cells were incubated for 24 hours, each well was 
rinsed with PBS, treated with the 5 pi of MTT dye (10 mg/ml MTT) and then re­
incubated for 4 hours at 37 °C. After 4 hours of incubation, the MTT dye was 
aspirated out and the cells re-rinsed with PBS. Each well was treated with 150 pi of 
DMSO and shaken constantly for 10 min while maintaining the temperature at 37° C. 
The absorbance of the cells was determined using a multiwell scanning 
spectrophotometer (ELISA plate reader) at a wavelength of 492 nm (Zonouzi et al, 
2013).
1.122.2) Viability of Ea.hy926 eells treated with egg albumen peptides
The viable Ea.hy926 cells were seeded in a 96-well plate at seeding rate of at 2 x 
10"^  cells per well as described in section 1 2 2 2 2  and incubated at 37 °C. After 24 
hours of incubation, the cells were sub-cultured in DMEM culture media treated with 
different concentrations of the 2 kDa fraction of egg albumen peptides and then re­
incubated ftirther for 24 hours. The DMEM media was aspirated from the wells, cells 
were rinsed with PBS and their viability determined using the MTT assay as 
described in section 1 2 2 2 2  (Zonouzi et al, 2013).
7.2.2.2.4 Viability of Ea.hy926 cells treated with t-butyl hydroperoxide (tBHP)
To assess the oxidation effect of the tBHP on cells, the Ea.hy926 cells were seeded 
in 96-well plates at a seeding rate of 2 x 10"^  cells per well and incubated at 37 °C for 
24 hours. The incubated cells were rinsed with PBS and treated with tBHP at different 
concentrations and re-incubated further for 2.5 hours. After incubation, the tBHP was 
aspirated from the wells and the cells rinsed with PBS. The viability of the tBHP- 
treated cells was assessed using MTT assay as described in section 1 2 2 2 2  (Zonouzi 
e/uf/., 2013).
7.2.2.2.5 Viability of Ea.hy926 cells treated with both peptides and tert-butyl 
hydroperoxide (tBHP)
To assess the oxidation effect of tBHP on cells in the presence of peptides, the 
Ea.hy926 cells were seeded in 96-well plates at a seeding rate of 2 x 10"^  cells per well
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and incubated at 37 °C for 24 hours. The incubated cells were then rinsed with PBS, 
treated with the 2 kDa egg albumen fraction and re-incubated for 24 hours. Then cells 
were re-rinsed with PBS and subjected to 1 mM tBHP for 2.5 hours, after which cell 
viability was assessed with the MTT assay described in 1.2222  (Zonouzi et ah,
2013).
1 2 2 2  Morphological changes of Ea.hy926 cells treated with egg albumen 
peptides
The Ea.hy926 cells were seeded in 25 cm  ^ culture flasks and incubated at 37 °C 
until an 80 % confluent monolayer was reached. The cells were then treated with 2 
kDa fraction of egg albumen peptides with 24 hours of incubation followed by 
treatment with 1 mM tBHP for 2.5 hours. The tBHP was then washed off with PBS. 
The morphological and cytological changes of the Ea.hy926 cells were examined with 
the aid of a phase contrast, Zeiss Telaval microscope incorporating a camera (Nikon, 
Japan).
7.2.2.4 Scavenging of reactive oxygen species (ROS) in Ea.hy926 cells treated 
with egg albumen peptides
7.2.2.4.1 Lucigenin-enhanced chemiluminescent measurement of ROS
Specific cellular generation of superoxide (O2*’) from Ea.hy926 cells was assessed 
with the lucigenin-enhanced chemiluminescence assay protocol described previously 
by Taubert et al. (2004) with slight modifications. The Ea.hy926 cells were seeded in 
a 25 cm  ^culture flask and incubated at 37 °C until an 80-100 % confluent monolayer 
was reached. The cells were then treated with egg albumen peptides (0.05 mg/ml) in a 
FBS-free media in the presenee and absence of 10 pM angiotensin 11 for 1 hour, rinsed 
twice with PBS and then dissociated by trypsinization. The dissociated cells were 
resuspended in a FBS-free media and then sonicated for 10 min. The cells were then 
redistributed into a 96-well plate and immediately treated with 200 pM lucigenin. The 
luminescence intensity of the lucigenin-treated cells was recorded for 90 seconds 
using a Single Probe Luminometer (GloMax® 96 Microplate Luminometer, 
promega).
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T.2.2.4.2 ROS measurement by fluorescence method with dihydroethidium 
(DHE)
The Ea.hy926 cells were seeded in a 25 cm  ^culture flask and incubated at 37 °C 
until an 80-100 % confluent monolayer was reached. The FBS media was added to 
the culture flask and incubated further for 24 hours, after which the cells were treated 
with the 2 kDa egg albumen fraction (0.05 mg/ml) in the presence and absence of 
angiotensin II for 1 hour. The cells were then rinsed with PBS and treated with 25 
pM 2-hydroxyethidium (DHE), incubated further for 20 min, re-rinsed and incubated 
further with PBS for 1 hour. The cells were then harvested from the culture flask 
using 500 pi of cold methanol, homogenized and then passed through a 0.22 pm 
membrane filter to dissociate the cells. Ethidium and DHE were detected by 
fluorescence emission detector at an emission wavelength of 580 nm with the aid of a 
fluorimeter (Varian USA) at an excitation wavelength o f480 nm (Kasase, 2009).
1.2.2.5 Nitric oxide measurement in the cells treated with egg albumen peptides
The Ea.hy926 cells were treated with different concentrations of 2 kDa fraction of 
egg albumen peptides and incubated at 37 °C for 24 hours. The production of nitric 
oxide (NO) was determined by measuring the nitrites (NO2"), the reduced form of 
NO, in the culture using a Griess reaction kit, according to the manufacturer’s 
instructions. The absorbance of the culture medium was determined using a 
microplate reader at a wavelength of 540 nm.
7.2.3 Statistical analysis
All assays were carried out in triplicate where values were expressed as a mean± 
SD. Statistical analyses were performed using the SPSS statistical package. To 
determine if the difference between mean pairs of samples was statistically 
significant, a one-way analysis of variance (ANOVA) was performed. The confidence 
intervals using a post-hoc test coupled with a t-test were used to assess the difference 
between mean pairs, where a P-value of < 0.05 was considered a significant.
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7.3 R ESU LTS AND D ISC U SSIO N
Endothelial cells are extensively used as in vitro model systems for studying 
various physiological and pathological cellular processes (Bouis et al, 2001). The 
EA.hy926 cells have morphological and functional characteristics that are similar to 
those of human macro-vascular endothelial cells (Ahn et al, 1995; Bouis et al, 
2001). Therefore, the Ea.hy926 cell line was suitable as an in vitro model system for 
studying the effect of peptides derived from egg white on the ROS production in 
human endothelial cells.
7.3.1 The relationship between Ea.hy926 cell concentration and  cell absorbance
The MTT colorimetric assay is extensively used in proliferation and cytotoxicity 
studies for the determination of cellular growth and the number of viable cells 
(Sylvester, 2011). The assay for cell viability is based on the spectrophotometric 
principle as described recently (Van Meerloo, et al, 2011; Zonouzi et al, 2013). 
Viable cells are metabolically active and therefore contain active NAD(P)H- 
dependent oxidoreductases and succinate dehydrogenases, which catalyze the electron 
transfer from the electron donor to an electron acceptor (Berridge et al, 2005). 
Therefore, when the yellow MTT (3 -[4,5-dimethylthiazol-2-yl]-2,5 diphenyl 
tétrazolium bromide) salt is absorbed by viable cells, the mitochondrial 
oxidoreductases and succinate dehydrogenases reduce the tétrazolium salt to form the 
dark blue/purple insoluble formazan dye crystals. The formazan dye crystals are 
impermeable to cell membranes and therefore, accumulate in the cytosols of viable 
cells (Berridge et al, 2005; Sylvester, 2011). The advantage of the MTT colorimetric 
assay is that the enzymatic conversion of the tétrazolium salt to formazan dye crystals 
occurs only in living cells with functional mitochondria. Therefore, the quantity of 
formazan dye crystals formed in exposed cells in 96-well plates is directly 
proportional to the number of viable and metabolically active cells per well 
(Sylvester, 2011).
The formazan dye crystals in the cytosol of viable cells in 96-well plates can be 
solubilized in DMSO. When solubilized, the formazan dye crystals absorb at a 
wavelength of 492 nm on an ELISA plate reader. The absorbance of the formed
150
formazan dye crystals in DMSO is directly proportional to the number of viable cells 
with functional mitochondria per well in a 96-well plate (Sylvester, 2011; Van 
Meerloo, et al, 2011). In the present study, the absorbance of the formazan dye 
crystals exhibited a linear relationship with the concentration of Ea.hy926 cells in the 
well plate (cells/well). The highest absorbance was observed when Ea.hy926 cell 
eoncentration was 50,000 per well (Fig 7.1).
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Figure 7.1 The 2-amino-7-dimethyIamino-3-phenazine hydroehloride (MTT) 
colorimetric assay for Ea.hy926 cell viability. The relationship between Ea.hy 926 cell 
concentrations and absorbance shows a linear relationship, with maximum absorbance 
at a cell concentration of 50,000 cells/well.
Data from the present study strongly supports the fact that the metabolic conversion 
of the tétrazolium salt to the formazan dye erystals was directly proportional to the 
number of viable cells per well (Sylvester, 2011). Although the MTT assay is widely 
considered as a reliable quantitative technique for the determination of cell viability 
and proliferation, it is susceptible to enzymatic interferences. For instance, it is 
observed that some non-mitochondrial (cystosolic) enzymes can catalyze the 
reduction of tétrazolium salt, suggesting that the MTT assay is not an absolute 
measure of cell viability (Sylvester, 2011; Van Meerloo, et al, 2011). Depending on 
cell function and energy requirements, different cells have a different number of 
functional mitochondria (Hayashi et al, 1994). For instance, muscle cells such as 
those of smooth muscle have a high number of mitochondria due to high energy 
requirement. This strongly suggests that the level of MTT reduction in muscle eells 
could be high and therefore, likely to overestimate the number of viable eells per well 
(Zhang and Cox, 1996). Therefore, the relationship between the formation of
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formazan dye crystals and the number of viable cells per well may not show a true 
linear relationship as required (Zhang and Cox, 1996).
7.3.2 Cell viability of Ea.hy 926 ceils treated with egg albumen peptides
Increased oxidative stress underlies poor cell survival due to induced apoptotic and 
necrotic cell death (Hanus et al, 2013). A stable redox potential (poise) of cells is 
maintained by endogenous antioxidant systems coupled with exogenous antioxidants. 
In the present study, the putative antioxidant activity of the 2 kDa egg albumen 
fraction was studied with respect to Ea.h 926 cell viability, in vitro.
The viability of Ea.hy926 cells seeded in 96-well plates and treated with different 
concentrations of the 2 kDa egg albumen fraction was compared with no treatment 
(control). The viability of the Ea.hy926 cells was presented as the absorbance of the 
proliferating cells treated with different concentrations (mg/ml) of 2 kDa egg albumen 
peptides in a 96-well plate based on the MTT colorimetric assay (Fig 7.2). While the 
2 kDa peptides were not cytotoxic to the Ea.hy926 cells, cells treated with 0.05 mg/ml 
of the peptides exhibited the highest viability (98 %) in relation to the control (100 
%). Ea.hy926 cells treated with 2 kDa peptides of higher concentrations (>0.05 
mg/ml) exhibited reduced cell viability. However, the ANOVA analysis showed that 
Ea.hy926 cell viability difference between peptide treatments and the control was not 
significant (p>0.05). This strongly suggests that, the 2 kDa fraction of egg albumen 
peptides at higher concentration were generally not cytotoxic to the Ea.hy926 cells as 
desired. Therefore, the highest concentration of the peptides exhibiting the optimum 
cell viability was suitable for further analyses.
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Figure 7.2 Viability of Ea.hy926 cells treated with different concentrations of egg 
albumen peptides (0.01-0.5 mg/ml). The optimal cell viability was observed at a peptide 
concentration of 0.05 mg/ml. Values (n=3) presented as mean±SD.
The percentage viability of Ea.hy926 cells treated with 0.05 mg/ml of 2 kDa egg 
albumen peptides fraction , 0.01 % ascorbic acid, 0.01 % trolox (6-hydroxy-2,5,7,8- 
tetramethylchromane-2-carboxylic acid) and the control (no treatment) were 
compared (Fig 7.3). Ea.hy926 cells treated with 0.01 % ascorbic acid exhibited the 
highest percentage cell viability compared to the control. The Ea.hy926 cells treated 
with 0.05 mg/ml of 2 kDa peptides exhibited significantly high viability (p<0.01) 
when compared to trolox. The ANOVA analysis showed that the Ea.hy926 cell 
viability difference between treatments and controls was not significant (p>0.05).
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Figure 7.3 Viability of Ea.hy926 cells treated with 0.05 mg/ml of egg albumen peptides 
compared to antioxidants 0.01 % ascorbic acid and 0.01 % trolox (positive controls) and 
the control (no treatment). Values (n=3) presented as mean±SD.
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Trolox and ascorbic acid are extensively known for their excellent antioxidant 
properties as scavengers for ROS and therefore, protect cells from oxidative damage 
(Arrigoni and De Tullio, 2002; Padayatty et al, 2003; Arellano et al, 2011). 
Therefore, comparing the putative antioxidant activity of the 2 kDa fraction of egg 
albumen peptides with that of well-established antioxidants was important. In the 
present study, it is evident that ascorbic acid exhibited the highest antioxidant activity 
(more than 100 % cell viability), followed by the 2 kDa peptides (cell viability 98.45 
%) and lastly trolox (97.74 % cell viability). Another similar previous study isolated 
four oligopeptides from egg albumen hydrolysates. The four oligopeptides exhibited 
excellent free radieal scavenging activity that was significantly higher than that of 
Trolox (Davalos et al, 2004). This strongly suggests that the 2 kDa fraction of egg 
albumen peptides at 0.05 mg/ml concentration has excellent antioxidant activity 
comparable to well known natural antioxidants (0.01 %). Indeed various studies have 
demonstrated the antioxidant activity in peptides derived from egg albumen 
hydrolysates (Davalos et al, 2004; Baratzadeh et al, 2013; Pokora et al, 2013).
7.3.3 Cell viability o f E a.hy 926 trea ted  w ith tert-bu ty l hydroperoxide (tBHP)
Tert-butyl hydroperoxide (tBHP) is an organic hydroperoxide (an oxidizing agent) 
extensively used in cell physiology studies to induce oxidative stress in a variety of 
cell cultures (Prasad et al, 2007). The present study investigated the cytotoxic effect 
of tBHP on Ea.hy929 cells. The Ea.hy926 cells were treated with different 
concentrations of the oxidizing agent in vitro. Figure 7.4 shows the MTT viability 
assay for Ea.hy926 cells treated with different concentration of tBHP versus the 
control (no treatment).
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Figure 7.4 Viability of Ea.hy926 cells exposed to different concentrations of tert-butyl 
hydroperoxide (tBHP). Values (n=3) presented as mean±SD.
It is evident that tBHP is cytotoxic to endothelial cells and the effect increases with 
tBHP concentration. It has been demonstrated that tBHP induces a cytotoxic effect in 
endothelial cells by producing the highly reactive hydroxyl radicals (Prasad et al, 
2007; Chappie et al, 2013). The in vivo Fenton reaction, which involves iron- 
catalyzed decomposition of hydrogen peroxide and superoxide generate the highly 
reactive hydroxide (OH-), hydroxyl radical (OH*) and t-butoxyl radicals (Lemire et 
a/., 2013).
Fe^  ^+ H2O2 Fe^  ^+ OH' + OH" (Fenton reaction)
These reactive radicals induce both apoptotic and necrotic cell death while the 
surviving cells have damaged DNA (Prasad et al, 2007; Chappie et al, 2013). They 
attack and cleave the sulphydryl groups and glutathione of endogenous antioxidant 
enzymes therefore, depleting the antioxidant capacity of the endogenous antioxidant 
system (Prasad et al, 2007; Chappie et al, 2013). Importantly, these reactive radicals 
react with biomolecules, particularly proteins and lipids, at diffusion-controlled rates 
to generate a series of additional free radicals such as the peroxyl radical (R3COO"), 
thiyl radical (RS‘), and a carbon-centred radical (R3C"), which cause oxidative cell 
injury (Lemire et al, 2013). At high concentrations, tBHP generates more reactive 
radicals therefore, increasing its cytotoxic effects to endothelial cells (Fan et al, 2004; 
Prasad et al, 2007; Chappie et al, 2013). Furthermore, the Ea.hy926 cells have
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negligible antioxidant capacity due to low levels of endogenous antioxidants, 
particularly SOD, GPX and catalase (De Moraes Mourao et ah, 2009).
7.3.4 The effect of tBHP on Ea.hy 926 cells pretreated with egg albumen peptides
To study the antioxidant effect of the 2 kDa fraction of egg albumen peptides, the 
Ea.hy926 cells pretreated with egg albumen peptides were exposed to 1 mM of tBHP 
and then incubated for 2.5 hours. The viability of the cells was then assessed using the 
MTT assay. Figure 7.5 shows that the viability of the endothelial cells treated with 
tBHP improved in the presence of egg albumen peptides. The endothelial cells treated 
with 0.05 mg/ml of the peptides alone, 1 mM of tBHP alone and tBHP + peptides, 
exhibited 98.21, 61.45 and 79.41 % viability respectively, in relation to the control. 
The ANOVA test showed that the cell viability difference between treatments and 
controls was significant (p<0.01). This strongly indicates that egg albumen peptides 
conferred a protective effect against oxidation and radicals generated by the tBHP.
Various studies have shown that food protein hydrolysates contain certain peptide 
fractions with antioxidant activity and therefore, protect cells from oxidative damage 
(Davalos et al, 2004; Udenigwe and Aluko, 2011; Chen et al, 2012; Wiriyaphan et 
al, 2012). Some of the antioxidant peptides have radical scavenging activity higher 
than that of trolox (Davalos et al, 2004). The antioxidant and radical scavenging 
activity of protein hydrolysates depend on the amino acid content and specific 
sequence of amino acids of the antioxidant oligopeptides present (Wiriyaphan et al,
2012). For instance. His, Tyr, Met, Lys, Trp, Cys, Phe and Pro amino acid residues 
exhibit antioxidant activity while some have additional free radical quenching 
activities. These amino acids have side chain groups, which serve as hydrogen donors 
(Udenigwe and Aluko, 2011; Wiriyaphan et al, 2012). For instance, the nonapeptide, 
Tyr-Ala-Glu-Glu-Arg-Tyr-Pro-Ile-Leu, containing two Tyr amino acid residues; a 
pentapeptide Tyr-Leu-Gly-Ala-Lys containing Tyr and Lys amino acid residues, were 
isolated from egg albumen hydrolysates. The two oligopeptides were shown to have 
antioxidant activity (Davalos et al, 2004; Chen et al, 2012).
In the present study, Ea.hy926 cells pre-treated with egg albumen peptides 
exhibited improved viability when exposed to reactive radicals generated by the
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tBHP. This strongly suggests that the 2 kDa peptides eontained His, Tyr, Met, Lys, 
Trp, Cys, Phe and Pro amino acid residues in their sequences. The amino acids 
provide hydrogen donors that queneh the oxidizing radical chain reactions therefore, 
reducing the rate of apoptotic and necrotic cell deaths (Udenigwe and Aluko, 2011; 
Wiriyaphan et al, 2012). However, the antioxidant effect of the egg albumen peptides 
may not be sufficient to completely quench the oxidative effects of the reactive 
radieals generated by the tBHP.
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Figure 7.5 Viability of Ea.hy926 cells treated with tert-butyl hydroperoxide (tBHP) in 
the presence or absence of egg albumen peptide, compared with tert-butyl 
hydroperoxide (tBHP)-treated and control (no treatment) cells. Values (n=3) presented 
as meaniSD.
7.3.5 Morphological changes in Ea.hy 926 cells treated with egg albumen peptide 
and tBHP
The morphological and cytological changes of the Ea.hy 926 cells treated with 
tBHP in the presenee of the 2 kDa egg albumen peptides were studied using phase- 
eontrast mieroseopy. Figure 7.6 shows the morphological characteristics of the 
Ea.hy926 cells exposed to tBHP in the presenee and absence of the 2 kDa fraetion of 
egg albumen peptides. The eontrol endothelial (no treatment) cells (Fig 7.6 A) shows 
a good eonfluent monolayer of Ea.hy926 eells on the culture flask surface, with few 
detaehed Ea.hy926 eells. The Ea.hy926 cells, treated with the egg albumen peptides 
alone (Fig 7.6 B), exhibited morphology eomparable to that of the eontrol cells, 
suggesting that the peptides have no effect on the morphology of the endothelial eells. 
The Ea.hy926 cells treated with tBHP in the absence of the 2 kDa egg albumen 
peptides exhibited degraded morphology charaeterized by detaehed eells, suggesting a
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high number of dead eells induced by the oxidative effeet of reaetive free radieals 
generated by the tBHP (Fig 7.6 D). However, Ea.hy926 eells treated with tBHP in the 
presence of the 2 kDa egg albumen peptides exhibited slightly degraded eell 
morphology (Fig 7.6 C), suggesting that the peptides protected the eells from the 
oxidative damage of the cytotoxic tBHP, probably due to the antioxidant and radieal 
scavenging activity.
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Figure 7.6 Phase-contrast microscopy images of Ea.hy926 cells: (A) no treatment 
(control) (B) cells treated with egg albumen peptides alone (C) cells treated with tBHP in 
the presence of egg albumen peptides (D) cells treated with tBHP alone.
7.3.6 Scavenging of reactive oxygen species (ROS) in Ea.hy926 cells treated with 
egg albumen peptides
7.3.6.1 Lucigenin-enhanced chemiluminescent measurement of ROS
It is more difficult to detect ROS in intact cells and tissues than in chemical 
systems (Guzik and Channon, 2005). The lucigenin-enhanced chemilumineseenee is a
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relatively sensitive technique for the detection of ROS in endothelial eells (Guzik and 
Channon, 2005). Lueigenin-enhanced ehemilumineseence is based on the principle 
that, when chemiluminescent probes (lucigenin) are exposed to superoxide (O2 
they ejeet light particles (photons) that are detectable by a luminometer. The O2 
reacts with the lucigenin-amplified chemilumineseenee probes and reduces the 
lucigenin cation (LC^ )^ to its cation radical (LC^). The LC^ radical subsequently 
reacts with another O2 to form the energy-rich dioxetane molecule (LCO2), which 
emits the excess energy as photons (Dikalov et ah, 2007).
While the mitochondrial ROS (mROS) is important in eell signalling pathways 
that regulate normal physiological processes, excess mROS can result in oxidative 
stress (Dikalov and Nazarewicz, 2013). Angiotensin II (Ang II) hormone is known to 
stimulate intracellular generation of mROS particularly O2 and H2O2 in endothelial 
cells by activating multi-components of the membrane-bound NAD(P)H oxidases in 
the mitochondria thereby, increasing mROS generation (Sachse and Wolf, 2007; 
Thakur et al, 2010; Dikalov and Nazarewicz, 2013). Consequently, Ang II is largely 
implicated in endothelial dysfunction and remodelling of cardiovascular and renal 
eells, inflammation (Dikalov and Nazarewicz, 2013). This strongly suggests that 
antioxidant-mediated inhibition of the Ang II activity should protect cells against 
oxidative stress from mROS (Dikalov and Nazarewicz, 2013). In the present study, 
the ROS scavenging capacity of Ea.hy926 cells in the presence of egg albumen 
peptides with or without Ang II was compared with that of eells treated with Ang II 
alone and the control (no treatment) using lucigenin-enhanced chemiluminescence 
technique. Figure 7.7 shows ROS scavenging capacity of Ea.hy926 cells in the 
presenee of 2 kDa fraction of egg albumen peptides in the presence and absence of the 
Ang II.
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Figure 7.7 Reactive oxygen species (ROS) production detection in Ea.hy926 cells treated 
with 2 kDa fraction of the egg albumen peptides in the presence or absence of 
angiotensin 11 (Ang II), compared to the control using the lucigenin-chemiluminescence 
method. Values (n=3) presented as means +SD.
The Ea.hy926 cells treated with Ang II alone exhibited oxidative stress 
characterised by high ehemilumineseence units, suggesting high production of the 
mROS. This strongly supports the view that the Ang II hormone stimulates 
overproduction of mROS, which causes endothelial dysfunction (Sachse and Wolf, 
2007; Thakur et ah, 2010; Dikalov and Nazarewicz, 2013). The Ea.hy926 cells treated 
with Ang II in the presenee of 2 kDa fraction of egg albumen peptides exhibited 
significantly reduced mROS (p<0.01) compared to eells treated with Ang II alone, 
suggesting that the peptides scavenged excess mROS (Udenigwe and Aluko, 2011; 
Wiriyaphan et al, 2012;). Cells treated with the egg albumen peptides alone 
exhibited significantly enhanced mROS scavenging activity as compared to the 
eontrol (p<0.05).
Data from the present study strongly suggest that the egg albumen peptides have 
considerable mROS scavenging activity. This can be attributed to the presenee of 
oligopeptides with amino acid sequences containing one or more of His, Tyr, Met, 
Lys, Trp, Cys, Phe and Pro amino acid residues known for their antioxidant and ROS 
scavenging aetivity (Udenigwe and Aluko, 2011; Wiriyaphan et al, 2012).
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12.6.2 ROS m easurem ent by a fluorescence m ethod with dihydroethidium  
(DHE)
In vitro ROS production in cells can also be detected by a fluorescent technique 
using the non-fluorescent DHE substrates such as dihydroethidium (DHE) and 2,7- 
dichlorofluoreseein (H2DCF). For instance, detection of O2 production is based on 
the oxidation of the non-fluoreseent DHE substrate to form a red fluorescent product 
(ethidium), which is measured as fluorescence intensity (Owusu-Ansah et al, 2008). 
In the present study, the ROS scavenging capacity of Ea.hy926 cells in the presenee 
of egg albumen peptides with or without Ang II was compared with that of eells 
treated with Ang 11 alone and the eontrol using DHE fluoreseenee technique.
As demonstrated using lucigenin-enhanced chemiluminescent method, Ea.hy926 
eells treated with the 2 kDa fraction of egg albumen peptides exhibited slight but not a 
significant drop in mROS production when compared with the eontrol (p>0.05). 
Similarly, Ea.hy926 eells treated with Ang II alone exhibited the highest mROS 
production. This confirms that Ang II activates mROS production in endothelial cells 
and therefore, is an important underling factor in the pathophysiology of endothelial 
dysfunction (Sachse and Wolf, 2007; Thakur et al, 2010). Cells treated with the egg 
albumen peptides and Ang II hormone exhibited a significant drop in mROS 
production, confirming that the peptides confer mROS scavenging activity (p<0.05).
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Figure 7.8 Reactive oxygen species (ROS) production detection in Ea.hy926 cells treated 
with 2 kDa fraction of the egg albumen peptides in the presence or absence of Ang II, 
compared to the control using the 2-hydroxyethidium (DHE) fluorescence technique. 
Values (n=3) presented as means ±SD.
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A previous study suggested that the lucigenin-enhanced ehemilumineseent 
technique is more sensitive than the DHE fluorescence technique for in vitro detection 
of mROS (Susanto et al, 2006). However, in the present study, it appears that the two 
techniques have comparable sensitivity in the detection and estimation of production 
of mROS in endothelial cells.
7.3.7 Effect of the 2 kDa fraction of the egg albumen peptides on nitric oxide 
production
Nitric oxide formation in eells also contributes to cellular oxidative stress and is 
also a powerful vasodilator (Luiking and Deutz, 2007). In the present study, the 
putative antioxidation effect of the 2 kDa fraction of the egg albumen peptides on the 
NO production in the Ea.hy926 cells was investigated using the Griess reagent kit. 
The Griess reagent kit allows the colorimetric determination of reduced products of 
NO particularly, nitrites, and nitrates.
Figure 7.9 shows NO production in Ea.hy926 eells treated with different 
concentrations of egg albumen peptides compared to the control cells. It is evident 
that the 2 kDa fraction of egg albumen peptides inhibited NO production in Ea.hy926 
cells, in a dose-dependent manner only up to a concentration of 0.05 mg/ml. The 
absorbance of the supernatants from Ea.hy926 eells treated with the 0.01, 0.02 and 
0.05 mg/ml of egg albumen peptides exhibited a significant reduction in NO 
production (p<0.05). The egg albumen peptides contain antioxidant amino acid 
residues such as His, Tyr, Met, Lys, Trp, Cys, Phe and Pro (Udenigwe and Aluko, 
2011; Wiriyaphan et al, 2012). Lys for instance, has been demonstrated to inhibit 
cellular NO production by blocking the preferential cationic amino acid transporters 
(CATs) particularly L-arginine (Closs and Graf, 2002; Luiking and Deutz, 2007; Cui 
et al, 2011). L-lysine blocks the uptake of the L-arg therefore, resulting in decreased 
intracellular production of NO (Luiking and Deutz, 2007; Cui et al, 2011).
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Figure 7.9 Nitric oxide (NO) production in Ea.hy926 cells in the presence of different 
concentrations of egg albumen peptides. Absorbance values (n=3) at 540 nm are 
presented as mean ± SD.
7.4 CONCLUSION
In the present study, it is evident that the 2 kDa fraction of egg albumen peptides 
has both antioxidant and ROS scavenging activity. Using the MTT colorimetric assay, 
this study shows that the bioaetive peptides enhance eell viability by protecting cells 
from necrotic and apoptotic deaths induced by strong oxidizing agents such as tBHP. 
Surprisingly, the antioxidant activity of the egg albumen peptides surpassed that of 
trolox to exhibit excellent antioxidant aetivity close to that of ascorbic acid. The 
eonfluent monolayer of Ea.hy926 cells exposed to tBHP in the presenee of egg 
albumen peptides exhibited eomparable morphology to the eontrol eells suggesting 
that the peptides protected the eells from necrotic and apoptotic death induced by the 
highly reaetive radicals from the tBHP. Ang II is known to activate increased 
mitochondrial production of mROS, and therefore, widely associated with endothelial 
dysfunction. Our data show that lueigenin-enhanced chemiluminescence and the DHE 
fluoreseenee techniques have eomparable sensitivity for in vitro detection of mROS. 
The egg albumen peptide inhibited Ang II mediated mROS production in Ea.hy926 
eells. The antioxidant activity of the egg albumen peptides can be attributed to the 
amino acids with antioxidant amino acid residues such as His, Tyr, Met, Lys, Trp, 
Cys, Phe and Pro. Importantly, NO is an important vasodilator in endothelial eells. 
The egg albumen peptides significantly reduced NO production in Ea.hy926 eells in a 
dose-dependent manner. It is possible that L-lysine in the egg albumen peptides
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blocked the uptake of the L-arginine required for intracellular synthesis of NO. The 
overall findings from the present study strongly indicates that the 2 kDa fraction of 
the egg albumen peptide possesses both antioxidant and ROS scavenging activity, that 
confers protection of cells from oxidative damage.
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CHAPTER 8
8. GENERAL DISCUSSION AND CONCLUSIONS
8.1 GENERAL DISCUSSION
8.1.1 Egg albumen protein and bioactive peptides
Egg white (albumen) is a complex mixture of nutrients such as proteins, vitamins, 
antioxidants, minerals, lipids and fats. Egg albumen comprises more than 24 different 
types of proteins. Major egg albumen proteins include ovalbumin (54 %), 
ovotransferrin (12 %), ovomucoid (11 %), ovomucin (3.5 %), lysozyme (3.4 %), G2 
globulin (4.0 %), G3 globulin (4.0 %), while the minor proteins are ovoinhibitor (1.5 
%), ovoglycoprotein (1.0 %), ovoflavoprotein (0.8 %), ovomacroglobulin (0.5 %), 
cystatin (0.05 %) and avidin (0.05 %). Egg albumen protein hydrolysates contain 
bioactive peptides, which exhibit significant antioxidant and antihypertensive 
activities, for instance, ovalbumin and ovotransferrin (Wiriyaphan et al, 2012). The 
observed antioxidant activities are largely attributed to the presence of bioactive 
peptides containing hydrophobic amino residues particularly His, Tyr, Met, Trp, Cys, 
Phe and Pro, and the positively charged Lys and Arg residues. The putative 
antioxidant activities of these amino residues is due to their side-chain groups which 
serve as hydrogen atom donors that quench the oxidative potential of radical and non­
radical RGS (Udenigwe and Aluko, 2011; Wiriyaphan et al, 2012). Therefore, the 
principle aim of the present study was to fractionate the putative bioactive peptides 
Ifom egg albumen hydrolysate and study their in vitro antioxidant and ACE-inhibitory 
activities.
8.1.2 Isolation and characterization of antioxidant peptides from egg albumen 
protein hydrolysate
The crude egg albumen protein hydrolysate was prepared by stepwise hydrolytic 
action of pancreatin and pepsin. Pepsin was suitable since it preferentially cleaves 
hydrophobic aromatic amino acid residues particularly Phe, Tyr, Trp and Leu 
(Kageyama et al, 2009). The in vitro antioxidant activity of the crude egg albumen 
protein hydrolysate was tested based on their putative ability to prevent lipid
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peroxidation in a linoleic acid model system using the ferric thiocyanate (FTC) and 
thiobarbituric acid (TEA) assays. The crude EAH (1 mg/ml) exhibited significant 
antioxidant activity as it inhibited linoleic acid peroxidation by 40 % as compared to 
the control (no antioxidants) but less than 0.01 BHT (95 %) and 0.01 % trolox (82 %).
Fractionation and purification of the putative antioxidant peptides present in the 
egg albumen protein hydrolysate yielded 2 kDa (57 %), 5 kDa (27 %), and 10 kDa 
(15 %) kDa molecular weight cut off (MWCO) peptide fi*actions. The hydrolytic 
activity of pepsin enzyme resulted in a high proportion of low molecular weight 
oligopeptides. The high recovery yield of the 2 kDa peptide fraction may be attributed 
to the exhaustive cleavage of peptide bonds involving the hydrophobic amino residues 
for example Phe-Val, Gln-His, Glu-Ala, Ala-Leu, Leu-Tyr, Tyr-Leu, Gly-Phe, Phe- 
Phe and Phe-Tyr were reported after pepsin digestion of egg albumen by Kageyama et 
al (2009).
The 2 kDa peptides exhibited the highest lipid peroxidation inhibition activity in 
the linoleic acid system based on both FTC and TEA assays. The 2,5, 10 kDa peptide 
fractions (1 mg/ml), (0.01 %) EHT and (0.01 %) trolox exhibited percentage linoleic 
acid inhibition of 76, 63, 53, 95 and 82 %, respectively, based on the FTC assay. 
Similarly, the peptides and positive controls inhibited lipid peroxidation by 39, 27, 17, 
78 and 70 %, respectively based on the TEA assay. It appears that the lipid 
peroxidation inhibition activity detected by the TEA assay was slightly lower than 
that detected by the FTC assay. This is because, while the FTC assay measures the 
concentration of the primary peroxidation products (hydroperoxides), the TEA assay 
measures the concentration of MDA, which is a secondary peroxidation product. 
Therefore, any chemical kinetic factors not favouring MDA formation from the 
primary hydroperoxides might have resulted in lower concentrations of MDA (Pawar 
et al, 2013). In general, however, it is evident that the antioxidant activity of the 
peptides was inversely related to the molecular weight, where the 2 kDa and 10 kDa 
peptides fractions exhibited the highest and lowest antioxidant activity, respectively 
(Davalos et al, ;2004Li and Li, 2013).
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Further purification of the 2 kDa peptide fraction by FPLC gel filtration on the 
Sephadex G-25 column yielded 13 sub-fractions. Based on the FTC assay, the GF26 
sub-fraction exhibited the highest lipid peroxidation activity (80 %) compared to the 
rest of the GF fractions. The antioxidant activity of GF26 sub-fraction (1 mg/ml) was 
slightly lower than those exhibited by 0.01 % BHT (95 %) and 0.01 % trolox (82 %). 
The GF26 amino acid profile comprised mainly Glu (14.9 %), Asp (8.5 %), Val (8.3 
%), Leu (7.7 %), Phe (7.2 %), Lys (6.5 %), lieu (6.2 %), Arg (5.8 %), Ala (5.6 %), 
and Met (5.3 %). The hydrophobic amino residues such as Phe, Val, Leu and Met, 
may have enhanced the antioxidant activity of the GF26 peptides, due to their radical 
scavenging activity.
8.1.3 A ntioxidant m echanism s of egg album en hydrolysate (EAH)
The putative antioxidant mechanisms for EAH were investigated based on their 
putative ability to scavenge for the DPPH*, OH* and O2’* radicals coupled with their 
ferric (Fe^ )^ reducing/antioxidant power and ferrous (Fe^ )^ ion chelation activities.
The ferric iron reducing power of the EAH was dose-dependent (Pokora et al,
2013). This can be attributed to the increased availability of antioxidant oligopeptides 
and free amino acid residues in higher EAH concentrations. The putative antioxidant 
peptides have amino acid residues, which act as electron donors to the ferric iron 
thereby, reducing it to the more stable ferrous form. However, the reducing power of 
1 mg/ml EAH was significantly lower (p<0.05) than that exhibited by the three 
synthetic antioxidants (0.01 % BHT, 0.01 % trolox and 0.01 % ascorbic acid). This 
suggests that while the EAH exhibited some antioxidant activity, its reducing power 
towards divalent and multivalent metal ions was relatively weak perhaps due low 
bioavailability of the antioxidant peptides and free amino residues present in the 
EAH.
Mineral metal elements such as Fe, Cu, Zn, Cr, Mn, and Co are important catalytic 
components of many enzymes (Kleczkowski and Gamcarz, 2012). However, these 
metals exhibit redox cycling reactions when present in excess and can catalyse the 
formation of highly reactive OH*, O2*' and NO* (Leopoldini et al, 2006; Amie et al.
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2007). The pro-oxidant activity of these metal elements can be moderated by metal 
chelators. The antioxidant peptides in the EAH can act as ligands, which can chelate 
pro-oxidant metal ions, and therefore block their pro-oxidant actions (Amic et al, 
2007). In the present study, the EAH exhibited ferrous (Fe "^  ^ ion chelation capacity, 
which increased with increased concentration of the EAH; thus the percentage 
chelation capacity increased from 4.5 % for 0.5 mg/ml to 43.2 % for 20 mg/ml. 
Surprisingly, 10 mg/ml EAH exhibited Fe^  ^ chelation (30.8 %), which was 
comparable to those of well-established synthetic antioxidants 0.01 % trolox (34.9 
%), 0.01 % BHT (29.9 %) and 0.01 % ascorbic acid (24.9 %). The presence of the 
hydrophobic amino residues such as Pro and Gly as well as the positively charged His 
residue have been associated with enhanced metal-chelation activity (Chen et al, 
1998; Rajapakse e /«/., 2005).
The radical scavenging activity of EAH was investigated based on the radical 
scavenging assays for DPPH*, OH*, and O2*' radicals. The EAH scavenged all the 
three radicals in a dose-dependent manner as observed by Sun et al (2013). 10 mg/ml 
of EAH exhibited radical scavenging activities that were significantly higher (p<0.05) 
to that of 0.01 % BHT, 0.01 % trolox and 0.01 % ascorbic acid. Inhibitory 
concentrations (IC50) of the EAH that scavenged 50 % of the initial concentration of 
DPPH* and O2 ' radicals were 23.46 mg/ml and 11.96 mg/ml respectively. The EAH 
contained hydrophobic peptides and free amino residues, which donated protons to 
stabilize the free radicals (Rajapakse et al, 2005; Li et al, 2008).
8.1.4 Angiotensin-I converting enzyme (ACE)-inhibitory peptides derived from 
egg albumen hydrolysate (EAH)
Hypertension causes more than 7.6 million CVD-related deaths each year. ACE 
enzyme plays a key role in the activation of hypertension. Therefore, the 
pharmacological action of common anti-hypertensive drugs involves inhibition of the 
ACE, which converts Ang-1 to Ang-11 (Wijesekara and Kim 2010). Due to intolerable 
side effects of some synthetic ACE inhibitors, there is increasing interest in ACE- 
inhibitory peptides derived from food protein hydrolysates. In the present study, the
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ACE-inhibitory activity of the EAH and its peptide fractions, were investigated based 
on the ACE catalyzed liberation of hippuric acid from the Hip-His-Leu substrate. The 
ACE-inhibitory activity of the hydrolysate was 59.0 ± 0.3 % with a corresponding 
IC50 value of 8.79 ± 0.56 mg/ml.
When the EAH was fractioned and purified by ultrafiltration, 2, 5 and 10 kDa 
peptide fractions were obtained with recovery yields of 57, 28 and 15 %, respectively. 
The peptide factions (10 mg/ml) exhibited ACE-inhibitory activities of 78 %, 71 % 
and 62 %, respectively and could potentially be added to a food product to achieve 
similar results to captopril, a synthetic antihypertensive drug that exhibited ACE- 
inhibitory activity of 96 %. Further fractionation of the 2 kDa peptides by FPLC gel 
filtration on Sephadex G-25 column yielded 13 different peaks GF fractions: 12, 17, 
23, 26, 29, 33, 35, 39, 41, 44, 47, 57 and 59. Of these fractions, GF29 exhibited the 
highest ACE-inhibitory activity 84.49 % with a corresponding I C 5 0  value of 5.76 
mg/ml. Further purification of the GF29 by RP-HPLC did not significantly improve 
the ACE-inhibitory activity. However, the I C 5 0  value reduced with purification: EAH 
(8.79 mg/ml), ultrafiltration (2 KDa) (6.01 mg/ml), gel filtration (GF29) (5.76 
mg/ml), and HPLC (17) (5.13 mg/ml). Complete hydrolysis of the HPLC fraction 17 
yielded higher proportions of hydrophobic amino acids such as Gly (7.65 %), Ala 
(6.97 %), Pro (6.08 %) and Val (8.20 %), as well as the positively charged Lys 
residue (19.34 %) and negatively charged Asp (10.45 %) and Glu (13.23 %) residues.
The observed ACE-inhibitory activity can be attributed to the presence of peptides 
with a high proportion of hydrophobic amino residues. Pepsin preferentially cleaves 
peptide bonds involving hydrophobic amino residues (Kageyama et al, 2009). A high 
proportion of peptides with hydrophobic amino acid residues in the C-terminus 
enhance hydrophobicity of the whole peptide, which improves bioavailability of the 
peptides to its molecular targets (Kageyama et al, 2009). In addition, the presence of 
a high proportion of the positively changed Lys amino acid residue increases the 
electric charge at the C-termini, therefore enhancing binding affinity of the peptides to 
the ACE (Pripp et al, 2005).
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Possible ACE-inhibitory mechanisms for the 2 kDa peptides were also evaluated 
based on the ACE-inhibitory rate using the Lineweaver-Burk plot. Based on KmA^ max 
the graphs of the negative control (HHL substrate alone), and the peptide (4 and 10 
mg/ml) solutions intersected almost at the same point along the 1/v-axis. This strongly 
indicates that the ACE-inhibitory peptides were competitive inhibitors (Mallikarjun- 
Gouda et al, 2006; Yu et al, 2006). Therefore, just like anti-hypertensive drugs such 
as captopril, enalapril, and lisinopril, it appears that the ACE-inhibitory peptides 
competitively bind to the active sites of the ACE thereby reducing the rate of ACE- 
catalyzed liberation of hippuric acid from the HHL residue (Tsai et al, 2006). The 
high proportion of hydrophobic amino acid residues in the peptides enhanced their 
binding to the ACE target. Furthermore, the presence of the positively charged Lys 
amino residue in the C-termini enhanced the binding affinity of the peptides (Pripp et 
al, 2005).
8.1.5 Antioxidant activity of the 2 kDa egg albumen peptides in caco-2 cells and 
transepithelial transport across caco-2 monolayer model
Both radical and non-radical ROS particularly OH", O2 ', NO", ROG", R0‘, H2O2 
and ^ 0 2  are generated in biological systems during normal metabolic processes 
(Kohen and Nyska, 2002). Accumulation of cellular ROS underlies oxidative damage 
of both structural and fimctional biomolecules therefore, reducing cell viability (Lee 
et al, 2007; Rahman, 2007). The in vitro antioxidant activity of the 2 kDa peptide 
fraction was investigated based on the MTT colorimetric assay of cells viability and 
morphological changes of caco-2 cells treated with synthetic oxidizing agent tert- 
butyl hydroperoxide (tBHP) in the presence or absence of the peptides.
The 2 kDa peptide fraction (0.1 mg/ml) significantly supported cell viability (99.45 
%) when compared to the positive controls: 0.01 % ascorbic acid (95.31 %) and 
trolox (92.74 %) (p<0.05). Cells treated with 3 mM of the cytotoxic tBHP exhibited 
reduced viability (63.32 %), which improved in the presence of the (0.01 mg/ml) 
peptides (84.91 %). 0.1 mg/ml 2 kDa peptide also inhibited lipid peroxidation 
(TBARS) in cells treated with 3mM tBHP. The enhanced cell viability and lipid 
peroxidation inhibition of the 2 kDa peptides can be attributed to their ability to
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scavenge reactive hydroxyl and r-bntoxyl radicals generated from tBHP through the 
Fenton’s reaction (Prasad et al, 2007; Chappie et al, 2013).
The energy-dependent apoptosis (cell death) involves activation of cellular 
caspases, which determines the fate of cells. Cells treated with 3 mM tBHP in the 
presence of the 2 kDa peptides exhibited significantly reduced caspase 3/7 activities 
(p<0.05), suggesting a reduced rate of apoptosis. The peptides also protected the 
morphological integrity of the confluent monolayer of caco-2 cells treated with 3 mM 
tBHP. This can be attributed to the radical scavenging activity of the peptides owing 
to their proton donating potential towards radical ROS.
Transepithelial transport of the peptides was also investigated using the 100 % 
confluent monolayers of caco-2 cells. The permeation of the 2 kDa peptides across 
the caco-2 monolayers did not alter the physiological integrity of the caco-2 
monolayers. This strongly indicates that a significant proportion of the peptides were 
resistant to cellular aminopeptidases present in caco-2 cell epithelium and were 
therefore, absorbed in their intact forms across the caco-2 cell epithelium.
8.1.6 Effect of 2 kDa egg albumen peptides on the activity of endogenous 
antioxidant enzymes
The endogenous antioxidant enzyme system includes superoxide dismutase 
(SOD), glutathione peroxidase (GPx) and catalase (CAT) enzymes. These enzymes 
collectively play a crucial role in maintaining the cellular oxidative poise. Therefore, 
activities of these enzymes in caco-2 cell cultures treated with the antioxidant 2 kDa 
peptides were probed using the appropriate enzyme activity assay kits.
Caco-2 cells treated with the peptides showed significant antioxidant activities of 
most of these enzymes, in a dose-dependent manner. Cells treated 3mM tBHP in the 
presence of the peptides exhibited significantly reduced enzyme activity when 
compared to tBHP-treated cells without peptides. This strongly suggests that the 2 
kDa peptides neutralized or scavenged most of the cellular ROS, therefore reducing 
the activity of these enzymes. However, these results are inconsistent with data from
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Yu and Kim (2009), which indicated that the antioxidant /-taurine amino acid 
increased enzyme activities of SOD, GPx and CAT in a dose-dependent manner. The 
role of different amino acids and peptides warrants more studies to elucidate their 
action.
8.1.7 Effect o f 2 kD a egg album en peptides on cellu lar RO S production in 
endothelial cells (Ea.hy926 Cells)
The in vitro effect of the 2 kDa peptides on cellular ROS generation was 
investigated using Ea.hy926, a HUVECs cell line. Cellular ROS concentration was 
determined based on the lucigenin-enhanced chemiluminescent method coupled with 
a fluorescence method with dihydroethidium (DHE). The viability of the Ea.hy926 
cells was based on the MTT colorimetric assay coupled with morphological changes 
by phase contrast microscopy.
The 2 kDa peptides enhanced the viability of the Ea.hy 926 cells in a dose- 
dependent manner, where the highest cell viability (98 %) was achieved with peptide 
concentration of 0.05 mg/ml. The peptides contained amino residues such as His, Tyr, 
Met, Trp, Cys, Phe and Pro amino acid residues in their C-termini coupled with some 
N-terminal Lys enhanced their antioxidant activities. Some of these amino acids can 
donate hydrogen therefore quenching the reactive radicals; this reduced the rate of 
ROS-induced apoptotic and necrotic cell deaths (Wiriyaphan et ah, 2012). The 2 kDa 
peptides also protected the morphological integrity of Ea.hy 926 confluent monolayer 
cells treated with the cytotoxic t-BHP, due to its radical scavenging activity.
Nitric oxide formation in cells enhances a vasodilative effect, suggesting that NO 
generation in vascular cells underlies the pathophysiology of hypertension (Luiking 
and Deutz, 2007). The putative antioxidant effect of the 2 kDa peptides on cellular 
NO production was investigated based on the Griess reagent kit in the Ea.hy926 cells. 
The 2 kDa peptides inhibited NO production in Ea.hy926 cells, in a dose-dependent 
manner up to a concentration of 0.05 mg/ml. This can be attributed to the Lys residue, 
which has been previously demonstrated to inhibit cellular NO production by 
blocking the preferential cationic amino acid transporters (CATs), particularly the L-
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arginine (Closs and Graf, 2002; Luiking and Deutz, 2007; Cui et ah, 2011). 
Therefore, high bioavailability of Lys sufficiently inhibits cellular uptake of the L- 
Arg therefore, reducing intracellular production of NO (Luiking and Deutz, 2007; Cui 
et al, 2011). This could also explain the antihypertensive effect of the 2 kDa 
peptides.
8.2 GENERAL CONCLUSIONS
• The stepwise hydrolysis of egg albumen by pepsin and pancreatin enzymes 
yielded egg albumen hydrolysate (EAH) comprising a significant proportion of 
hydrophobic peptides with putative antioxidant and ACE-inhibitory activity. 
This study indicated that pepsin preferentially cleaved peptide bonds involving 
hydrophobic amino residues therefore yielding > 50 % of the 2 kDa peptides.
• The crude EAH exhibited significant antioxidant activity, which increased on 
further fi-actionation and purification. These results indicated that purification 
enhanced the bioavailability and activity of the antioxidant peptides.
EAH (0.5-20 mg/ml) exhibited ferric iron reducing power, lipid peroxidation 
inhibition activity, metal-chelation, and radical scavenging in a dose-dependent 
manner. The antioxidant activities exhibited by 2 kDa peptides were comparable 
to those exhibited by 0.01 % trolox and 0.01 % BHT.
It is evident that the presence of the hydrophobic amino acids such as Asp, Glu, 
Gly, Ala, Pro and Val, in the C-terminus of the peptides increased their 
hydrophobicity and accessibility to their molecular targets thereby acting as 
effective antioxidants.
Some of the hydrophobic amino residues acted as proton/electron donors while 
others acted as ligands, therefore exhibiting a variety of antioxidant activities.
Based on MTT colorimetric assay of caco-2 cell viability, the 2 kDa peptides 
showed 99.5 % viability and protected caco-2 cells from the cytotoxic effects
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induced by 3mM tBHP. The peptides significantly reduced caspase 3/7 activities 
of the cells, indicating reduced apoptotic and necrotic death rates of the caco-2 
cells.
The 2 kDa egg albumen peptides were excellent scavengers of ROS and 
therefore, reduced the cellular enzyme activity of SOD and CAT in a dose- 
dependent manner.
The 2 kDa peptides fraction also exhibited competitive ACE-inhibitory activity 
(as shown by a Lineweaver-Burk plot), suggesting that it may be potentially 
useful for nutraceutical antihypertensive application.
The high proportion of Lys residues in the 2 kDa peptide fraction enhanced the 
inhibition of cellular NO production probably by blocking the preferential 
cationic amino acid transporters (CATs), particularly the L-arginine transporter, 
therefore reducing intracellular production of NO.
During transepithelial transport of 2 kDa peptides in caco-2 cells, the majority of 
the peptides (produced by gastro-intestinal enzymes) were resistant to cellular 
aminopeptidases and are therefore, likely to be absorbed in their intact forms 
across epithelial cells in the gastrointestinal tract.
8.3 FUTURE WORK
Findings from the present study have highlighted possible areas warranting further 
studies:
• Given its ACE inhibition activity and mechanism, future work will investigate 
the antihypertensive effect of the egg albumen peptides using an in vivo model 
system, particularly spontaneously hypertensive rats (SHR).
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Based on the antioxidant activity exhibited in vitro in the present study, future 
work will investigate the in vivo antioxidant effect of the 2 kDa peptides 
fraction on cancer remission or progression in mice with induced colon cancer
To investigate the antioxidant activity of egg albumen peptides in vitro on 
liver and breast cancer cells.
To investigate the antihypercholesterolemic egg albumen peptides that confer 
cholesterol-lowering effects.
To investigate the immunomodulatory activity of egg albumen peptides.
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